( (TITLE (S (S (NP-SBJ (NN RanBP2)) (VP (VBZ Modulates) (NP (NML (NML (NN Cox11)) (CC and) (NML (NN Hexokinase) (CD I))) (NNS Activities)))) (CC and) (S (NP-SBJ (NP (NN Haploinsufficiency)) (PP (IN of) (NP (NN RanBP2)))) (VP (VBZ Causes) (NP (NP (NNS Deficits)) (PP (IN in) (NP (NN Glucose) (NN Metabolism)))))))) )
( (HEADING (NP (NN Abstract))) )
( (S (NP-SBJ (NP (DT The) (ADJP (NN Ran) (HYPH -) (VBG binding)) (NN protein) (CD 2)) (-LRB- -LRB-) (NP (NN RanBP2))) (-RRB- -RRB-) (VP (VBZ is) (NP-PRD (DT a) (JJ large) (ADJP (JJ multimodular) (CC and) (JJ pleiotropic)) (NN protein))) (. .)) )
( (S (NP-SBJ-1 (NP (JJ Several) (JJ molecular) (NNS partners)) (PP (IN with) (NP (NP (JJ distinct) (NNS functions)) (VP (VBG interacting) (ADVP (RB specifically)) (PP (IN with) (NP (NP (JJ selective) (NNS modules)) (PP (IN of) (NP (NN RanBP2))))))))) (VP (VBP have) (VP (VBN been) (VP (VBN identified) (NP-1 (-NONE- *))))) (. .)) )
( (S (ADVP (RB Yet)) (, ,) (NP-SBJ-1 (NP (NP (DT the) (NN significance)) (PP (IN of) (NP (NP (DT these) (NNS interactions)) (PP (IN with) (NP (NN RanBP2)))))) (CC and) (NP (NP (DT the) (ADJP (JJ genetic) (CC and) (JJ physiological)) (NN role) (-LRB- -LRB-) (AFX s) (-RRB- -RRB-)) (PP (IN of) (NP (NN RanBP2))) (PP-LOC (IN in) (NP (DT a) (NML (JJ whole) (HYPH -) (NN animal)) (NN model))))) (VP (VBP remain) (ADJP-PRD (JJ elusive))) (. .)) )
( (S (ADVP (RB Here)) (, ,) (NP-SBJ (PRP we)) (VP (VBP report) (NP (NP (DT the) (NN identification)) (PP (IN of) (NP (NP (NP (CD two) (JJ novel) (NNS partners)) (PP (IN of) (NP (NN RanBP2)))) (CC and) (NP (NP (DT a) (JJ novel) (JJ physiological) (NN role)) (PP (IN of) (NP (NN RanBP2))) (PP-LOC (IN in) (NP (DT a) (NN mouse) (NN model)))))))) (. .)) )
( (S (NP-SBJ (NN RanBP2)) (VP (VP (VBZ associates) (ADVP-MNR (ADVP (FW in) (FW vitro)) (CC and) (ADVP (FW in) (FW vivo)))) (CC and) (VP (VBZ colocalizes) (PP (IN with) (NP (NP (NP (DT the) (JJ mitochondrial) (NN metallochaperone)) (, ,) (NP (NN Cox11))) (, ,) (CC and) (NP (NP (NP (DT the) (NN pacemaker)) (PP (IN of) (NP (NN glycolysis)))) (, ,) (NP (NP (NN hexokinase) (NN type) (CD I)) (-LRB- -LRB-) (NP (NN HKI)))))) (-RRB- -RRB-) (PP-MNR (IN via) (NP (PRP$ its) (ADJP (NN leucine) (HYPH -) (JJ rich)) (NN domain))))) (. .)) )
( (S (NP-SBJ (NP (DT The) (ADJP (NN leucine) (HYPH -) (JJ rich)) (NN domain)) (PP (IN of) (NP (NN RanBP2)))) (ADVP (RB also)) (VP (VBZ exhibits) (NP (NP (JJ strong) (NN chaperone) (NN activity)) (PP (IN toward) (NP (NP (ADJP (JJ intermediate) (CC and) (JJ mature)) (NN folding) (NNS species)) (PP (IN of) (NP (NN Cox11)))))) (S-ADV (NP-SBJ (-NONE- *PRO*)) (VP (VBG supporting) (NP (NP (DT a) (NN chaperone) (NN role)) (PP (IN of) (NP (NN RanBP2))) (PP (IN in) (NP (DT the) (NN cytosol))) (PP-TMP (IN during) (NP (NN Cox11) (NN biogenesis))))))) (. .)) )
( (S (NP-SBJ (NN Cox11)) (ADVP (RB partially)) (VP (VBZ colocalizes) (PP (IN with) (NP (NN HKI))) (, ,) (S-ADV (ADVP (RB thus)) (NP-SBJ (-NONE- *PRO*)) (VP (VBG supporting) (NP (NP (ADJP (JJ additional) (CC and) (JJ distinct)) (NNS roles)) (PP (IN in) (NP (NN cell) (NN function))))))) (. .)) )
( (S (S (NP-SBJ (NN Cox11)) (VP (VBZ is) (NP-PRD (NP (DT a) (JJ strong) (NN inhibitor)) (PP (IN of) (NP (NN HKI)))))) (, ,) (CC and) (S (NP-SBJ (NN RanBP2)) (VP (VBZ suppresses) (NP (NP (DT the) (JJ inhibitory) (NN activity)) (PP (IN of) (NP (NN Cox11))) (PP (IN over) (NP (NN HKI)))))) (. .)) )
( (S (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO To) (VP (VB probe) (NP (NP (NP (DT the) (JJ physiological) (NN role)) (PP (IN of) (NP (NN RanBP2)))) (CC and) (NP (NP (PRP$ its) (NN role)) (PP (IN in) (NP (NN HKI) (NN function)))))))) (, ,) (NP-SBJ-1 (NP (DT a) (NN mouse) (NN model)) (VP (VBG harboring) (NP (DT a) (ADJP (RB genetically) (VBN disrupted)) (NN RanBP2) (NN locus)))) (VP (VBD was) (VP (VBN generated) (NP-1 (-NONE- *)))) (. .)) )
( (S (S (NP-SBJ (NN RanBP2) (SYM −) (HYPH /) (SYM −)) (VP (VBP are) (ADJP-PRD (RB embryonically) (JJ lethal)))) (, ,) (CC and) (S (NP-SBJ (NP (NN haploinsufficiency)) (PP (IN of) (NP (NN RanBP2))) (PP (IN in) (NP (DT an) (JJ inbred) (NN strain)))) (VP (VBZ causes) (NP (NP (DT a) (JJ pronounced) (NN decrease)) (PP (IN of) (NP (NML (NN HKI) (CC and) (NN ATP)) (NNS levels))) (ADVP (RB selectively)) (PP-LOC (IN in) (NP (DT the) (JJ central) (JJ nervous) (NN system)))))) (. .)) )
( (S (NP-SBJ (JJ Inbred) (NML (NN RanBP2) (SYM +) (HYPH /) (SYM −)) (NNS mice)) (ADVP (RB also)) (VP (VBP exhibit) (NP (NP (NNS deficits)) (PP (IN in) (NP (NP (NN growth) (NNS rates)) (CC and) (NP (NN glucose) (NN catabolism))))) (PP (IN without) (NP (NP (NN impairment)) (PP (IN of) (NP (NP (NN glucose) (NN uptake)) (CC and) (NP (NN gluconeogenesis))))))) (. .)) )
( (S (NP-SBJ-1 (DT These) (NNS phenotypes)) (VP (VBP are) (VP (VBN accompanied) (NP-1 (-NONE- *)) (PP (IN by) (NP-LGS (NP (DT a) (NN decrease)) (PP (IN in) (NP (NP (DT the) (JJ electrophysiological) (NNS responses)) (PP (IN of) (NP (ADJP (JJ photosensory) (CC and) (JJ postreceptoral)) (NNS neurons))))))))) (. .)) )
( (S (ADVP (RB Hence)) (, ,) (NP-SBJ (NP (NN RanBP2)) (CC and) (NP (PRP$ its) (NNS partners))) (VP (VBP emerge) (PP (IN as) (NP (NP (JJ critical) (NNS modulators)) (PP (IN of) (NP (NP (JJ neuronal) (NN HKI)) (, ,) (NP (NN glucose) (NN catabolism)) (, ,) (NP (NN energy) (NN homeostasis)) (, ,) (CC and) (NP (NP (NNS targets)) (PP (IN for) (NP (NP (JJ metabolic) (, ,) (NN aging) (NNS disorders)) (CC and) (NP (JJ allied) (NNS neuropathies)))))))))) (. .)) )
( (HEADING (NP (NN Synopsis))) )
( (S (NP-SBJ (NP (DT The) (ADJP (NN Ran) (HYPH -) (VBG binding)) (NN protein) (CD 2)) (-LRB- -LRB-) (NP (NN RanBP2))) (-RRB- -RRB-) (VP (VBZ is) (NP-PRD (NP (DT a) (JJ large) (NN protein)) (PP (IN with) (NP (JJ several) (NNS domains))))) (. .)) )
( (S (SBAR-ADV (IN Although) (S (NP-SBJ-1 (JJ several) (NN protein) (NNS partners)) (VP (VBD were) (VP (VBN found) (S (NP-SBJ-1 (-NONE- *)) (VP (TO to) (VP (VB interact) (PP (IN with) (NP (NP (JJ selective) (NNS domains)) (PP (IN of) (NP (NN RanBP2)))))))))))) (, ,) (NP-SBJ-2 (NP (NN none)) (PP-3 (-NONE- *ICH*))) (PP-TMP (IN to) (NP (DT this) (NN date))) (VP (VBD were) (VP (VBN found) (NP-2 (-NONE- *)) (PP-3 (IN toward) (NP (PRP$ its) (JJ large) (NML (NML (ADJP (NN leucine) (HYPH -) (JJ rich)) (NN domain)) (-LRB- -LRB-) (NML (NN LD))))))) (-RRB- -RRB-) (. .)) )
( (S (NP-SBJ (ADJP (NN Cell) (HYPH -) (VBN based)) (NNS experiments)) (VP (VBP support) (NP (NP (JJ several) (NNS roles)) (PP (IN of) (NP (NN RanBP2))) (PP (IN in) (NP (NN cell) (NN function))) (, ,) (PP (JJ such) (IN as) (NP (NP (NP (DT the) (NN production)) (PP (IN of) (NP (JJ functional) (NN proteins)))) (, ,) (NP (NP (NN control)) (PP (IN of) (NP (NP (NN protein) (NN trafficking)) (PP (IN between) (NP (DT the) (UCP (JJ nuclear) (CC and) (NN cytosol)) (NNS compartments)))))) (, ,) (CC and) (NP (NP (NN control)) (PP (IN of) (NP (NP (JJ multiple) (NNS facets)) (VP (VBG underlying) (NP (NN cell) (NN division)))))))))) (. .)) )
( (S (ADVP (RB Still)) (, ,) (NP-SBJ-1 (NP (DT the) (ADJP (JJ genetic) (CC and) (JJ physiological)) (NNS implications)) (PP (PP (IN of) (NP (NP (DT the) (NNS interactions)) (PP (IN between) (NP (NP (NN RanBP2)) (CC and) (NP (PRP$ its) (NNS partners)))))) (CC and) (PP (IN of) (NP (NP (DT the) (NN function)) (PP (IN of) (NP (NN RanBP2))) (PP (IN in) (NP (DT a) (NML (JJ whole) (HYPH -) (NN animal)) (NN model))))))) (VP (VBP remain) (ADJP-PRD (JJ elusive))) (. .)) )
( (S (NP-SBJ (DT The) (NNS authors)) (VP (VP (VBP report) (NP (NP (DT the) (NN identification)) (PP (IN of) (NP (NP (NP (CD two) (JJ novel) (JJ mitochondrial) (NNS partners)) (PP (IN of) (NP (NP (DT the) (NN LD)) (PP (IN of) (NP (NN RanBP2)))))) (, ,) (NP (NP (NN Cox11)) (CC and) (NP (NP (NN hexokinase) (NN type) (CD I)) (-LRB- -LRB-) (NP (NN HKI)))))))) (-RRB- -RRB-) (: ;) (CC and) (VP (PP-MNR (IN with) (NP (JJ multidisciplinary) (NNS approaches))) (VBP probe) (NP (NP (DT the) (NN role)) (PP (IN of) (NP (NP (NN RanBP2)) (CC and) (NP (PRP$ its) (NN LD)))) (PP (IN on) (NP (NP (NN Cox11)) (, ,) (NP (NN HKI)) (, ,) (CC and) (NP (NP (NNS functions)) (VP (VBN allied) (NP (-NONE- *)) (PP (IN to) (NP (DT these)))))))))) (. .)) )
( (S (NP-SBJ (DT The) (NNS authors)) (VP (VBD found) (SBAR (IN that) (S (NP-SBJ (NN RanBP2)) (VP (VBZ exhibits) (NP (NP (NN chaperone) (NN activity)) (PP (IN toward) (NP (NN HKI) (CC and) (NN Cox11)))))))) (. .)) )
( (S (NP-SBJ (NN RanBP2) (CC and) (NN Cox11)) (ADVP (RB profoundly)) (VP (VBP modulate) (NP (NN HKI) (NN activity))) (. .)) )
( (S (ADVP (RB Moreover)) (, ,) (NP-SBJ (NP (JJ partial) (NML (NML (NN loss)) (HYPH -) (PP (IN of) (HYPH -) (NP (NN function))))) (PP (IN of) (NP (NN RanBP2))) (PP-LOC (IN in) (NP (DT a) (NN mouse) (NN model)))) (VP (VP (VBZ induces) (NP (NP (NP (NNS deficits)) (PP (IN in) (NP (NN growth) (NNS rates)))) (CC and) (NP (NP (NN breakdown)) (PP (IN of) (NP (NN glucose)))))) (, ,) (VP (VBZ promotes) (NP (NP (DT the) (JJ down) (HYPH -) (NN regulation)) (PP (IN of) (NP (NML (NN HKI) (CC and) (NN ATP)) (NNS levels))) (ADVP (RB selectively)) (PP-LOC (IN in) (NP (DT the) (JJ central) (JJ nervous) (NN system))))) (, ,) (CC and) (VP (VBZ impairs) (NP (JJ visual) (NN function)))) (. .)) )
( (S (NP-SBJ (DT These) (NNS findings)) (VP (VBP support) (NP (NP (DT a) (JJ critical) (NN role)) (PP (IN of) (NP (NP (NN RanBP2)) (CC and) (NP (PRP$ its) (NNS partners)))) (PP (IN in) (NP (NP (JJ metabolic) (NNS processes)) (CC and) (NP (VBN allied) (NN disease) (NNS states)))))) (. .)) )
( (HEADING (NP (NN Introduction))) )
( (S (NP-SBJ (DT The) (NN RanBP2) (HYPH /) (NN Nup358)) (VP (VBZ is) (NP-PRD (NP (DT a) (JJ unique) (NML (NML (NN vertebrate)) (CC and) (NML (JJ large) (NN scaffold))) (NN protein)) (VP (VBN comprised) (NP (-NONE- *)) (PP (IN of) (NP (JJ multiple) (ADJP (JJ structural) (CC and) (JJ functional)) (NNS domains))))) (PRN (-LRB- [) (NP (NP (CD 1)) (PP (SYM –) (NP (CD 4)))) (-RRB- ]))) (. .)) )
( (S (NP-SBJ (NP (NP (JJ Several) (NNS roles)) (PP (IN of) (NP (NN RanBP2)))) (SBAR-1 (-NONE- *ICH*))) (VP (VBP have) (VP (VBN emerged) (SBAR-1 (WHNP-2 (WDT that)) (S (NP-SBJ-2 (-NONE- *T*)) (VP (VBP implicate) (NP (NN RanBP2)) (PP (IN in) (NP (NP (JJ nucleocytoplasmic) (NN trafficking) (PRN (-LRB- [) (NP (CD 3) (, ,) (CD 5)) (-RRB- ]))) (, ,) (NP (NN protein) (NN biogenesis) (PRN (-LRB- [) (NP (CD 6) (, ,) (CD 7)) (-RRB- ]))) (, ,) (NP (NP (DT the) (NN formation)) (PP (IN of) (NP (DT the) (JJ mitotic) (NN spindle)))) (, ,) (NP (NP (NN assembly)) (PP (IN of) (NP (DT the) (JJ nuclear) (NN envelope))) (PRN (-LRB- [) (NP (CD 8)) (-RRB- ]))) (, ,) (CC and) (NP (NP (DT the) (NN integration)) (PP (IN of) (NP (DT the) (NML (JJ nuclear) (NN envelope)) (NN breakdown))) (PP (IN with) (NP (NN kinetochore) (NML (NN formation) (CC and) (NN maturation)))) (PP-TMP (IN during) (NP (JJ early) (JJ mitotic) (NN progression))) (PRN (-LRB- [) (NP (CD 9)) (-RRB- ])))))))))) (. .)) )
( (S (NP-SBJ (NP (DT The) (JJ specific) (NN interaction)) (PP (IN of) (NP (NN RanBP2))) (PP (IN with) (NP (NP (DT a) (JJ diverse) (NN set)) (PP (IN of) (NP (NNS partners)))))) (ADVP (RB likely)) (VP (VBZ reflects) (NP (NP (DT a) (JJ pleiotropic) (NN role)) (PP (IN of) (NP (NN RanBP2))) (PP (IN in) (NP (NN cell) (NN function))) (, ,) (PP (ADVP (RB possibly)) (IN through) (NP (NP (DT the) (NN integration)) (PP (IN of) (NP (JJ multiple) (NNS pathways))))))) (. .)) )
( (S (PP (IN On) (NP (DT the) (JJ other) (NN hand))) (, ,) (NP-SBJ (NP (DT the) (ADJP (NP (NP (NN cell)) (-LRB- -LRB-) (NP (NN tissue))) (-RRB- -RRB-) (HYPH -) (JJ selective)) (NN interaction)) (PP (IN of) (NP (NN RanBP2))) (PP (IN with) (NP (NP (DT some)) (PP (IN of) (NP (PRP$ its) (NNS partners)))))) (VP (MD may) (ADVP (RB also)) (VP (VB impart) (NP (ADJP (NN cell) (HYPH -) (JJ restricted)) (NNS roles)) (PP (IN to) (NP (NN RanBP2))))) (. .)) )
( (S (S (PP (IN For) (NP (NN example))) (, ,) (NP-SBJ (NP (NP (DT the) (ADJP (NN Ran) (HYPH -) (VBG binding)) (NNS domains)) (S-TTL-FRM (NP-SBJ (NN RBDn)) (VP (SYM =) (NP (NP (CD 1)) (PP (SYM -) (NP (CD 4))))))) (PP (IN of) (NP (NN RanBP2)))) (VP (VBP associate) (PP (IN with) (NP (NP (DT the) (JJ nuclear) (NN import) (NN co-receptor)) (, ,) (NP (NN importin) (HYPH -) (NN β)))) (PRN (-LRB- [) (NP (CD 10) (, ,) (CD 11)) (-RRB- ])))) (, ,) (CC and) (S (NP-SBJ (NP (NNS antibodies)) (PP (IN against) (NP (NN RanBP2)))) (VP (VBP inhibit) (NP (NP (DT the) (NML (JJ nuclear) (NN import)) (NN pathway)) (PP-LOC (IN in) (NP (NN HeLa) (NNS cells)))) (PRN (-LRB- [) (NP (CD 3)) (-RRB- ])))) (: ;) (CC but) (S (NP-SBJ-1 (PDT such) (DT a) (NN role)) (VP (VBZ seems) (S (NP-SBJ-1 (-NONE- *)) (ADJP-PRD (JJ dispensable))) (PP-LOC (IN in) (NP (NN Xenopus) (NNS oocytes))) (PRN (-LRB- [) (NP (CD 12)) (-RRB- ])))) (. .)) )
( (S (PP (IN In) (NP (NN addition))) (, ,) (NP-SBJ (NP (DT the) (NN combination)) (PP (IN of) (NP (NP (NP (DT the) (ADJP (NN C) (HYPH -) (JJ terminal)) (NNS domains)) (, ,) (NP (NN RBD4) (CC and) (NN CY))) (-LRB- -LRB-) (PP (IN of) (NP (NN RanBP2)))))) (-RRB- -RRB-) (, ,) (VP (VP (VP (VBZ associates) (PP (IN with) (NP (NP (NP (DT a) (NN subset)) (PP (IN of) (NP (ADJP (NP (NN G) (NN protein)) (HYPH -) (VBN coupled)) (NNS receptors)))) (, ,) (NP (NP (DT the) (ADJP (JJ red) (HYPH /) (JJ green)) (NN opsin)) (, ,) (VP (VBN expressed) (NP (-NONE- *)) (PP-LOC (IN in) (NP (JJ photosensory) (NNS neurons)))))))) (CC and) (VP (VBZ enhances) (NP (NN opsin) (JJ functional) (NN production)) (PRN (-LRB- [) (NP (CD 6) (, ,) (CD 7)) (-RRB- ])))) (, ,) (SBAR-ADV (IN while) (S (NP-SBJ (NP (DT the) (NN interaction)) (PP (IN of) (NP (NP (DT the) (NN KBD)) (PP (IN of) (NP (NN RanBP2))))) (PP (IN with) (NP (NP (NP (DT a) (NN subset)) (PP (IN of) (NP (DT the) (JJ conventional) (ADJP (NN microtubule) (HYPH -) (VBN based)) (NN motor) (NN proteins)))) (, ,) (NP (NP (DT the) (NNS kinesins)) (, ,) (NP (NN KIF5B) (CC and) (NN KIF5C)))))) (, ,) (VP (VBZ occurs) (ADVP (RB selectively)) (PP-LOC (IN in) (NP (NP (DT the) (JJ central) (JJ nervous) (NN system)) (-LRB- -LRB-) (NP (NN CNS)))) (-RRB- -RRB-) (PRN (-LRB- [) (NP (CD 13)) (-RRB- ])))))) (. .)) )
( (S (NP-SBJ-1 (NP (NP (DT A) (JJ diverse) (NN set)) (PP (IN of) (NP (JJ additional) (JJ molecular) (NNS partners)))) (, ,) (NP (NP (RB each)) (VP (VBG associating) (ADVP (RB specifically)) (PP (IN with) (NP (NP (DT a) (JJ selective) (NN domain)) (PP (IN of) (NP (NN RanBP2)))))))) (, ,) (VP (VBP are) (ADJP-PRD (JJ likely) (S (NP-SBJ-1 (-NONE- *)) (VP (TO to) (VP (VB impart) (CC and) (VB integrate) (NP (NP (JJ additional) (NNS roles)) (PP (IN to) (NP (NN RanBP2))))))))) (. .)) )
( (S (PP (IN For) (NP (NN example))) (, ,) (NP-SBJ (NP (NP (NP (DT the) (ADJP (NN cyclophilin) (HYPH -) (JJ like)) (NN domain)) (-LRB- -LRB-) (NP (NN CLD))) (-RRB- -RRB-) (, ,) (NP (DT the) (UCP (NML (JJ internal) (NN repeat) (PRN (-LRB- -LRB-) (NP (NN W1W2) (HYPH /) (NN IR)) (-RRB- -RRB-))) (, ,) (CC and) (ADJP (NP (NN zinc) (HYPH -) (NN finger)) (JJ rich) (PRN (-LRB- -LRB-) (NP (NN ZnF)) (-RRB- -RRB-)))) (NNS domains))) (PP (IN of) (NP (NN RanBP2)))) (VP (VBP associate) (ADVP (RB specifically)) (PP (IN with) (NP (NP (NNS components)) (PP (IN of) (NP (NP (NP (DT the) (NN 19S) (NN cap)) (PP (IN of) (NP (DT the) (NN proteasome))) (PRN (-LRB- [) (NP (CD 14)) (-RRB- ]))) (, ,) (NP (NP (DT the) (NN E2) (ADJP (NP (NN SUMO) (HYPH -) (CD 1) (HYPH -)) (VBG conjugating)) (NN enzyme)) (-LRB- -LRB-) (NP (NN Ubc9)) (-RRB- -RRB-) (PRN (-LRB- [) (NP (CD 15)) (-RRB- ]))) (, ,) (CC and) (NP (NP (DT the) (NML (JJ nuclear) (NN export)) (NN receptor)) (, ,) (NP (NML (NN CRM1) (HYPH /) (NN exportin)) (HYPH -) (CD 1)) (PRN (-LRB- [) (CD 16) (-RRB- ]))))))) (, ,) (ADVP (RB respectively))) (. .)) )
( (S (NP-SBJ-1 (NN RanBP2)) (NP-ADV (PRP itself)) (VP (VBD was) (ADVP (RB also)) (VP (VBN found) (S (NP-SBJ-1 (-NONE- *)) (VP (TO to) (VP (VB exhibit) (NP (NML (NN SUMO1) (NN E3) (NN ligase)) (NN activity)) (PRN (-LRB- [) (NP (CD 17)) (-RRB- ])) (, ,) (S-ADV (NP-SBJ (-NONE- *PRO*)) (VP (VBG supporting) (NP (NP (DT a) (JJ direct) (NN link)) (PP (IN between) (NP (NP (ADJP (NN RanBP2) (HYPH -) (JJ mediated)) (NML (NML (NN SUMO) (HYPH -) (CD 1)) (NN substrate)) (NN modification)) (CC and) (NP (NP (NN relocation)) (PP (IN of) (NP (NP (ADJP (NP (NN SUMO) (HYPH -) (CD 1)) (VBN modified)) (JJ cytosolic) (NNS substrates)) (-LRB- -LRB-) (NP (ADVP (FW e.g.)) (, ,) (NN RanGAP)))) (-RRB- -RRB-) (PP (IN to) (NP (NP (DT the) (JJ cytosolic) (NN face)) (PP (IN of) (NP (NP (DT the) (JJ nuclear) (NN pore) (NN complex)) (-LRB- -LRB-) (NP (NN NPC)))))))))) (-RRB- -RRB-) (PRN (-LRB- [) (NP (CD 18)) (-RRB- ]))))))))) (. .)) )
( (S (ADVP (RB Finally)) (, ,) (NP-SBJ-1 (NN RanBP2)) (VP (VBD was) (ADVP (RB also)) (VP (VBN found) (S (NP-SBJ-1 (-NONE- *)) (VP (TO to) (VP (VB localize) (ADVP (RB prominently)) (PP (PP (IN to) (NP (NP (DT the) (ADJP (NNS mitochondria) (HYPH -) (JJ rich)) (JJ ellipsoid) (JJ subcellular) (NN compartment)) (PP (IN of) (NP (JJ photosensory) (NNS neurons))) (PRN (-LRB- [) (NP (CD 19)) (-RRB- ])))) (CC and) (PP (IN to) (NP (NP (ADJP (NN RanGTPase) (HYPH -) (VBN restricted)) (NNS foci)) (PP (IN along) (NP (JJ cytoplasmic) (NNS tracks) (PRN (-LRB- [) (NP (CD 19)) (-RRB- ]))))))) (, ,) (PP (IN in) (NP (NP (NN addition)) (PP (IN to) (NP (NP (PRP$ its) (NN localization)) (PP (IN at) (NP (NP (JJ cytoplasmic) (NNS fibrils)) (VP (VBG emanating) (PP (IN from) (NP (JJ nuclear) (NNS pores)))))))))) (PRN (-LRB- [) (NP (CD 2) (, ,) (CD 3) (, ,) (CD 10) (, ,) (CD 12) (, ,) (CD 19)) (-RRB- ]))))))) (. .)) )
( (S (NP-SBJ (VBG Emerging) (NN evidence)) (VP (VBZ supports) (SBAR (IN that) (S (NP-SBJ (NP (DT the) (ADJP (NN CNS) (HYPH -) (JJ selective)) (NNS effects)) (PP (IN of) (NP (NN RanBP2)))) (VP (MD may) (ADVP (RB also)) (VP (VB underlie) (NP (NP (DT the) (NN pathogenesis)) (PP (IN of) (NP (JJ certain) (NNS neuropathies))))))))) (. .)) )
( (S (NP-SBJ-1 (NN Parkin)) (VP (VP (VBZ is) (ADVP (RB ubiquitously)) (VP (VBN expressed) (NP-1 (-NONE- *)))) (CC and) (VP (VBZ interacts) (PP (IN with) (NP (NP (DT the) (ADJP (NN Ubc9) (HYPH -) (VBG interacting)) (NN domain)) (PP (IN of) (NP (NN RanBP2))))) (PRN (-LRB- [) (NP (CD 20)) (-RRB- ])))) (. .)) )
( (S (NP-SBJ (DT This)) (VP (VBZ promotes) (NP (NP (DT the) (NML (NN ubiquitination) (CC and) (NN degradation))) (PP (IN of) (NP (NN RanBP2))) (PRN (-LRB- [) (NP (CD 20)) (-RRB- ]))) (, ,) (PP-MNR (ADVP (RB possibly)) (IN via) (NP (NP (DT the) (NN interaction)) (PP (IN of) (NP (NP (DT the) (NN CLD) (NN domain)) (PP (IN of) (NP (NN RanBP2))))) (PP (IN with) (NP (NP (DT the) (NML (NN 19S) (NN cap)) (NNS subunits)) (PP (IN of) (NP (DT the) (NN proteasome))))) (PRN (-LRB- [) (NP (CD 14)) (-RRB- ]))))) (. .)) )
( (S (ADVP (RB Interestingly)) (, ,) (NP-SBJ-1 (NP (NP (DT the) (JJ small) (NN yeast) (NML (NML (ADJP (NN Ran) (HYPH -) (VBG binding)) (NN protein) (CD 1)) (-LRB- -LRB-) (NML (NN RanBP1)))) (-RRB- -RRB-) (, ,) (NP (NN Yrb1p))) (, ,) (PP (IN with) (NP (NP (JJ strong) (NN homology)) (PP (IN to) (NP (NP (DT the) (ADJP (NN Ran) (HYPH -) (VBG binding)) (NNS domains)) (PP (IN of) (NP (NN RanBP2)))))))) (, ,) (VP (VBZ is) (ADVP (RB also)) (VP (VBN required) (NP-1 (-NONE- *)) (PP (IN for) (NP (ADJP (NP (NN cell) (HYPH -) (NN cycle)) (VBN regulated)) (NN protein) (NN degradation))) (PRN (-LRB- [) (NP (CD 21)) (-RRB- ])))) (. .)) )
( (S (S (NP-SBJ (NP (NN Parkin)) (, ,) (PP (IN like) (NP (NN RanBP2))) (PRN (-LRB- [) (NP (CD 17)) (-RRB- ]))) (, ,) (VP (VBZ has) (NP (NML (NN E3) (HYPH -) (NN ligase)) (NN activity)) (PRN (-LRB- [) (NP (NP (CD 22)) (PP (SYM –) (NP (CD 24)))) (-RRB- ])))) (: ;) (CC and) (S (NP-SBJ (NP (NN loss)) (HYPH -) (PP (IN of) (HYPH -) (NP (NN function))) (PP (IN of) (NP (NN parkin)))) (VP (VBZ leads) (PP (IN to) (NP (NML (JJ early) (NN onset)) (ADJP (JJ autosomal) (JJ recessive)) (JJ juvenile) (NN Parkinsonism))) (PRN (-LRB- [) (NP (CD 25)) (-RRB- ])))) (. .)) )
( (S (S (SBAR-ADV (IN While) (S (NP-SBJ-1 (NP (DT the) (JJ dopaminergic) (ADJP (JJ neuronal) (HYPH -) (VBN restricted)) (NNS effects)) (PP (IN of) (NP (NP (NNS mutations)) (PP-LOC (IN in) (NP (NN parkin)))))) (VP (VBP are) (RB not) (ADJP-PRD (JJ understood)) (PRN (-LRB- [) (NP (CD 25)) (-RRB- ]))))) (, ,) (NP-SBJ (NML (NN parkin) (SYM −) (HYPH /) (SYM −)) (NNS mice)) (VP (VBP exhibit) (NP (NP (JJ mitochondrial) (NN dysfunction)) (CC and) (NP (NML (NN energy) (CC and) (NN growth)) (NNS deficits))))) (, ,) (CC and) (S (NP-SBJ (NP (DT a) (NN fraction)) (PP (IN of) (NP (NN parkin)))) (VP (VBZ localizes) (PP (IN to) (NP (NP (NP (DT the) (JJ cytoplasmic) (NN face)) (PP (IN of) (NP (DT the) (NNS mitochondria)))) (, ,) (SBAR (WHADVP-3 (WRB where)) (S (NP-SBJ-2 (-NONE- *PRO*)) (ADVP (RB together) (PP (IN with) (NP (JJ other) (NNS partners)))) (VP (VBZ is) (VP (VBN thought) (S (NP-SBJ-2 (-NONE- *)) (VP (VP (TO to) (VP (VB promote) (NP (NP (DT the) (NN degradation)) (PP (IN of) (NP (JJ selective) (JJ mitochondrial) (NNS substrates)))))) (CC and) (VP (TO to) (VP (VB exert) (NP (DT a) (JJ neuroprotective) (NN function)) (PRN (-LRB- [) (NP (NP (CD 26)) (PP (SYM –) (NP (CD 29)))) (-RRB- ])))))) (ADVP-LOC-3 (-NONE- *T*)))))))))) (. .)) )
( (S (NP-SBJ (DT These) (NNS data)) (VP (VBP suggest) (SBAR (IN that) (S (NP-SBJ (NP (NNS deficits)) (PP (IN in) (NP (NN RanBP2) (CC and) (NN parkin)))) (VP (MD may) (VP (VP (VB share) (NP (ADJP (-LRB- -LRB-) (AFX patho) (-RRB- -RRB-) (JJ physiological)) (NNS pathways))) (CC and) (VP (VB support) (NP (NP (DT a) (JJ multifaceted) (NN role)) (PP (IN of) (NP (NN RanBP2)))))))))) (. .)) )
( (S (ADVP (RB Yet)) (NP-SBJ-1 (NP (JJ clear) (NNS functions)) (PP (IN of) (NP (NN RanBP2))) (PP (IN in) (NP (NML (NN animal) (CC and) (NN cell)) (NN physiology)))) (VP (VBP remain) (ADJP-PRD (JJ elusive))) (. .)) )
( (S (ADVP (RB Here)) (, ,) (NP-SBJ (PRP we)) (VP (VBP report) (PP (PP (IN on) (NP (NP (DT the) (NML (NN identification) (CC and) (NN function))) (PP (IN of) (NP (NP (NP (NP (CD two) (JJ novel) (NNS partners)) (PP (IN of) (NP (NN RanBP2)))) (, ,) (NP (NP (NN Cox11)) (CC and) (NP (NP (NN hexokinase) (NN type) (CD I)) (-LRB- -LRB-) (NP (NN HKI))))) (-RRB- -RRB-) (, ,) (SBAR (WHNP-1 (WDT which)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBP interact) (PP (IN with) (NP (NP (NP (DT a) (UCP (JJ large) (CC and) (NN orphan)) (NN domain)) (PP (IN of) (NP (NN RanBP2)))) (, ,) (NP (NP (DT the) (ADJP (NN leucine) (HYPH -) (JJ rich)) (NN domain)) (-LRB- -LRB-) (NP (NN LD)))))))))))) (-RRB- -RRB-) (: ;) (CC and) (PP (IN on) (NP (NP (DT the) (NN outcome)) (PP (IN of) (NP (NP (JJ partial) (NML (NML (NN loss)) (HYPH -) (PP (IN of) (HYPH -) (NP (NN function))))) (PP (IN of) (NP (NN RanBP2))))) (PP (IN on) (NP (NP (NN HKI)) (, ,) (NP (NN animal) (NN physiology)) (, ,) (CC and) (NP (NML (NN glucose) (HYPH /) (NN energy)) (NN metabolism)))))))) (. .)) )
( (HEADING (NP (NNS Results))) )
( (HEADING (S (NP-SBJ (NP (DT The) (NN LD)) (PP (IN of) (NP (NN RanBP2)))) (VP (VBZ Interacts) (PP (IN with) (NP (NN Cox11) (CC and) (NN HKI)))))) )
( (S (NP-SBJ (NP (DT The) (NN LD)) (PP (IN of) (NP (NN RanBP2))) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 1A)) (-RRB- -RRB-))) (VP (VBZ is) (NP-PRD (NP (NP (DT a) (UCP (JJ large) (CC and) (NN orphan)) (NN domain)) (PP (IN of) (NP (NP (QP (SYM ~) (CD 700)) (NNS residues)) (-LRB- -LRB-) (NP (QP (SYM ~) (CD 80)) (NN kDa))))) (-RRB- -RRB-) (, ,) (SBAR (WHPP-2 (IN for) (WHNP (WDT which))) (S (NP-SBJ-1 (DT no) (JJ molecular) (NNS partners)) (VP (VBP have) (VP (VBN been) (VP (VBN identified) (NP-1 (-NONE- *)) (PP-TMP (IN until) (NP (DT this) (NN date))) (PP-PRP-2 (-NONE- *T*))))))))) (. .)) )
( (S (NP-SBJ-1 (NML (NN Brain) (CC and) (NN retina)) (NN yeast) (NML (CD two) (HYPH -) (NN hybrid)) (NNS libraries)) (VP (VBD were) (VP (VBN screened) (NP-1 (-NONE- *)) (PP-MNR (IN with) (NP (NN LD))))) (. .)) )
( (S (NP-SBJ-1 (NN Cox11)) (VP (VBD was) (VP (VBN identified) (NP-1 (-NONE- *)) (PP (IN as) (NP (NP (DT a) (NN partner)) (PP (IN to) (NP (DT this) (NN domain))))) (PRN (-LRB- -LRB-) (NP (NN Figure) (NML (NN 1B) (CC and) (NN 1C))) (-RRB- -RRB-)))) (. .)) )
( (S (NP-SBJ (NN Cox11)) (VP (VBZ is) (NP-PRD (NP (DT a) (NN metallochaperone)) (VP (VBN implicated) (NP (-NONE- *)) (PP (IN in) (NP (NML (NN cytochrome) (NN c) (NN oxidase)) (NN assembly))))) (PRN (-LRB- [) (NP (CD 30) (, ,) (CD 31)) (-RRB- ]))) (. .)) )
( (S (NP-SBJ (NP (NML (NN Structure) (HYPH -) (NN function)) (NN analysis)) (PP (IN of) (NP (NP (DT the) (NN interaction)) (PP (IN between) (NP (NP (NN mCox11)) (, ,) (NP (NP (NN LD)) (PP (IN of) (NP (NN RanBP2)))) (, ,) (CC and) (NP (NP (NNS subdomains)) (ADVP (RB thereof))))))) (, ,) (PP (IN with) (NP (JJ quantitative) (NN yeast) (NML (CD two) (HYPH -) (NN hybrid)) (NNS assays))) (PRN (-LRB- [) (NP (CD 32)) (-RRB- ]))) (, ,) (VP (VBD showed) (NP (NP (JJ optimal) (NN interaction)) (PP (IN between) (NP (DT the) (JJ intact) (NML (NN LD) (CC and) (NN Cox11)) (NN proteins)))) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 1C)) (-RRB- -RRB-))) (. .)) )
( (S (NP-SBJ (NP (ADJP (VB Pull) (HYPH -) (RP down)) (NNS assays)) (PP (IN of) (NP (JJ retinal) (NNS extracts))) (PP (IN with) (NP (NML (NML (NN glutathione) (NN S) (HYPH -) (NN transferase)) (-LRB- -LRB-) (NML (NN GST))) (-RRB- -RRB-) (HYPH -) (NN LD)))) (VP (VBZ precipitates) (NP (NP (NP (DT a) (ADJP (NP (NN sodium) (NN dodecyl) (NN sulfate)) (HYPH -) (JJ resistant)) (NN dimer) (NN isoform)) (PP (IN of) (NP (NN Cox11))) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 1D)) (, ,) (NP (JJ top) (NN panel)) (-RRB- -RRB-))) (, ,) (SBAR (WHNP-1 (WDT which)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBZ does) (RB not) (VP (VB bind) (PP (IN to) (NP (NP (NN GST) (HYPH -) (NN LDZIP)) (ADVP (RB alone)))))))))) (. .)) )
( (S (PP (IN In) (NP (NP (NN addition)) (PP (IN to) (NP (NN Cox11))))) (, ,) (NP-SBJ (PRP we)) (ADVP (RB also)) (VP (VBD found) (SBAR (IN that) (S (NP-SBJ (NP (JJ other) (JJ mitochondrial) (NNS components)) (PP (JJ such) (IN as) (NP (NP (DT the) (ADJP (NP (JJ outer) (NN membrane)) (HYPH -) (VBN associated)) (NN protein)) (, ,) (NP (NP (NN HKI) (PRN (-LRB- [) (NP (CD 33)) (-RRB- ])) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 1D)) (, ,) (NP (JJ bottom) (NN panel)) (-RRB- -RRB-))) (CC and) (NP (NN mHsp70) (CIT (-LRB- -LRB-) (JJ unpublished) (NNS data) (-RRB- -RRB-))))))) (, ,) (VP (VBD associated) (NP (-NONE- *)) (PP (IN with) (NP (NP (NN LD)) (PP (IN of) (NP (NN RanBP2))))))))) (. .)) )
( (S (NP-SBJ (DT This) (NN association)) (VP (VBD was) (ADJP-PRD (RB highly) (JJ specific) (PP (IN toward) (NP (DT the) (NN HKI) (NN isoform)))) (, ,) (SBAR-PRP (IN because) (S (NP-SBJ (NN HKII) (, ,) (NN HKIII) (, ,) (CC and) (NN glucokinase)) (VP (VBD did) (RB not) (VP (VB interact) (PP (IN with) (NP (NP (DT the) (NN LD)) (PP (IN of) (NP (NN RanBP2))))) (CIT (-LRB- -LRB-) (JJ unpublished) (NNS data) (-RRB- -RRB-))))))) (. .)) )
( (S (NP-SBJ (NP (DT The) (NN interaction)) (PP (IN of) (NP (NN Cox11) (, ,) (NN HKI) (, ,) (CC and) (NN mHsp70))) (PP (IN with) (NP (NN RanBP2)))) (VP (VBD occurred) (ADVP-MNR (FW in) (FW vivo)) (PP-LOC (IN in) (NP (JJ retinal) (NNS extracts))) (, ,) (SBAR-TMP (IN since) (S (S (NP-SBJ (NP (NNS antibodies)) (PP (IN against) (NP (DT these) (CC and) (NN RanBP2)))) (VP (VBD coimmunoprecipitated) (NP (NP (NN RanBP2) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 1E)) (-RRB- -RRB-))) (CC and) (NP (NN HKI) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 1F)) (-RRB- -RRB-)))) (, ,) (ADVP (RB respectively)))) (, ,) (CC and) (S (NP-SBJ-1 (DT these) (NNS interactions)) (VP (VBD were) (VP (VBN observed) (NP-1 (-NONE- *)) (PP-LOC (IN across) (NP (JJ different) (NNS tissues))) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN S1)) (-RRB- -RRB-)))))))) (. .)) )
( (S (SBAR-PRP (IN Since) (S (NP-SBJ (NN RanBP2)) (VP (VBZ exhibits) (NP (NN chaperone) (NN activity))))) (, ,) (NP-SBJ (PRP we)) (VP (VBD assessed) (SBAR (IN whether) (S (NP-SBJ=2 (NP (NP (DT the) (NN interaction)) (PP (IN between) (NP (NP (NP (DT the) (NN LD)) (PP (IN of) (NP (NN RanBP2)))) (CC and) (NP (NN Cox11))))) (NAC-1 (-NONE- *ICH*))) (VP (VBD was) (ADJP-PRD (JJ direct)) (NAC-1 (CC and) (NP (NP (DT the) (NN chaperone) (NN activity)) (PP (IN of) (NP (NN LD))) (PP (IN toward) (NP (NP (VBG folding) (NNS species)) (PP (IN of) (NP (NN Cox11))))))))))) (. .)) )
( (S (NP-SBJ-1 (NML (NN Reconstitution) (NN binding)) (NNS assays)) (VP (VBD were) (VP (VBN carried) (NP-1 (-NONE- *)) (PRT (RP out)) (PP (IN between) (NP (NP (VBN purified) (NN LD)) (CC and) (NP (NP (NP (NN Cox11)) (, ,) (VP (ADVP (RB fully) (CC and) (RB partially)) (VBN denatured) (NP (-NONE- *)) (PP-MNR (IN with) (NP (NN GnHCl) (CC and) (NN urea))) (, ,) (ADVP (RB respectively)))) (, ,) (CC and) (NP (JJ native) (NN Cox11) (PRN (-LRB- -LRB-) (NP (NN Figure) (NML (NN 1G) (CC and) (NN 1H))) (-RRB- -RRB-)))))))) (. .)) )
( (S (NP-SBJ (ADJP (JJ Partial) (VBN denatured)) (NN Cox11)) (VP (VBZ exhibits) (NP (NP (ADJP (ADJP (RB significantly) (JJR higher)) (CC and) (ADJP (NN concentration) (HYPH -) (JJ dependent))) (NN binding) (NN affinity)) (PP (IN toward) (NP (NN LD)))) (PP (VBN compared) (PP (IN with) (NP (DT the) (ADJP (ADJP (JJ native)) (CC and) (ADJP (RB fully) (VBN denatured))) (NN Cox11)))) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 1G)) (-RRB- -RRB-))) (. .)) )
( (S (PP (IN In) (NP (NN addition))) (, ,) (NP-SBJ (NP (JJ native) (NN Cox11)) (VP (VBN purified) (NP (-NONE- *)) (PP-TMP (IN upon) (NP (NN expression))) (PP (IN in) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NP (NN CuSO4)) (-LRB- -LRB-) (NP (NP (DT a) (JJ prosthetic) (NN group)) (VP (ADVP (RB tightly)) (VBN bound) (NP (-NONE- *)) (PP (IN to) (NP (NN Cox11))))))))) (-RRB- -RRB-) (PRN (-LRB- [) (NP (CD 31)) (-RRB- ])))) (, ,) (VP (VBZ shows) (NP (NP (ADJP (RB significantly) (JJR higher)) (NN binding) (NN activity)) (PP (IN toward) (NP (NP (DT the) (NN LD)) (PP (IN of) (NP (NN RanBP2))))) (, ,) (PP (IN than) (PP (IN in) (NP (NP (DT the) (NN absence)) (PP (IN of) (NP (NN CuSO4))))))) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 1H)) (-RRB- -RRB-))) (. .)) )
( (HEADING (NP (NN Figure) (CD 1))) )
( (HEADING (S (NP-SBJ (NP (DT The) (NN LD)) (PP (IN of) (NP (NN RanBP2)))) (VP (VBZ Interacts) (PP (IN with) (NP (NN Cox11) (CC and) (NN HKI)))))) )
( (CAPTION (NP (LST (-LRB- -LRB-) (LS A) (-RRB- -RRB-)) (NP (NP (JJ Primary) (NN structure)) (PP (IN of) (NP (NN RanBP2)))) (CC and) (NP (PRP$ its) (ADJP (JJ structural) (HYPH /) (JJ functional)) (NNS domains)) (. .))) )
( (CAPTION (S (NP-SBJ-1 (NP (DT The) (ADJP (NN N) (HYPH -) (JJ terminal)) (NN LD)) (PP (IN of) (NP (NN RanBP2)))) (VP (VBZ is) (VP (VBN underlined) (NP-1 (-NONE- *)))) (. .))) )
( (CAPTION (NP (LST (-LRB- -LRB-) (LS B) (-RRB- -RRB-)) (NP (NN Sequence) (NN alignment)) (PP (IN of) (NP (UCP (JJ murine) (CC and) (NN yeast)) (NN Cox11))) (. .))) )
( (CAPTION (S (NP-SBJ-1 (DT The) (NN yeast) (NN Cox11) (ADJP (NP (NN C) (HYPH -) (CC and) (NN N)) (HYPH -) (JJ terminal)) (NNS domains)) (VP (VBP are) (ADVP (RB poorly)) (VP (VBN conserved) (NP-1 (-NONE- *)))) (. .))) )
( (CAPTION (S (NP-SBJ (NP (NN Arrow)) (CC and) (NP (JJ solid) (NN line))) (VP (VBP denote) (NP (NP (DT the) (VBN predicted) (NML (JJ mitochondrial) (NN cleavage)) (NN site)) (CC and) (NP (ADJP (NN membrane) (HYPH -) (VBG spanning)) (NN domain)))) (. .))) )
( (CAPTION (S (NP-SBJ (NP (DT The) (ADJP (JJ dotted) (CC and) (JJ dashed)) (NNS lines)) (PP (IN above) (NP (DT the) (JJ aligned) (NNS sequences)))) (VP (VBP represent) (, ,) (ADVP (RB respectively)) (, ,) (NP (NP (NML (NML (NN Cox11) (HYPH -) (NN N)) (CC and) (NML (NN Cox11) (HYPH -) (NN C))) (NNS constructs)) (VP (VBN shown) (NP (-NONE- *)) (PP (IN in) (NP (NN Figure) (NN 1C)))))) (. .))) )
( (CAPTION (NP (LST (-LRB- -LRB-) (LS C) (-RRB- -RRB-)) (NP (NML (NN Structure) (HYPH -) (NN function)) (NN analysis)) (PP (IN of) (NP (NP (DT the) (NN interaction)) (PP (IN between) (NP (NP (NP (DT the) (NN LD)) (PP (IN of) (NP (NN RanBP2)))) (CC and) (NP (NN Cox11)))))) (. .))) )
( (CAPTION (S (NP-SBJ (NP (JJ Optimal) (NN interaction)) (PP (IN between) (NP (NP (DT the) (NN LD)) (CC and) (NP (NN Cox11))))) (VP (VBD occurred) (PP (IN in) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NP (NNS constructs)) (VP (VBG comprising) (NP (CC both) (NP (DT the) (JJ complete) (NN LD)) (CC and) (NP (NN Cox11))))))))) (. .))) )
( (CAPTION (S (SBAR-ADV (IN Although) (S (NP-SBJ (NP (NP (NN removal)) (PP (IN of) (NP (DT the) (JJ cytosolic) (NN N) (HYPH -) (JJ terminal)))) (-LRB- -LRB-) (NP (NN Cox11) (HYPH -) (NN C))) (-RRB- -RRB-) (ADVP (RB significantly)) (VP (VBD decreased) (NP (NP (DT the) (NN interaction)) (PP (IN with) (NP (NN LD))))))) (, ,) (NP-SBJ (NP (NP (NP (DT the) (JJ mitochondrial) (NN intermembrane) (NN domain)) (PP (IN of) (NP (NN Cox11)))) (-LRB- -LRB-) (NP (NN Cox11) (HYPH -) (NN C))) (-RRB- -RRB-) (ADVP (RB together) (PP (IN with) (NP (NP (NP (DT the) (ADJP (NN C) (HYPH -) (JJ terminal)) (NN half)) (PP (IN of) (NP (NN LD)))) (-LRB- -LRB-) (NP (NN LD) (HYPH -) (NN C)))))) (-RRB- -RRB-) (VP (VBD retained) (NP (NP (JJS most)) (PP (IN of) (NP (DT the) (NN interaction) (NN activity))))) (. .))) )
( (CAPTION (S (NP-SBJ (NP (NN LD) (HYPH -) (NN N)) (CC and) (NP (NN LD) (HYPH -) (NN C))) (VP (VBD ended) (CC and) (VBD began) (PP (IN with) (NP (NP (DT the) (NML (NN leucine) (NN zipper)) (NN domain)) (PP (IN of) (NP (NN RanBP2)))))) (. .))) )
( (CAPTION (S (NP-SBJ (ADJP (JJ White) (CC and) (JJ black)) (NNS bars)) (VP (VBP denote) (NP (NP (NML (NN β) (HYPH -) (NN galactosidase)) (NN activity)) (CC and) (NP (NP (NN growth) (NNS rates)) (PP (IN in) (NP (JJ selective) (NN growth) (NN medium))))) (, ,) (ADVP (RB respectively))) (. .))) )
( (CAPTION (FRAG (S (NP-SBJ (NP (NNS Results)) (VP (VBN shown) (NP (-NONE- *)))) (VP (VBP represent) (NP (DT the) (NML (NN mean) (SYM ±) (NN SD))))) (, ,) (S-FRM (NP-SBJ (NN n)) (VP (SYM =) (NP (CD 3)))) (. .))) )
( (CAPTION (NP (LST (-LRB- -LRB-) (LS D) (-RRB- -RRB-)) (NP (NN GST) (ADJP (VB pull) (HYPH -) (RP down)) (NNS assays)) (PP (IN with) (NP (NP (NP (DT the) (NN LD)) (PP (IN of) (NP (NN RanBP2)))) (CC and) (NP (PRP$ its) (NML (NML (NML (NN leucine) (NN zipper)) (NN domain)) (CC and) (NML (JJ retinal) (NNS extracts)))))) (. .))) )
( (CAPTION (S (NP-SBJ (NP (NP (DT The) (NN LD)) (, ,) (CONJP (CC but) (RB not)) (NP (DT the) (NML (NN leucine) (NN zipper)) (NN domain))) (PP (IN of) (NP (NN RanBP2)))) (, ,) (VP (VBP associate) (PP (IN with) (NP (NP (NN Cox11) (PRN (-LRB- -LRB-) (NP (JJ top) (NN panel)) (, ,) (NP (NN lane) (CD 1)) (-RRB- -RRB-))) (CC and) (NP (NN HKI) (PRN (-LRB- -LRB-) (NP (JJ bottom) (NN panel)) (, ,) (NP (NN lane) (CD 1)) (-RRB- -RRB-)))))) (. .))) )
( (CAPTION (S (LST (-LRB- -LRB-) (LS E) (-RRB- -RRB-)) (NP-SBJ (NP (NN Coimmunoprecipitation)) (PP (IN of) (NP (NN RanBP2))) (PP (IN with) (NP (NP (NNS antibodies)) (PP (IN against) (NP (PRP$ its) (JJ molecular) (NNS partners)))))) (VP (VBZ shows) (SBAR (IN that) (S (NP-SBJ (NN RanBP2)) (VP (VBZ forms) (NP (NP (DT a) (JJ complex)) (PP-1 (-NONE- *ICH*))) (ADVP-MNR (FW in) (FW vivo)) (PP-1 (IN with) (NP (NP (NN HKI) (PRN (-LRB- -LRB-) (NP (NNS lanes) (NML (CD 1) (CC and) (CD 2))) (-RRB- -RRB-))) (, ,) (NP (NN mHsp70) (PRN (-LRB- -LRB-) (NP (NN lane) (CD 3)) (-RRB- -RRB-))) (, ,) (CC and) (NP (NN Cox11) (PRN (-LRB- -LRB-) (NP (NN lane) (CD 4)) (-RRB- -RRB-))))))))) (. .))) )
( (CAPTION (S (NP-SBJ (NNS Lanes) (NML (CD 5) (, ,) (CD 6) (, ,) (CC and) (CD 7))) (VP (VBP are) (NP-PRD (NP (NN control) (NN immunoprecipitation) (NNS reactions)) (PP (IN with) (NP (NP (JJ different) (NNS antibodies)) (PP (IN against) (NP (NP (NP (DT the) (NN RanBP2) (NNS domains)) (, ,) (NP (NN KBD) (, ,) (NN ZnF) (, ,) (CC and) (NN XAFXFG))) (PP (IN of) (NP (NNS nucleoporins))))))))) (. .))) )
( (CAPTION (NP (LST (-LRB- -LRB-) (LS F) (-RRB- -RRB-)) (NP (JJ Reciprocal) (NN coimmunoprecipitation)) (PP (IN of) (NP (NN HKI))) (PP (IN with) (NP (NP (NP (NNS antibodies)) (PP (IN against) (NP (NN RanBP2)))) (-LRB- -LRB-) (VP (VP (VBN used) (NP (-NONE- *))) (CC and) (VP (VBN shown) (NP (-NONE- *)) (PP (IN in) (-LRB- -LRB-) (NP (NN E))))))) (-RRB- -RRB-) (-RRB- -RRB-) (. .))) )
( (CAPTION (NP (LST (-LRB- -LRB-) (LS G) (-RRB- -RRB-)) (NP (NN Reconstitution) (ADJP (VB pull) (HYPH -) (RP down)) (NNS assays)) (PP (IN with) (NP (NP (VBN purified) (NN LD)) (CC and) (NP (NP (VBG increasing) (NNS concentrations)) (PP (IN of) (NP (ADJP (ADJP (JJ native) (PRN (-LRB- -LRB-) (NP (JJ top) (NN panel)) (-RRB- -RRB-))) (, ,) (ADJP (VBN denatured) (PRN (-LRB- -LRB-) (NP (JJ middle) (NN panel)) (-RRB- -RRB-))) (, ,) (CC and) (ADJP (RB partially) (VBN denatured) (PRN (-LRB- -LRB-) (NP (JJ bottom) (NN panel)) (-RRB- -RRB-)))) (NN Cox11))) (, ,) (ADVP (RB respectively))))) (, ,) (PP (IN in) (NP (NP (DT the) (NML (NN absence) (CC and) (NN presence))) (PP (IN of) (NP (NP (NP (VBG denaturating) (NN agent)) (, ,) (NP (NN GnHCl))) (CC and) (NP (NP (JJ chaotropic) (NN agent)) (, ,) (NP (NN urea))))))) (. .))) )
( (CAPTION (S (NP-SBJ (NP (NN Folding) (NNS intermediates) (PRN (-LRB- -LRB-) (NP (JJR lower) (NN panel)) (-RRB- -RRB-))) (PP (IN of) (NP (NN Cox11)))) (VP (VBP exhibit) (NP (NP (DT the) (JJS highest) (NN binding) (NN activity)) (PP (IN toward) (NP (NP (DT the) (NN LD)) (PP (IN of) (NP (NN RanBP2))))))) (. .))) )
( (CAPTION (NP (LST (-LRB- -LRB-) (LS H) (-RRB- -RRB-)) (NP (JJ Similar) (NNS experiments)) (PP (IN as) (PP (IN in) (-LRB- -LRB-) (NP (NN G)))) (-RRB- -RRB-) (PP (IN but) (PP (IN in) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NP (JJ native) (NN Cox11)) (VP (VBN expressed) (NP (-NONE- *)) (PP (IN in) (NP (NP (DT the) (NML (NML (NN absence) (PRN (-LRB- -LRB-) (NP (JJ top) (NN panel)) (-RRB- -RRB-))) (CC or) (NML (NN presence) (PRN (-LRB- -LRB-) (NP (JJ bottom) (NN panel)) (-RRB- -RRB-))))) (PP (IN of) (NP (NN CuSO4))))))))))) (. .))) )
( (CAPTION (S (NP-SBJ (NP (DT The) (JJ mature) (NN isoform)) (PP (IN of) (NP (DT the) (NN metallochaperone)))) (VP (VBZ has) (NP (NP (DT an) (VBN increased) (NN affinity)) (PP (IN toward) (NP (NP (DT the) (NN LD)) (PP (IN of) (NP (NN RanBP2))))))) (. .))) )
( (CAPTION (NP (NP (NP (NN LD)) (, ,) (NP (ADJP (NN leucine) (HYPH -) (JJ rich)) (NN domain))) (: ;) (NP (NP (NN LZ)) (, ,) (NP (NML (NN leucine) (NN zipper)) (NN domain))) (: ;) (NP (NP (NP (NN RBD1)) (PP (SYM –) (NP (CD 4)))) (, ,) (NP (NP (NML (NN Ran) (HYPH -) (NN binding)) (NNS domains)) (NP-ADV (QP (CD 1) (SYM –) (CD 4))))) (: ;) (NP (NP (NN ZnF)) (, ,) (NP (NML (NN zinc) (NN finger)) (NN cluster) (NN domain))) (: ;) (NP (NP (NN KBD)) (, ,) (NP (NML (NML (NML (NN kinesin)) (-LRB- -LRB-) (NML (NN KIF5B) (HYPH /) (NN KIF5C))) (-RRB- -RRB-) (HYPH -) (NN binding)) (NN domain))) (: ;) (NP (NP (NN CLD)) (, ,) (NP (ADJP (NN cyclophilin) (HYPH -) (JJ like)) (NN domain))) (: ;) (NP (NP (NN IR)) (, ,) (NP (NML (JJ internal) (NN repeat)) (NN domain))) (: ;) (NP (NP (NN CY)) (, ,) (NP (NN cyclophilin) (NN domain))) (. .))) )
( (HEADING (S (NP-SBJ (NN Cox) (CD 11)) (VP (VP (VBZ Inhibits) (NP (NP (NN HKI) (NN Activity)) (CC and) (NP (NP (DT the) (NN LD)) (PP (IN of) (NP (NN RanBP2)))))) (VP (VBZ Reverses) (NP (NP (DT the) (NN Inhibition)) (PP (IN of) (NP (NN Cox11))) (PP (IN over) (NP (NN HKI)))))))) )
( (S (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO To) (VP (VB probe) (SBAR (IN whether) (S (NP-SBJ (NP (DT the) (NN interaction)) (PP (IN of) (NP (NN Cox11) (CC and) (NN HKI))) (PP (IN with) (NP (NP (DT the) (NN LD)) (PP (IN of) (NP (NN RanBP2)))))) (VP (VBZ modulates) (NP (NP (DT the) (JJ enzymatic) (NN activity)) (PP (IN of) (NP (NN HKI)))))))))) (, ,) (NP-SBJ (PRP we)) (ADVP-TMP (RB first)) (VP (VBD examined) (NP (NP (DT the) (NN effect)) (PP (IN of) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG increasing) (NP (NP (NNS concentrations)) (PP (IN of) (NP (NN Cox11))))))) (PP (IN on) (NP (NP (DT the) (JJ initial) (NNS rates)) (PP (IN of) (NP (NN HKI) (JJ enzymatic) (NN activity)))))) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 2A)) (-RRB- -RRB-))) (. .)) )
( (S (S (NP-SBJ (NN Cox11)) (ADVP (RB strongly)) (VP (VBZ inhibits) (NP (NN HKI) (NN activity)) (PP-MNR (IN in) (NP (DT a) (ADJP (NN concentration) (HYPH -) (JJ dependent)) (NN fashion))))) (, ,) (CC and) (S (PP (IN at) (NP (NP (QP (SYM ~) (CD 15)) (NN nM)) (PP (IN of) (NP (NN Cox11))))) (, ,) (NP-SBJ-1 (NN HKI) (NN activity)) (VP (MD could) (RB not) (VP (VB be) (VP (VBN recorded) (NP-1 (-NONE- *)) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 2A)) (-RRB- -RRB-)))))) (. .)) )
( (S (NP-SBJ (NN Cox11)) (VP (VBZ behaves) (PP (IN as) (NP (NP (DT a) (JJ partial) (JJ noncompetitive) (NN inhibitor)) (PP (IN of) (NP (NN HKI))))) (PP-MNR (IN by) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG affecting) (NP (NP (DT the) (NN Vmax)) (PP (IN of) (NP (NN HKI))) (PP (IN for) (NP (NN glucose)))) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 2B)) (-RRB- -RRB-)))))) (. .)) )
( (S (ADVP-TMP (RB Then)) (, ,) (NP-SBJ (PRP we)) (VP (VBD evaluated) (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (NP (DT the) (NN LD)) (PP (IN of) (NP (NN RanBP2))))) (PP (IN on) (NP (DT the) (NN HK) (NN activity)))) (PP (IN in) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NP (NP (DT a) (VBN fixed) (JJ inhibitory) (NN concentration)) (PP (IN of) (NP (NN Cox11)))) (, ,) (NP (NP (VBG saturating) (NN concentration)) (PP (IN of) (NP (NN glucose) (NN substrate)))) (, ,) (CC and) (NP (NP (VBG increasing) (NNS concentrations)) (PP (IN of) (NP (NN LD))))))))) (. .)) )
( (S (S (SBAR-ADV (IN As) (S (NP-SBJ-2 (-NONE- *PRO*)) (VP (VBN shown) (NP-2 (-NONE- *)) (PP (IN in) (NP (NN Figure) (NN 2C)))))) (, ,) (NP-SBJ (DT the) (NN LD) (NN domain)) (ADVP-MNR (RB sharply)) (VP (VBD reversed) (NP (NP (DT the) (JJ inhibitory) (NN effect)) (PP (IN of) (NP (NN Cox11))) (PP (IN on) (NP (NN HKI) (NN activity)))) (PP-MNR (IN in) (NP (DT a) (ADJP (NN concentration) (HYPH -) (JJ dependent)) (NN manner))))) (, ,) (CC but) (S (PP (IN under) (NP (NP (ADJP (VBG saturating) (-LRB- -LRB-) (CC and) (JJ stochiometric)) (-RRB- -RRB-) (NNS amounts)) (PP (IN of) (NP (NN LD))))) (, ,) (NP-SBJ (NP (DT the) (NN velocity)) (PP (IN of) (NP (DT the) (NN reaction)))) (VP (VBD did) (RB not) (VP (VB reach) (NP (NP (DT that)) (VP (VBN observed) (NP (-NONE- *)) (PP (IN for) (NP (NN HKI) (NN activity))) (PP (IN in) (NP (NP (DT the) (NN absence)) (PP (IN of) (NP (NN Cox11))))) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 2A)) (-RRB- -RRB-)))) (, ,) (S-ADV (NP-SBJ (-NONE- *PRO*)) (VP (VBG suggesting) (SBAR (-NONE- *0*) (S (NP-SBJ (DT the) (NN LD)) (PP (IN by) (NP (PRP itself))) (VP (MD may) (ADVP (RB also)) (VP (VB have) (NP (NP (DT an) (NN effect)) (PP (IN on) (NP (NN HKI) (NN activity))))))))))))) (. .)) )
( (S (ADVP (RB Indeed)) (, ,) (NP-SBJ (NP (DT a) (NN saturating) (NN concentration)) (PP (IN of) (NP (NN LD)))) (VP (VBD reduced) (NP (NP (NP (DT the) (NN Vmax)) (CONJP (CC but) (RB not)) (NP (DT the) (NN Km))) (PP (IN of) (NP (NN HKI))) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 2D)) (-RRB- -RRB-))) (PP-EXT (IN by) (NP (QP (SYM ~) (CD 20)) (NN %))) (PP (IN under) (NP (JJ similar) (NNS conditions)))) (. .)) )
( (HEADING (NP (NN Figure) (CD 2))) )
( (HEADING (NP (NP (NN Effect)) (PP (IN of) (NP (NN Cox11) (CC and) (NN RanBP2))) (PP (IN on) (NP (NN HKI) (NN Activity))))) )
( (CAPTION (NP (LST (-LRB- -LRB-) (LS A) (-RRB- -RRB-)) (NP (NP (NN Saturation) (NNS kinetics)) (, ,) (NP-ADV (NN rate) (CC versus) (NN glucose))) (PP (IN of) (NP (NN HKI) (PRN (-LRB- -LRB-) (NP (CD 0.24) (NNS μg)) (-RRB- -RRB-)))) (PP (IN in) (NP (NP (DT the) (NML (NML (NN absence) (PRN (-LRB- -LRB-) (NP (JJ solid) (NNS circles)) (-RRB- -RRB-))) (CC and) (NML (NN presence)))) (PP (IN of) (NP (NN Cox11))))) (PRN (-LRB- -LRB-) (FRAG (NP (JJ open) (NNS circles)) (, ,) (NP (CD 0.25) (NNS nM))) (: ;) (FRAG (NP (JJ solid) (NNS triangles)) (, ,) (NP (CD 7.5) (NNS nM))) (-RRB- -RRB-)) (. .))) )
( (CAPTION (S (NP-SBJ (NP (DT The) (NN activity)) (PP (IN of) (NP (NN HKI)))) (VP (VBZ decreases) (PP (IN with) (NP (NP (VBG increasing) (NNS concentrations)) (PP (IN of) (NP (NN Cox11)))))) (. .))) )
( (CAPTION (S (NP-SBJ-1 (DT No) (JJ measurable) (NN HKI) (NN activity)) (VP (VBD was) (VP (VBN recorded) (NP-1 (-NONE- *)) (PP (IN in) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NP (CD 15) (NNS nM)) (PP (IN of) (NP (NN Cox11))))))) (CIT (-LRB- -LRB-) (JJ unpublished) (NNS data) (-RRB- -RRB-)))) (. .))) )
( (CAPTION (NP (LST (-LRB- -LRB-) (LS B) (-RRB- -RRB-)) (NP (NML (NNP Hanes) (HYPH -) (NNP Wolf)) (NN plot)) (PP (IN of) (PRN (-LRB- -LRB-) (NP (NN A)) (-RRB- -RRB-)) (-LRB- -LRB-) (NP (NP (NP (CD 1)) (PP (SYM /) (NP (NN rate)))) (CC versus) (NP (NN glucose)))) (-RRB- -RRB-) (PP (IN in) (NP (NP (DT the) (NML (NN absence) (CC and) (NN presence))) (PP (IN of) (NP (NP (VBN fixed) (NNS concentrations)) (PP (IN of) (NP (NN Cox11))))))) (. .))) )
( (CAPTION (S (NP-SBJ (NP (NN Linearity)) (PP (IN of) (NP (JJ reciprocal) (NNS plots)))) (ADVP (RB also)) (VP (VBD supported) (NP (NP (DT the) (JJ hyperbolic) (NN behavior)) (PP (IN of) (NP (DT the) (NNS reactions)))) (CIT (-LRB- -LRB-) (JJ unpublished) (NNS data) (-RRB- -RRB-))) (. .))) )
( (CAPTION (S (NP-SBJ (NN Cox11)) (VP (VBZ behaves) (PP (IN as) (NP (NP (DT a) (JJ noncompetitive) (NN inhibitor)) (PP (IN of) (NP (NN HKI))))) (PP-MNR (IN by) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG reducing) (NP (NP (NP (DT the) (NN Vmax)) (PP (IN of) (NP (NN HKI)))) (CONJP (CC but) (RB not)) (NP (NP (PRP$ its) (NN Km)) (PP (IN toward) (NP (NN glucose))))))))) (. .))) )
( (CAPTION (S (LST (-LRB- -LRB-) (LS C) (-RRB- -RRB-)) (NP-SBJ-1 (NN HKI) (NN rate)) (VP (VBZ is) (VP (VBN plotted) (NP-1 (-NONE- *)) (PP (IN as) (NP (NP (DT a) (NN function)) (PP (IN of) (NP (NN LD) (NN concentration))))) (PP (IN at) (NP (NML (NML (VBG saturating) (NN glucose)) (CC and) (NML (VBN fixed) (NN Cox11) (PRN (-LRB- -LRB-) (NP (CD 7.5) (NNS nM)) (-RRB- -RRB-)))) (NNS concentrations))))) (. .))) )
( (CAPTION (S-IMP (NP-SBJ (-NONE- *PRO*)) (VP (VB Note) (SBAR (IN that) (S (NP-SBJ (NP (VBG increasing) (NNS concentrations)) (PP (IN of) (NP (NP (DT the) (NN LD)) (PP (IN of) (NP (NN RanBP2)))))) (VP (VBP reverse) (NP (NP (DT the) (NN inhibition)) (PP (IN of) (NP (NN HKI) (NN activity))) (PP (IN by) (NP (NN Cox11)))))))) (. .))) )
( (CAPTION (S (NP-SBJ-1 (NP (DT A) (ADJP (RB half) (HYPH -) (JJ maximal)) (NN effect)) (PP (IN of) (NP (NP (DT the) (NN LD)) (PP (IN of) (NP (NN RanBP2))))) (PP (IN on) (NP (NN HKI) (NN activity))) (PP (IN in) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NP (CD 7.5) (NNS nM)) (PP (IN of) (NP (NN Cox11)))))))) (VP (VBD was) (VP (VBN observed) (NP-1 (-NONE- *)) (PP (IN at) (NP (NP (DT a) (NN concentration)) (PP (IN of) (NP (NP (QP (SYM ~) (CD 0.05)) (NNS nM)) (PP (IN of) (NP (NN LD))))))))) (. .))) )
( (CAPTION (NP (LST (-LRB- -LRB-) (LS D) (-RRB- -RRB-)) (NP (NML (NN Rate) (CC versus) (NN glucose)) (NN plot)) (PP (IN in) (NP (NP (DT the) (NML (NN absence) (CC and) (NN presence))) (PP (IN of) (NP (NP (DT the) (NN LD)) (PP (IN of) (NP (NN RanBP2))))))) (. .))) )
( (CAPTION (S (PP (IN At) (NP (NP (DT a) (NN saturating) (NN concentration)) (PP (IN of) (NP (NP (DT the) (NN LD)) (PP (IN of) (NP (NN RanBP2))))) (PRN (-LRB- -LRB-) (NP (CD 3.75) (NNS nM)) (-RRB- -RRB-)))) (, ,) (NP-SBJ-1 (DT the) (NN HKI) (NN activity)) (VP (VBD was) (VP (VBN reduced) (NP-1 (-NONE- *)) (PP-EXT (IN by) (NP (QP (IN about) (CD 20)) (NN %))))) (. .))) )
( (CAPTION (NP (NP (NP (NN v)) (, ,) (NP (NN rate))) (: ;) (NP (NP (NN S)) (, ,) (NP (NN glucose))) (. .))) )
( (HEADING (S (NP-SBJ (NN RanBP2)) (VP (VBZ Colocalizes) (PP (IN with) (NP (NN HK1) (, ,) (NN Cox11) (, ,) (CC and) (NN mHsp70))) (PP-LOC (IN in) (NP (NP (DT the) (NN Retina)) (CC and) (NP (VBN Cultured) (NNS Neurons))))))) )
( (S (PP (IN In) (NP (NP (NN addition)) (PP (IN to) (NP (NP (PRP$ its) (NN presence)) (PP (IN at) (NP (NP (DT the) (NN vicinity)) (PP (IN of) (NP (NNS NPCs))))))))) (, ,) (NP-SBJ (PRP we)) (VP (VBP have) (VP (VBN shown) (ADVP-TMP (RB previously)) (SBAR (IN that) (S (NP-SBJ-1 (NN RanBP2)) (VP (VBZ is) (UCP-PRD (VP (VBN localized) (NP-1 (-NONE- *)) (PP-LOC (IN to) (NP-2 (-NONE- *RNR*)))) (CC and) (ADJP (JJ abundant) (PP-LOC (IN in) (NP-2 (-NONE- *RNR*)))) (NP-2 (NP (DT the) (ADJP (NNS mitochondria) (HYPH -) (JJ rich)) (JJ ellipsoid) (JJ subcellular) (NN compartment)) (PP (IN of) (NP (NP (ADJP (NN photosensory) (PRN (-LRB- -LRB-) (NP (NN photoreceptor)) (-RRB- -RRB-))) (NNS neurons)) (PP (IN of) (NP (DT the) (NN retina))))))) (PRN (-LRB- [) (NP (CD 19)) (-RRB- ]))))))) (. .)) )
( (S (NP-SBJ (PRP We)) (VP (VBD extended) (NP (NP (DT the) (JJ subcellular) (NN colocalization) (NNS studies)) (PP (IN on) (NP (NP (NN RanBP2)) (CC and) (NP (PRP$ its) (JJ novel) (NNS partners))))) (PP-MNR (IN by) (NP (NN immunocytochemistry))) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB determine) (SBAR (IN if) (S (NP-SBJ (NN RanBP2) (, ,) (NN Cox11) (, ,) (NN HKI) (, ,) (CC and) (NN mHsp70)) (VP (VBP colocalize) (PP-LOC (IN in) (NP (NP (JJ hippocampal) (NNS neurons) (PRN (-LRB- -LRB-) (NP (NP (NN Figure) (NN 3A)) (PP (SYM –) (NP (NN 3C)))) (-RRB- -RRB-))) (, ,) (NP (NML (JJ cerebral) (NN cortex)) (NNS neurons) (PRN (-LRB- -LRB-) (NP (NP (NN Figure) (NN 3D)) (PP (SYM –) (NP (NN 3F)))) (-RRB- -RRB-))) (, ,) (NP (NP (JJ ellipsoid) (-LRB- -LRB-) (ADJP (NNS mitochondria) (HYPH -) (JJ rich)) (-RRB- -RRB-) (JJ subcellular) (NNS compartments)) (PP (IN of) (NP (NP (JJ photosensory) (NNS neurons)) (PP (IN of) (NP (DT the) (NN retina) (PRN (-LRB- -LRB-) (NP (NP (NN Figure) (NN 3G)) (PP (SYM –) (NP (NN 3O)))) (-RRB- -RRB-))))))) (, ,) (CC and) (NP (NP (VBN dissociated) (NML (NML (JJ primary) (NN glia)) (CC and) (NML (NN neuron) (NNS cultures)))) (PP (IN from) (NP (DT the) (NN brain))) (PRN (-LRB- -LRB-) (NP (NP (NN Figure) (NN 3P)) (PP (SYM –) (NP (NN 3Z)))) (-RRB- -RRB-)))))))))))) (. .)) )
( (S (NP-SBJ (NP (JJ Double) (NN immunostaining)) (PP (IN with) (NP (NP (NNS antibodies)) (PP (IN against) (NP (DT these) (NN proteins)))))) (VP (VBD showed) (SBAR (IN that) (S (NP-SBJ (PRP they)) (VP (VBP colocalize) (PP (IN to) (NP (DT the) (NNS mitochondria))) (PRN (-LRB- -LRB-) (NP (NP (NN Figure) (NN 3A)) (PP (SYM –) (NP (NN 3Z)))) (-RRB- -RRB-)))))) (. .)) )
( (HEADING (NP (NN Figure) (CD 3))) )
( (HEADING (NP (NP (NN Localization)) (PP (IN of) (NP (NP (NN RanBP2)) (CC and) (NP (PRP$ Its) (NN LD) (JJ Molecular) (NNS Partners)))))) )
( (CAPTION (S (-LRB- -LRB-) (NP-SBJ (NP (NN A)) (PP (SYM –) (NP (NN F)))) (-RRB- -RRB-) (VP (VBP are) (NP-PRD (NP (NP (JJ thin) (NNS cryosections)) (PP (IN of) (NP (NP (DT an) (NN area)) (PP (IN of) (NP (DT the) (NML (NML (NN hipocampus) (PRN (-LRB- -LRB-) (NP (NN CA1) (NNS neurons)) (-RRB- -RRB-))) (CC and) (NML (JJ cerebral) (NN cortex))) (, ,) (ADVP (RB respectively))))))) (, ,) (VP (VBN immunostained) (NP (-NONE- *)) (PP (IN against) (NP (NP (NN HKI) (PRN (-LRB- -LRB-) (NP (NN A) (CC and) (NN D)) (-RRB- -RRB-))) (, ,) (NP (NN RanBP2) (PRN (-LRB- -LRB-) (NP (NN B) (CC and) (NN E)) (-RRB- -RRB-))) (, ,) (CC and) (NP (NP (VBN merged) (NNS images)) (ADVP (RB thereof)) (PRN (-LRB- -LRB-) (NP (NN C) (CC and) (NN F)) (-RRB- -RRB-)))))))) (. .))) )
( (CAPTION (S-IMP (NP-SBJ (-NONE- *PRO*)) (VP (VB Note) (SBAR (IN that) (S (SBAR-ADV (IN while) (S (NP-SBJ-1 (NN RanBP2) (CC and) (NN HKI)) (VP (VP (VBP are) (ADVP (RB widely)) (VP (VBN expressed) (NP-1 (-NONE- *)) (PP (IN among) (NP-2 (-NONE- *RNR*))))) (CC and) (VP (VBP colocalize) (PP (IN to) (NP-2 (-NONE- *RNR*)))) (NP-2 (JJ hippocampal) (NNS neurons)) (PRN (-LRB- -LRB-) (NP (NN C)) (-RRB- -RRB-))))) (, ,) (NP-SBJ-3 (NP (NN HKI) (NML (NN expression) (CC and) (NN localization))) (PP (IN with) (NP (NN RanBP2)))) (VP (VBZ is) (VP (VBN restricted) (NP-3 (-NONE- *)) (PP (IN to) (NP (NP (NP (DT a) (NN subset)) (PP (IN of) (NP (JJ cortical) (NNS neurons)))) (-LRB- -LRB-) (NP (JJ likely) (NNS interneurons))))) (-RRB- -RRB-) (PRN (-LRB- -LRB-) (NN F) (-RRB- -RRB-)))))) (. .))) )
( (CAPTION (S (NP-SBJ-1 (NP (NNS Images)) (PP (IN of) (NP (NP (DT the) (JJ distal) (NN region)) (PP (IN of) (NP (NP (JJ bovine) (JJ retinal) (NNS cryosections)) (VP (VBG comprising) (NP (NP (NN part)) (PP (IN of) (NP (NP (DT the) (JJ nuclear) (NN layer)) (PP (IN of) (NP (NP (NN photoreceptor) (NNS neurons)) (CC and) (NP (PRP$ their) (JJ inner) (-LRB- -LRB-) (ADJP (JJ myoid) (CC and) (JJ ellipsoid)) (-RRB- -RRB-) (NN segment) (NN compartment))))))) (PRN (-LRB- -LRB-) (NP (NP (NN G)) (PP (SYM –) (NP (NN O)))) (-RRB- -RRB-)))))))) (VP (VBP are) (VP (VBN immunostained) (NP-1 (-NONE- *)) (PP (IN against) (NP (NP (NN mHsp70) (PRN (-LRB- -LRB-) (NP (NN G)) (-RRB- -RRB-))) (CC and) (NP (NN RanBP2) (PRN (-LRB- -LRB-) (NP (NN H)) (-RRB- -RRB-))) (, ,) (NP (NN mHsp70) (PRN (-LRB- -LRB-) (NP (NN J)) (-RRB- -RRB-))) (CC and) (NP (NN Cox11) (PRN (-LRB- -LRB-) (NP (NN K)) (-RRB- -RRB-))) (, ,) (NP (NN HKI) (PRN (-LRB- -LRB-) (NP (NN M)) (-RRB- -RRB-))) (CC and) (NP (NN Cox11) (PRN (-LRB- -LRB-) (NP (NN N)) (-RRB- -RRB-))) (, ,) (CC and) (NP (NP (VBN merged) (NNS images)) (ADVP (RB thereof))))) (PRN (-LRB- -LRB-) (NP (NP (NN I)) (PP (SYM –) (NP (NN O)))) (-RRB- -RRB-)))) (. .))) )
( (CAPTION (S-IMP (NP-SBJ (-NONE- *PRO*)) (VP (VB Note) (NP (NP (NP (DT the) (JJ prominent) (NN localization)) (PP (IN of) (NP (NN RanBP2) (, ,) (NN mHsp70) (, ,) (CC and) (NN Cox11))) (PP-LOC (IN at) (NP (NP (DT the) (ADJP (NNS mitochondria) (HYPH -) (JJ rich)) (JJ ellipsoid) (NN compartment)) (PP (IN of) (NP (NNS photoreceptors)))))) (CC and) (NP (NP (DT the) (NN colocalization)) (PP (IN of) (NP (NN RanBP2) (CC and) (NN Cox11))) (PP (IN with) (NP (NN mHsp70))) (PRN (-LRB- -LRB-) (NP (NN I) (CC and) (NN L)) (-RRB- -RRB-)))) (, ,) (SBAR-ADV (IN while) (S (NP-SBJ-1 (NP (NN HKI) (NN colocalization)) (PP (IN with) (NP (NN Cox11)))) (VP (VBD was) (VP (VBN limited) (NP-1 (-NONE- *)) (PP (IN to) (NP (VBN restricted) (NNS foci))) (PRN (-LRB- -LRB-) (NP (NN R)) (, ,) (NP (NNS arrowheads)) (-RRB- -RRB-))))))) (. .))) )
( (CAPTION (S (NP-SBJ (NP (NML (JJ High) (HYPH -) (NN resolution)) (NNS images)) (PP (IN of) (NP (VBN dissociated) (NML (NML (JJ primary) (JJ cerebral) (NNS neurons)) (CC and) (NML (JJ glial) (NNS cells)))))) (VP (VBD confirmed) (SBAR (IN that) (S (NP-SBJ (NP (DT the) (NN colocalization)) (PP (IN of) (NP (NN HKI) (CC and) (NN Cox11)))) (VP (VBD was) (ADJP-PRD (RB highly) (JJ restricted) (PRN (-LRB- -LRB-) (NP (NP (NN P)) (PP (SYM –) (NP (NN R)))) (-RRB- -RRB-))) (, ,) (SBAR-ADV (IN while) (S (NP-SBJ (NN RanBP2)) (ADVP (RB extensively)) (VP (VBD colocalized) (PP (IN with) (NP (NP (NN HKI) (PRN (-LRB- -LRB-) (NP (NP (NN S)) (PP (SYM –) (NP (NN U)))) (-RRB- -RRB-))) (CC and) (NP (NN mHsp70) (PRN (-LRB- -LRB-) (NP (NP (NN V)) (PP (SYM –) (NP (NN Z)))) (-RRB- -RRB-)))))))))))) (. .))) )
( (CAPTION (S (NP-SBJ (NP (NN Scale) (NNS bars)) (PP (IN in) (NP (NP (NP (NN A)) (PP (SYM –) (NP (NN O)))) (CC and) (NP (NP (NN P)) (PP (SYM –) (NP (NN Z))))))) (VP (VBP are) (NP-PRD (NML (CD 40) (CC and) (CD 10)) (NNS μm)) (, ,) (ADVP (RB respectively))) (. .))) )
( (CAPTION (NP (NP (NN ONL)) (, ,) (NP (JJ outer) (JJ nuclear) (NN layer)) (. .))) )
( (HEADING (S (NP-SBJ (NP (NN Haploinsufficiency)) (PP (IN of) (NP (NN RanBP2)))) (VP (VBZ Causes) (NP (NP (NP (VBN Decreased) (NNS Levels)) (PP (IN of) (NP (NN HKI)))) (CC and) (NP (NP (JJ Partial) (NN Mislocalization)) (PP (IN of) (NP (NN HKI)))))))) )
( (S (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO To) (VP (VB determine) (NP (NP (DT the) (JJ physiological) (NNS implications)) (PP (IN of) (NP (NP (DT the) (NN interaction)) (PP (IN between) (NP (NP (NN RanBP2)) (CC and) (NP (NN HKI)) (-LRB- -LRB-) (CC and) (NP (JJ other) (NNS partners)))))))))) (-RRB- -RRB-) (, ,) (NP-SBJ (PRP we)) (VP (VBD employed) (NP (NP (DT a) (JJ murine) (NML (JJ embryonic) (NN stem)) (NN 129Ola) (NN cell) (NN line)) (PP (IN with) (NP (NP (DT a) (VBN targeted) (NN RanBP2) (NN locus)) (VP (VBN produced) (NP (-NONE- *)) (PP (IN by) (NP-LGS (NN gene) (HYPH -) (NN trapping))) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB produce) (NP (JJ stable) (UCP (ADJP (JJ inbred) (PRN (-LRB- -LRB-) (ADJP (JJ coisogenic)) (-RRB- -RRB-))) (CC and) (NML (JJ mixed) (NN background))) (NNS lines)) (, ,) (ADVP (RB respectively))))))))) (PRN (-LRB- -LRB-) (NP (NN Figure) (NML (NN 4A) (CC and) (NN 4B))) (-RRB- -RRB-))) (. .)) )
( (S (NP-SBJ (NP (NN Genotyping)) (PP (IN of) (NP (NML (CD 299) (NN F2)) (NN offspring)))) (VP (VBD revealed) (NP (NP (NP (DT a) (NML (NML (NN RanBP2) (SYM +) (HYPH /) (SYM +)) (SYM :) (NML (NN RanBP2) (SYM +) (HYPH /) (SYM −)) (SYM :) (NML (NN RanBP2) (SYM −) (HYPH /) (SYM −))) (NN distribution)) (-LRB- -LRB-) (NP (CD 89) (SYM :) (CD 210) (SYM :) (CD 0))) (-RRB- -RRB-) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VP (VBD deviated) (PP (IN from) (NP (DT the) (VBN expected) (JJ Mendelian) (NN ratio)))) (CC and) (VP (VBZ supports) (SBAR (IN that) (S (NP-SBJ (DT the) (NML (NN RanBP2) (SYM −) (HYPH /) (SYM −)) (NNS mice)) (VP (VBD were) (ADJP-PRD (RB embryonically) (JJ lethal))))))))))) (. .)) )
( (S (NP-SBJ (NN E12.5) (NNS embryos)) (VP (VBP show) (NP (NP (JJ strong) (NN expression)) (PP (IN of) (NP (NN RanBP2))) (PP-LOC (PP (IN in) (NP (DT the) (JJ optic) (NN vesicle))) (CC and) (PP (IN throughout) (NP (NP (JJ much)) (PP (IN of) (NP (NP (DT the) (NN embryo)) (, ,) (SBAR (WHNP-1 (WDT which)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBD had) (NP (DT no) (JJ apparent) (JJ developmental) (NNS abnormalities))))))))))) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 4C)) (-RRB- -RRB-))) (. .)) )
( (S (S (PP (IN In) (NP (NP (NN agreement)) (PP (IN with) (NP (JJ previous) (NN immunocytochemistry) (NN analysis) (PRN (-LRB- [) (NP (CD 19)) (-RRB- ])))))) (, ,) (NP-SBJ-1 (DT the) (NN RanBP2) (NN gene)) (VP (VBZ is) (VP (VBN expressed) (NP-1 (-NONE- *)) (PP-LOC (IN across) (NP (JJ mature) (JJ retinal) (NNS neurons)))))) (, ,) (CC but) (S (NP-SBJ (NP (NN expression)) (PP-LOC (IN in) (NP (NP (NN ganglion) (NNS cells)) (PP (IN of) (NP (DT the) (JJ adult) (NN retina)))))) (VP (VBD was) (ADJP-PRD (RB extremely) (JJ strong)) (PRN (-LRB- -LRB-) (NP (NN Figure) (NML (NN 4D) (CC and) (NN 4E))) (-RRB- -RRB-)))) (. .)) )
( (HEADING (NP (NN Figure) (CD 4))) )
( (HEADING (NP (NP (NN Insertion) (NN Mutagenesis)) (PP (IN of) (NP (DT the) (JJ Murine) (NN RanBP2) (NN Gene))))) )
( (CAPTION (NP (LST (-LRB- -LRB-) (LS A) (-RRB- -RRB-)) (NP (NN Diagram)) (PP (IN of) (NP (NP (NP (DT the) (JJ genomic) (NN region)) (PP (IN of) (NP (NN RanBP2)))) (VP (VBN disrupted) (NP (-NONE- *)) (PP (IN by) (NP-LGS (NP (NML (NN insertion) (NN trap)) (NN mutagenesis)) (PP (IN with) (NP (NP (DT a) (JJ bicistronic) (NN reporter) (NN vector)) (PP-LOC (IN between) (NP (NN exon) (NML (CD 1) (CC and) (CD 2))))))))))) (. .))) )
( (CAPTION (S (NP-SBJ (DT The) (JJ bicistronic) (NN transcript)) (VP (VBZ produces) (NP (CD two) (NN proteins)) (PP (IN under) (NP (NP (NN regulation)) (PP (IN of) (NP (NN RanBP2)))))) (. .))) )
( (CAPTION (S (PP-TMP (IN Upon) (NP (NP (NN splicing)) (PP (IN of) (NP (NN RanBP2))))) (, ,) (NP-SBJ-1 (NP (DT a) (NN fusion)) (PP (IN between) (NP (NP (NN exon) (CD 1)) (CC and) (NP (NP (NN β) (HYPH -) (NN geo)) (-LRB- -LRB-) (NP (NP (DT a) (NN fusion)) (PP (IN between) (NP (DT the) (NML (NML (NN β) (HYPH -) (NN gal)) (CC and) (NML (NN neo))) (NNS genes)))))))) (-RRB- -RRB-) (VP (VBZ is) (VP (VBN generated) (NP-1 (-NONE- *)) (, ,) (SBAR-ADV (IN while) (S (NP-SBJ-2 (NP (JJ human) (JJ placental) (NN alkaline) (NN phophatase)) (-LRB- -LRB-) (NP (NN PLAP))) (-RRB- -RRB-) (VP (VBZ is) (ADVP-MNR (RB independently)) (VP (VBN translated) (NP-2 (-NONE- *)) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (DT the) (NML (JJ internal) (NN ribosome) (NN entry)) (NN site)))))))))) (. .))) )
( (CAPTION (S (S-ADV (NP-SBJ (-NONE- *PRO*)) (ADJP-PRD (JJ Consistent) (PP (IN with) (NP (JJ previous) (NNS studies))))) (, ,) (NP-SBJ-1 (NP (DT the) (NN expression)) (PP (IN of) (NP (DT the) (JJ former)))) (VP (VBZ is) (VP (VBN directed) (NP-1 (-NONE- *)) (PP (IN to) (NP (NN cell) (NNS bodies))) (, ,) (SBAR-ADV (IN while) (S (NP-SBJ-2 (NP (NN expression)) (PP (IN of) (NP (DT the) (JJ latter)))) (VP (VBZ is) (VP (VBN targeted) (NP-2 (-NONE- *)) (PP (IN to) (NP (DT the) (JJ axonal) (NNS processes))) (PRN (-LRB- [) (NP (CD 67) (, ,) (CD 68)) (-RRB- ])))))))) (. .))) )
( (CAPTION (S (NP-SBJ (JJ Transcriptional) (NML (CD 5) (SYM ′)) (NN RACE) (NN analysis)) (VP (VBZ detects) (NP (NP (DT a) (NN fusion)) (PP (IN between) (NP (NP (NN exon) (CD 1)) (CC and) (NP (NN β) (HYPH -) (NN geo)))))) (. .))) )
( (CAPTION (NP (LST (-LRB- -LRB-) (LS B) (-RRB- -RRB-)) (NP (NNP Southern) (NN analysis)) (PP (IN of) (NP (NP (DT the) (NN RanBP2) (NN locus)) (PP (IN of) (NP (NP (UCP (NML (JJ wild) (HYPH -) (NN type)) (CC and) (ADJP (JJ heterozygous))) (JJ genomic) (NN DNA)) (PP (IN of) (NP (NP (NNS tails)) (PP (IN of) (NP (NP (NN F1) (NNS mice)) (VP (VBN digested) (NP (-NONE- *)) (PP-MNR (IN with) (NP (NP (NN PpuMI) (PRN (-LRB- -LRB-) (NP (JJ left) (NN panel)) (-RRB- -RRB-))) (CC and) (NP (NN HindIII) (PRN (-LRB- -LRB-) (NP (JJ right) (NN panel)) (-RRB- -RRB-))))) (PP-MNR (IN with) (NP (NP (NNS probes)) (PP-LOC (IN at) (NP (NP (DT the) (NML (NML (CD 3) (SYM ′) (PRN (-LRB- -LRB-) (NP (JJ left) (NN panel)) (-RRB- -RRB-))) (CC and) (NML (CD 5) (SYM ′) (PRN (-LRB- -LRB-) (NP (JJ right) (NN panel)) (-RRB- -RRB-)))) (NN flanking) (NNS regions)) (PP (IN of) (NP (DT the) (NN insertion) (NN breakpoint)))))))))))))))) (. .))) )
( (CAPTION (S (NP-SBJ (NN Q1)) (VP (VBZ is) (NP-PRD (NP (DT a) (NN cosmid)) (VP (VBG containing) (NP (DT the) (NN RanBP2) (NN gene)) (PP (IN up) (PP (IN to) (NP (NN exon) (CD 20)))) (PRN (-LRB- [) (NP (CD 4)) (-RRB- ]))))) (. .))) )
( (CAPTION (NP (LST (-LRB- -LRB-) (LS C) (-RRB- -RRB-)) (NP (JJ Lateroventral) (NN view)) (PP (IN of) (NP (NP (DT a) (NML (JJ whole) (HYPH -) (NN mount)) (NN stain)) (PP (IN of) (NP (DT a) (NML (QP (SYM ~) (CD 12.5)) (NN dpc)) (JJ heterozygous) (NN embryo))) (PP (IN for) (NP (NML (NML (NN PLAP)) (CC and) (NML (NN β) (HYPH -) (NN gal) (PRN (-LRB- -LRB-) (NP (NN inset) (NN picture)) (-RRB- -RRB-)))) (NNS activities))))) (. .))) )
( (CAPTION (S (SBAR-ADV (IN Although) (S (NP-SBJ-1 (NN PLAP)) (VP (VBD was) (ADVP (RB broadly)) (VP (VBN expressed) (NP-1 (-NONE- *)) (-LRB- -LRB-) (NP-LOC (ADVP (FW e.g.)) (, ,) (NNS somites) (, ,) (NNS limbs) (, ,) (CC and) (NN CNS)))))) (-RRB- -RRB-) (, ,) (NP-SBJ (DT the) (NML (NML (NN PLAP)) (CC and) (NML (NN β) (HYPH -) (NN Gal) (PRN (-LRB- -LRB-) (NP (NN inset) (NN picture)) (-RRB- -RRB-)))) (NN expression)) (VP (VBD was) (ADJP-PRD (RB particularly) (JJ high)) (PP-LOC (IN in) (NP (DT the) (JJ optic) (NN vesicle))) (PRN (-LRB- -LRB-) (NP (NN arrow)) (-RRB- -RRB-))) (. .))) )
( (CAPTION (NP (NP (NML (NN X) (HYPH -) (NN gal)) (ADJP (ADJP (JJ single) (PRN (-LRB- -LRB-) (NP (NN D)) (-RRB- -RRB-))) (CC and) (ADJP (JJ combined))) (NN staining)) (PP (IN with) (NP (NN PLAP) (PRN (-LRB- -LRB-) (NP (NN E)) (-RRB- -RRB-)))) (PP (IN of) (NP (NP (DT a) (JJ retinal) (NN section)) (PP (IN of) (NP (DT a) (ADJP (NP (CD 3) (HYPH -) (NN mo)) (HYPH -) (JJ old)) (NML (NN RanBP2) (SYM +) (HYPH /) (SYM −)) (NN mouse))))) (. .))) )
( (CAPTION (S (S-ADV (NP-SBJ (-NONE- *PRO*)) (ADJP-PRD (JJ Consistent) (PP (IN with) (NP (JJ previous) (NN immunocytochemistry) (NNS studies))))) (, ,) (NP-SBJ-1 (NML (NN β) (HYPH -) (NN Gal)) (NN activity)) (VP (VBZ is) (VP (VBN detected) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (NP (DT the) (NML (NML (JJ neuroretinal) (NNS bodies)) (CC and) (NML (JJ inner) (NN segment) (NN compartment)))) (PP (IN of) (NP (NP (NNS photoreceptors)) (PP (IN with) (NP (NP (ADJP (RB conspicuously) (JJ strong)) (NN expression)) (PP-LOC (IN in) (NP (NN ganglion) (NNS cells))))))))))) (. .))) )
( (CAPTION (S (NP-SBJ-1 (NN PLAP) (NN expression)) (VP (VBZ is) (VP (VBN found) (NP-1 (-NONE- *)) (PP-LOC (IN throughout) (NP (NP (DT the) (ADJP (JJ plexiform) (HYPH /) (JJ synaptic)) (NNS layers)) (CC and) (NP (NP (JJ outer) (NN segment)) (PP (IN of) (NP (NNS photoreceptors)))))) (PRN (-LRB- -LRB-) (NP (NN E)) (-RRB- -RRB-)))) (. .))) )
( (CAPTION (NP (NP (NP (NN GC)) (, ,) (NP (NN ganglion) (NN cell))) (: ;) (NP (NP (NN PLAP)) (, ,) (NP (JJ human) (JJ placental) (NN alkaline) (NN phophatase))) (: ;) (NP (NP (NN ROS)) (, ,) (NP (NN rod) (JJ outer) (NN segment))) (: ;) (NP (NP (NN RIS)) (, ,) (NP (NN rod) (JJ inner) (NN segment))) (: ;) (NP (NP (NN ONL)) (, ,) (NP (JJ outer) (JJ nuclear) (NN layer))) (: ;) (NP (NP (NN OPL)) (, ,) (NP (JJ outer) (JJ plexiform) (-LRB- -LRB-) (JJ synaptic) (-RRB- -RRB-) (NN layer))) (: ;) (NP (NP (NN INL)) (, ,) (NP (JJ inner) (JJ nuclear) (NN layer))) (: ;) (NP (NP (NN IPL)) (, ,) (NP (JJ inner) (JJ plexiform) (-LRB- -LRB-) (JJ synaptic) (-RRB- -RRB-) (NN layer))) (: ;) (NP (NP (NN GC)) (, ,) (NP (NML (NN ganglion) (NN cell)) (NN layer))) (. .))) )
( (S (PP (IN In) (NP (NP (NN light)) (PP (IN of) (NP (NP (NP (DT the) (NN association)) (ADVP (FW in) (FW vivo)) (PP (IN of) (NP (NN RanBP2))) (PP (IN with) (NP (NN Cox11) (CC and) (NN HKI))) (PRN (-LRB- -LRB-) (NP (NNS Figures) (NML (CD 1) (CC and) (CD 3))) (-RRB- -RRB-))) (, ,) (NP (NP (JJ profound) (ADJP (FW in) (FW vitro)) (NN modulation)) (PP (IN of) (NP (ADJP (NN HKI) (JJ enzymatic)) (NN activity))) (PP (IN by) (NP (NN RanBP2) (CC and) (NN Cox11))) (PRN (-LRB- -LRB-) (NP (NN Figure) (CD 2)) (-RRB- -RRB-))) (, ,) (CC and) (NP (NP (DT the) (JJ critical) (NN role)) (PP (IN of) (NP (NN HKI))) (PP (IN in) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG catalyzing) (NP (NP (DT a) (ADJP (NN rate) (HYPH -) (VBG limiting)) (NN step)) (PP (IN of) (NP (NN glycolysis)))))))))))) (, ,) (NP-SBJ (PRP we)) (VP (VBD probed) (SBAR (IN whether) (S (NP-SBJ (NML (NN RanBP2) (SYM +) (HYPH /) (SYM −)) (NNS mice)) (VP (VBD presented) (NP (NP (NNS disturbances)) (PP (IN in) (NP (NP (NN HKI)) (, ,) (NP (NN Cox11)) (, ,) (CC and) (NP (NN energy) (NN homeostasis))))))))) (. .)) )
( (S (S (NP-SBJ (NP (JJ Monoallelic) (NN expression)) (PP (IN of) (NP (NN RanBP2)))) (VP (VBZ does) (RB not) (VP (VB affect) (NP (NP (NP (DT the) (NN number)) (PP (IN of) (NP (NNS NPCs)))) (CC and) (NP (NP (PRP$ their) (NN distribution)) (PP-LOC (IN in) (NP (JJ hippocampal) (NNS neurons))))) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 5A)) (, ,) (NP (JJ unpublished) (NNS data)) (-RRB- -RRB-))))) (, ,) (CC but) (S (NP-SBJ (PRP it)) (VP (VBD led) (PP (IN to) (NP (NP (JJ consistent) (JJR lower) (NN expression)) (PP (IN of) (NP (NN RanBP2))) (PP (IN by) (NP (QP (JJR more) (IN than) (CD 50)) (NN %))) (PP-LOC (IN in) (NP (NP (NP (DT the) (NN CNS)) (-LRB- -LRB-) (NP (NN brain) (CC and) (NN retina))) (-RRB- -RRB-) (PP-LOC (PP (IN in) (NP (NN 129Ola) (PRN (-LRB- -LRB-) (NP (NP (NN Figure) (NN 5B)) (PP (SYM –) (NP (NN 5D)))) (-RRB- -RRB-)))) (, ,) (CONJP (CC but) (RB not)) (PP (IN in) (NP (NML (NN C57BL) (HYPH /) (NN 6J) (HYPH /) (NN 129Ola)) (NNS backgrounds)))))))) (CIT (-LRB- -LRB-) (JJ unpublished) (NNS data) (-RRB- -RRB-)))) (. .)) )
( (S (ADVP (RB Hence)) (, ,) (NP-SBJ (PRP we)) (VP (VBD focused) (NP (PRP$ our) (NN analysis)) (PP (IN on) (NP (DT the) (JJ inbred) (NML (NN RanBP2) (SYM +) (HYPH /) (SYM −)) (NN 129Ola) (NN mouse) (NN line)))) (. .)) )
( (S (SBAR-ADV (IN Although) (S (NP-SBJ-1 (NP (DT the) (NNS levels)) (PP (IN of) (NP (NN RanBP2)))) (VP (VBD were) (VP (VBN decreased) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (NP (DT the) (NML (NN retina) (, ,) (NN brain) (, ,) (CC and) (NN hippocampus))) (PP (IN of) (NP (NML (NN RanBP2) (SYM +) (HYPH /) (SYM −)) (NNS mice))))) (PP-EXT (IN by) (NP (NP (QP (SYM ~) (CD 50)) (NN %)) (PP (SYM –) (NP (CD 60) (NN %))))) (PRN (-LRB- -LRB-) (NP (NN Figure) (NML (NN 5B) (CC and) (NN 5C))) (-RRB- -RRB-)))))) (, ,) (NP-SBJ-2 (NP (DT the) (NNS levels)) (PP (IN of) (NP (NP (NP (NNS others) (NNS nucleoporins)) (, ,) (NP (NN Nup153) (CC and) (NN Nup62))) (, ,) (CC and) (NP (NN mHsp70) (CC and) (NN Cox11))))) (, ,) (VP (VBD remained) (ADJP-PRD (JJ unchanged)) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 5B)) (, ,) (NP (JJ unpublished) (NNS data)) (-RRB- -RRB-))) (. .)) )
( (S (PP (IN In) (NP (NN addition))) (, ,) (NP-SBJ (PRP we)) (VP (VBD observed) (NP (NP (NP (DT a) (JJ strong) (NN decrease)) (PP (IN of) (NP (NP (DT the) (NNS levels)) (PP (IN of) (NP (NN HKI)))))) (-LRB- -LRB-) (NP (QP (CD 3) (HYPH -) (IN to) (RB 4-fold)))) (-RRB- -RRB-) (PRN (-LRB- -LRB-) (NP (NN Figure) (NML (NN 5B) (CC and) (NN 5C))) (-RRB- -RRB-))) (. .)) )
( (S (NP-SBJ (DT This) (NN decrease)) (VP (VBD was) (ADJP-PRD (JJ selective) (PP (IN to) (NP (DT the) (NN CNS)))) (, ,) (SBAR-PRP (IN since) (S (NP-SBJ-1 (NN HKI) (NNS levels)) (VP (VBD remained) (ADJP-PRD (RB largely) (JJ unaffected)) (PP-LOC (IN in) (NP (DT the) (NML (NML (JJ skeletal) (NN muscle)) (, ,) (NML (NN spleen)) (, ,) (CC and) (NML (NN liver)))))))) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 5D)) (-RRB- -RRB-))) (. .)) )
( (S (SBAR-PRP (IN Because) (S (S (NP-SBJ (NN HKI)) (VP (VBZ plays) (NP (DT a) (JJ key) (NN role)) (PP (IN in) (NP (NP (DT the) (NN production)) (PP (IN of) (NP (NN energy) (JJ intermediate) (NNS substrates))))))) (CC and) (S (NP-SBJ (NN HKI)) (VP (VBZ is) (NP-PRD (NP (ADVP (RB virtually)) (DT the) (JJ sole) (NN HK) (NN isoform)) (VP (VBN expressed) (NP (-NONE- *)) (PP-LOC (IN in) (NP (DT the) (NN CNS))))))) (PRN (-LRB- [) (NP (CD 33) (, ,) (CD 34)) (-RRB- ])))) (, ,) (NP-SBJ (PRP we)) (VP (VBD probed) (NP (NP (DT the) (NN impact)) (PP (IN of) (NP (NML (NN HKI) (CC and) (NN RanBP2)) (NN reduction))) (PP (IN in) (NP (NP (DT the) (NNS levels)) (PP (IN of) (NP (NN ATP))))))) (. .)) )
( (S (SBAR-ADV (IN As) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (VBN shown) (NP-1 (-NONE- *)) (PP (IN in) (NP (NN Figure) (NN 5E)))))) (, ,) (NP-SBJ (EX there)) (VP (VBD was) (NP-PRD (NP (ADJP (JJ significant) (CC and) (JJ concordant)) (NN reduction)) (PP (IN in) (NP (NP (NNS levels)) (PP (IN of) (NP (NN ATP))) (PP-LOC (PP (IN in) (NP (NP (DT the) (NN CNS)) (-LRB- -LRB-) (NP (NN brain) (CC and) (NN retina)))) (-RRB- -RRB-) (, ,) (CONJP (CC but) (RB not)) (PP (IN in) (NP (JJ non-neuronal) (NNS tissues)))))))) (. .)) )
( (S (ADVP-TMP (RB Finally)) (, ,) (NP-SBJ (PRP we)) (ADVP (RB also)) (VP (VBD observed) (NP (NP (ADJP (JJ partial) (CC and) (JJ selective)) (NN delocalization)) (PP (PP (IN of) (NP (NN HKI))) (, ,) (CONJP (CC but) (RB not)) (PP (IN of) (NP (NN Cox11)))) (, ,) (PP-LOC (PP (IN from) (NP (DT the) (JJ ellipsoid) (-LRB- -LRB-) (ADJP (NNS mitochondria) (HYPH -) (JJ rich)) (-RRB- -RRB-) (NML-1 (-NONE- *RNR*)))) (PP (IN to) (NP (DT the) (JJ adjacent) (JJ myoid) (NML-1 (-NONE- *RNR*)))) (NML-1 (NML (JJ subcellular) (NN compartment)) (PP (IN of) (NP (NN rod) (JJ photosensory) (NNS neurons))))) (PRN (-LRB- -LRB-) (NP (NP (NN Figure) (NN S2A)) (PP (SYM –) (NP (NN S2E)))) (-RRB- -RRB-)))) (. .)) )
( (S (NP-SBJ-1 (DT This)) (VP (VBD was) (ADVP (RB also)) (VP (VBN accompanied) (NP-1 (-NONE- *)) (PP (IN by) (NP-LGS (NP (VBN reduced) (NN HKI) (NNS levels)) (PP-LOC (PP (IN in) (NP (DT the) (JJ inner) (NN retina))) (, ,) (PP (PP (IN in) (ADJP (JJ particular))) (IN in) (NP (DT the) (JJ inner) (JJ plexiform) (-LRB- -LRB-) (JJ synaptic) (-RRB- -RRB-) (NN layer)))))) (PRN (-LRB- -LRB-) (NP (NP (NN Figure) (NN S2A)) (PP (SYM –) (NP (NN S2E)))) (-RRB- -RRB-)))) (. .)) )
( (HEADING (NP (NN Figure) (CD 5))) )
( (HEADING (S (NP-SBJ (NP (NN Haploinsufficiency)) (PP (IN of) (NP (NN RanBP2)))) (VP (VBZ Causes) (NP (NP (DT a) (NN Decrease)) (PP (IN in) (NP (NP (NN HKI) (NN Protein)) (CC and) (NP (NN ATP) (NNS Levels)))))))) )
( (CAPTION (NP (LST (-LRB- -LRB-) (LS A) (-RRB- -RRB-)) (NP (JJ Quantitative) (NN analysis)) (PP (IN of) (NP (NNS NPCs))) (PP (IN in) (NP (NP (VBN dissociated) (JJ hippocampal) (NNS neurons)) (PP (IN of) (NP (UCP (NML (JJ wild) (HYPH -) (NN type) (PRN (-LRB- -LRB-) (NP (SYM +) (HYPH /) (SYM +)) (-RRB- -RRB-))) (CC and) (ADJP (NN heterozygote) (PRN (-LRB- -LRB-) (NP (SYM +) (HYPH /) (SYM −)) (-RRB- -RRB-)))) (NNS mice))))) (PP-TMP (IN upon) (NP (NP (NN immunostaining)) (PP (IN with) (NP (NN mAb414))))) (. .))) )
( (CAPTION (S (NP-SBJ-1 (NP (DT No) (NN difference)) (PP (IN in) (NP (NP (NP (NP (DT the) (NN density)) (PP (IN of) (NP (NNS NPCs)))) (-LRB- -LRB-) (NP (NP (QP (CD 3) (SYM –) (CD 4)) (NN NPC)) (PP (SYM /) (NP (NN μm2))))) (-RRB- -RRB-) (PP-LOC (IN at) (NP (DT the) (JJ nuclear) (NN envelope))))) (PP-2 (-NONE- *ICH*))) (VP (VBD was) (VP (VBN found) (NP-1 (-NONE- *)) (PP-2 (IN between) (NP (NML (NML (NN RanBP2) (SYM +) (HYPH /) (SYM +)) (CC and) (NML (NN RanBP2) (SYM +) (HYPH /) (SYM −))) (NNS mice))))) (. .))) )
( (CAPTION (NP (LST (-LRB- -LRB-) (LS B) (-RRB- -RRB-)) (NP (NNS Immunoblots)) (PP (IN with) (NP (NP (NML (NML (NML (NN anti-RanBP2) (HYPH /) (NN Nup153) (HYPH /) (NN Nup62)) (-LRB- -LRB-) (NML (NN mAb414))) (-RRB- -RRB-) (, ,) (NML (SYM −) (NN HKI)) (, ,) (NML (SYM −) (NN mHsp70)) (, ,) (CC and) (NML (SYM −) (NN Cox11))) (NNS antibodies)) (PP (IN of) (NP (NP (ADJP (ADJP (JJ retinal) (PRN (-LRB- -LRB-) (NP (JJ top) (NN panel)) (-RRB- -RRB-))) (CC and) (ADJP (JJ hippocampal))) (NNS homogenates)) (PP (IN of) (NP (NML (NML (SYM +) (HYPH /) (SYM +)) (CC and) (NML (SYM +) (HYPH /) (SYM −))) (NNS mice))))))) (. .))) )
( (CAPTION (S (PP (IN In) (NP (NP (NN comparison)) (PP (IN to) (NP (NN RanBP2) (SYM +) (HYPH /) (SYM +))))) (, ,) (NP-SBJ (NML (NN RanBP2) (SYM +) (HYPH /) (SYM −)) (NNS mice)) (VP (VBP exhibit) (NP (NP (DT a) (NN reduction)) (PP (IN in) (NP (NP (DT the) (NN expression) (NNS levels)) (PP (PP (IN of) (NP (NN RanBP2) (CC and) (NN HKI))) (CONJP (CC but) (RB not)) (PP (IN of) (NP (JJ other) (NN proteins)))))))) (. .))) )
( (CAPTION (NP (LST (-LRB- -LRB-) (LS C) (-RRB- -RRB-)) (NP (JJ Quantitative) (NN analysis)) (PP (IN of) (NP (NP (JJ relative) (NML (NN protein) (NN expression)) (NNS levels)) (PP (IN of) (NP (NN RanBP2) (, ,) (NN Cox11) (, ,) (NN HKI) (, ,) (CC and) (NN mHsp70))))) (PP-LOC (IN in) (NP (NP (DT the) (NN hippocampus)) (PP (IN of) (NP (NML (NML (NN RanBP2) (SYM +) (HYPH /) (SYM +)) (CC and) (NML (NN RanBP2) (SYM +) (HYPH /) (SYM −))) (NNS mice))))) (. .))) )
( (CAPTION (S (NP-SBJ (EX There)) (VP (VBZ is) (NP-PRD (NP (NML (QP (SYM ~) (CD 2)) (HYPH -) (CC and) (RB 4-fold)) (NN reduction)) (PP (IN of) (NP (NN RanBP2) (CC and) (NN HKI)))) (PP-LOC (IN in) (NP (NN heterozygote) (NNS mice)))) (. .))) )
( (CAPTION (S (LST (-LRB- -LRB-) (LS D) (-RRB- -RRB-)) (NP-SBJ-1 (NP (DT The) (NN level)) (PP (IN of) (NP (NN HKI)))) (VP (VBZ is) (VP (VBN reduced) (NP-1 (-NONE- *)) (PP-LOC (PP (IN in) (NP (DT the) (NN brain))) (CONJP (CC but) (RB not)) (PP (IN in) (NP (NP (NP (JJ other) (JJ non-neuronal) (NNS tissues)) (VP (VBN tested) (NP (-NONE- *)))) (-LRB- -LRB-) (NP (NN muscle) (, ,) (NN spleen) (, ,) (CC and) (NN liver))))))) (-RRB- -RRB-) (. .))) )
( (CAPTION (S (LST (-LRB- -LRB-) (LS E) (-RRB- -RRB-)) (NP-SBJ-1 (DT The) (JJ total) (NN ATP) (NN level)) (VP (VBZ is) (VP (VBN reduced) (NP-1 (-NONE- *)) (PP-LOC (PP (IN in) (NP (NP (DT the) (NN CNS) (NNS tissues)) (-LRB- -LRB-) (NP (NN brain) (CC and) (NN retina)))) (-RRB- -RRB-) (CONJP (CC but) (RB not)) (PP (IN in) (NP (NP (NP (JJ non-neuronal) (NNS tissues)) (VP (VBN tested) (NP (-NONE- *)))) (-LRB- -LRB-) (NP (ADVP (FW e.g.)) (, ,) (NN spleen))))))) (-RRB- -RRB-) (. .))) )
( (HEADING (NP (NP (JJ Metabolic) (NNS Disturbances)) (VP (VBN Caused) (NP (-NONE- *)) (PP (IN by) (NP-LGS (NP (NN Haploinsufficiency)) (PP (IN of) (NP (NN RanBP2)))))))) )
( (S (NP-SBJ (NP (DT The) (NN growth) (NNS rates)) (PP (IN of) (NP (NP (JJ inbred) (NML (NN RanBP2) (SYM +) (HYPH /) (SYM −)) (NNS mice)) (PP (IN on) (NP (NML (NML (JJ high) (HYPH -) (NN fat)) (-LRB- -LRB-) (NML (NML (QP (SYM ~) (CD 10)) (NN %)) (NN fat))) (-RRB- -RRB-) (NN diet)))))) (VP (VBD were) (ADJP-PRD (ADJP (RB significantly) (JJR slower)) (PP (IN than) (NP (NML (NN RanBP2) (SYM +) (HYPH /) (SYM +)) (NNS mice)))) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 6A)) (-RRB- -RRB-))) (. .)) )
( (S (S-TMP (NP-SBJ (-NONE- *PRO*)) (VP (VBG Beginning) (PP-TMP (IN at) (NP (NP (QP (IN around) (CD 4)) (NNS mo)) (PP (IN of) (NP (NN age))))))) (, ,) (NP-SBJ (NML (NN RanBP2) (SYM +) (HYPH /) (SYM −)) (NNS mice)) (VP (VBP exhibit) (NP (NP (DT a) (ADJP (JJ significant) (JJR slower)) (NN gain)) (PP (IN in) (NP (NN body) (NN mass))) (PP (IN than) (NP (NML (JJ wild) (HYPH -) (NN type)) (NNS mice)))) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 6A)) (-RRB- -RRB-))) (. .)) )
( (S (PP (IN In) (NP (NN addition))) (, ,) (NP-SBJ (NML (NN RanBP2) (SYM +) (HYPH /) (SYM −)) (JJ inbred) (NNS mice)) (VP (VBD presented) (NP (NP (NP (NNS deficits)) (PP (IN in) (NP (NN body) (NN mass)))) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBD were) (VP (VBN erased) (NP-1 (-NONE- *)) (PP-MNR (IN by) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG changing) (NP (DT the) (JJ genetic) (NN background)) (PP (IN to) (NP (DT a) (JJ mixed) (NN C57BL) (HYPH /) (NN 6J) (HYPH /) (NN 129Ola))))))))))) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 6B)) (-RRB- -RRB-))) (. .)) )
( (S (NP-SBJ (NN Food) (NN consumption)) (VP (VBD did) (RB not) (VP (VB account) (PP (IN for) (NP (NP (DT the) (NML (NN body) (NN weight)) (NNS differences)) (VP (VBN observed) (NP (-NONE- *))))) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 6C)) (-RRB- -RRB-)))) (. .)) )
( (HEADING (NP (NN Figure) (CD 6))) )
( (HEADING (S (NP-SBJ (NP (NML (NN RanBP2) (SYM +) (HYPH /) (SYM −)) (NNS Mice)) (PP (IN on) (NP (NML (JJ High) (HYPH -) (NN Fat)) (NN Diet)))) (VP (VBP Exhibit) (NP (NP (NNS Deficits)) (PP (IN in) (NP (NN Growth))))))) )
( (CAPTION (S (S (LST (-LRB- -LRB-) (LS A) (-RRB- -RRB-)) (PP (IN In) (NP (NP (NN comparison)) (PP (IN to) (NP (NML (JJ wild) (HYPH -) (NN type)) (NNS mice))))) (, ,) (NP-SBJ (NML (NN RanBP2) (SYM +) (HYPH /) (SYM −)) (NNS mice)) (VP (VBP show) (NP (JJR slower) (NN growth) (NNS rates)) (S-TMP (NP-SBJ (-NONE- *PRO*)) (VP (VBG beginning) (PP-TMP (IN at) (NP (NP (CD 4) (NNS mo)) (PP (IN of) (NP (NN age))))))) (PRN (-LRB- -LRB-) (NP (NN arrow)) (-RRB- -RRB-)))) (, ,) (CC and) (S (NP-SBJ-1 (NP (DT the) (NN difference)) (PP (IN in) (NP (NN body) (NN weight))) (PP (IN between) (NP (DT these)))) (VP (VBZ is) (VP (VBN maintained) (NP-1 (-NONE- *)) (ADVP-TMP (RB afterward))))) (. .))) )
( (CAPTION (S-IMP (NP-SBJ (-NONE- *PRO*)) (VP (VB Note) (SBAR (IN that) (S (NP-SBJ (NML (NN RanBP2) (SYM +) (HYPH /) (SYM −)) (NNS mice)) (VP (VBP lack) (NP (NP (DT the) (NN growth) (NN spur)) (VP (VBN observed) (NP (-NONE- *)) (PP-LOC (IN in) (NP (NP (NML (JJ wild) (HYPH -) (NN type)) (NNS mice)) (PP-TMP (IN between) (NP (NP (NML (CD 3) (CC and) (CD 4)) (NNS mo)) (PP (IN of) (NP (NN age))))))))))))) (. .))) )
( (CAPTION (S (LST (-LRB- -LRB-) (LS B) (-RRB- -RRB-)) (PP (IN In) (NP (NP (NN comparison)) (PP (IN to) (NP (NP (JJ inbred) (NML (NN RanBP2) (SYM +) (HYPH /) (SYM −)) (NNS mice)) (-LRB- -LRB-) (NP (NN 129Ola) (JJ genetic) (NN background)))))) (-RRB- -RRB-) (, ,) (NP-SBJ-1 (NP (DT the) (NN difference)) (PP (IN in) (NP (NN body) (NN weight))) (PP (IN between) (NP (NML (NML (NN RanBP2) (SYM +) (HYPH /) (SYM +)) (CC and) (NML (NN RanBP2) (SYM +) (HYPH /) (SYM −))) (NNS mice)))) (VP (VBZ is) (VP (VBN masked) (NP-1 (-NONE- *)) (PP-TMP (IN upon) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG placing) (NP (DT these)) (PP-LOC (IN on) (NP (DT a) (JJ mixed) (NML (NN 129Ola) (HYPH /) (NN C57Bl6)) (JJ genetic) (NN background)))))))) (. .))) )
( (CAPTION (S (LST (-LRB- -LRB-) (LS C) (-RRB- -RRB-)) (NP-SBJ (NML (NML (NN RanBP2) (SYM +) (HYPH /) (SYM +)) (CC and) (NML (NN RanBP2) (SYM +) (HYPH /) (SYM −))) (JJ inbred) (NNS mice)) (VP (VBP exhibit) (NP (NP (JJ similar) (NNS rates)) (PP (IN of) (NP (NN food) (NN consumption))))) (. .))) )
( (CAPTION (S (NP-SBJ-1 (NP (NNS Mice)) (PP (IN in) (-LRB- -LRB-) (NP (NN A) (-RRB- -RRB-) (, ,) (-LRB- -LRB-) (NN B) (-RRB- -RRB-) (, ,) (CC and) (-LRB- -LRB-) (NN C)))) (-RRB- -RRB-) (VP (VBD were) (VP (VBN placed) (NP-1 (-NONE- *)) (PP (IN on) (NP (DT a) (NML (JJ high) (HYPH -) (NN fat)) (NN diet))) (PP-TMP (IN since) (NP (NN birth))) (PRN (-LRB- -LRB-) (S-FRM (NP-SBJ (NN n)) (VP (SYM =) (NP (CD 5)))) (-RRB- -RRB-)))) (. .))) )
( (S (NP-SBJ (NP (NN HKI)) (PP-LOC (IN in) (NP (NP (DT the) (NN CNS)) (-LRB- -LRB-) (NP (NN brain) (CC and) (NN retina))))) (-RRB- -RRB-) (VP (VBZ accounts) (ADVP (RB virtually)) (PP (IN for) (NP (NP (DT all) (NML (NML (NML (NN expression)) (PP (IN of) (NP (NN HK) (NNS isozymes)))) (CC and) (NML (NN glucose) (NN utilization)))) (PP-LOC (IN in) (NP (DT the) (NN CNS))))) (PRN (-LRB- [) (NP (CD 33) (, ,) (CD 34)) (-RRB- ]))) (. .)) )
( (S (S (ADVP (RB Moreover)) (, ,) (NP-SBJ (NN glucose)) (VP (VBZ is) (NP-PRD (NP (DT the) (JJ sole) (NN reliance) (NN source)) (PP (IN of) (NP (NN energy))) (PP-LOC (IN in) (NP (DT the) (NN CNS))) (PP (IN under) (NP (JJ normal) (NNS conditions)))))) (, ,) (S (NP-SBJ (DT the) (NN CNS)) (VP (VBZ lacks) (NP (NML (NN glucose) (NN storage)) (NNS sources)))) (, ,) (CC and) (S (PP (IN despite) (NP (NP (DT the) (JJ disproportionate) (NN mass)) (PP (IN of) (NP (DT the) (NN CNS))) (PP (IN to) (NP (NP (DT the) (NN rest)) (PP (IN of) (NP (DT the) (NN body))))))) (, ,) (NP-SBJ (DT the) (NN CNS)) (VP (VBZ consumes) (ADVP-TMP (RB daily)) (NP (NP (NP (QP (IN about) (CD 60)) (NN %)) (PP (IN of) (NP (NP (DT the) (NN body) (POS 's)) (NN glucose)))) (CC and) (NP (NP (CD 25) (NN %)) (PP (IN of) (NP (DT the) (JJ total) (NN oxygen))))) (PRN (-LRB- [) (NP (CD 35) (, ,) (CD 36)) (-RRB- ])))) (. .)) )
( (S (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO To) (VP (VB determine) (NP (NP (DT the) (NN impact)) (PP (IN of) (NP (NN RanBP2) (NN haploinsufficiency))) (PP (IN on) (NP (NP (DT the) (NML (NN utilization) (, ,) (NN formation) (, ,) (CC and) (NN uptake))) (PP (IN of) (NP (NN glucose))))))))) (, ,) (NP-SBJ (PRP we)) (VP (VBD carried) (PRT (RP out)) (NP (JJ several) (JJ physiological) (NNS assays))) (. .)) )
( (S (PP (IN In) (NP (NP (NN contrast)) (PP (IN to) (NP (NP (NNS mice)) (VP (VBN placed) (NP (-NONE- *)) (PP (IN on) (NP (DT a) (JJ normal) (NN chow) (NN diet) (PRN (-LRB- -LRB-) (NP (NML (QP (SYM ~) (CD 5)) (NN %)) (NN fat)) (: ;) (NP (JJ unpublished) (NNS data)) (-RRB- -RRB-))))))))) (, ,) (NP-SBJ (NP (NML (NN RanBP2) (SYM +) (HYPH /) (SYM −)) (NNS mice)) (PP (IN on) (NP (DT a) (NML (JJR higher) (NN fat)) (NN diet) (PRN (-LRB- -LRB-) (NP (NML (QP (SYM ~) (CD 10)) (NN %)) (NN fat)) (-RRB- -RRB-))))) (VP (VBD performed) (ADVP (RB significantly) (RBR worse)) (PP (IN in) (NP (DT the) (NML (NN glucose) (NN tolerance)) (NN test))) (S-ADV (NP-SBJ (-NONE- *PRO*)) (VP (VBG beginning) (PP-TMP (IN at) (NP (NP (CD 6) (NNS mo)) (PP (IN of) (NP (NN age))))) (PRN (-LRB- -LRB-) (NP (NN Figure) (NML (NN 7A) (CC and) (NN 7B))) (-RRB- -RRB-)))) (, ,) (S-ADV (NP-SBJ (-NONE- *PRO*)) (ADVP (RB thus)) (VP (VBG supporting) (SBAR (IN that) (S (NP-SBJ (DT the) (NML (NN RanBP2) (SYM +) (HYPH /) (SYM −)) (NNS mice)) (VP (VBD exhibited) (NP (NP (DT a) (NN deficit)) (PP (IN in) (NP (NN glucose) (NN clearance)))))))))) (. .)) )
( (S (NP-SBJ-1 (DT This) (NN deficit)) (VP (VBD was) (VP (VBN rescued) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (NP (NML (NN RanBP2) (SYM +) (HYPH /) (SYM −)) (NNS mice)) (PP (IN of) (NP (VBN mixed) (NML (NN C57BL) (HYPH /) (NN 6J) (HYPH /) (NN 129Ola)) (NN background))))) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN S3)) (-RRB- -RRB-)))) (. .)) )
( (S (NP-SBJ-1 (NN Glucose) (NN clearance)) (VP (VBD was) (RB not) (VP (VBN affected) (NP-1 (-NONE- *)) (PP-PRP (IN due) (IN to) (NP (NP (DT a) (NN disturbance)) (PP (IN in) (NP (ADJP (NN insulin) (HYPH -) (JJ mediated)) (NN glucose) (NN uptake))))) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 7C)) (-RRB- -RRB-)))) (. .)) )
( (S (ADVP-TMP (RB Then)) (, ,) (NP-SBJ (PRP we)) (VP (VBD probed) (SBAR (IN whether) (S (NP-SBJ (NN RanBP2)) (VP (VBZ induces) (NP (NP (NP (NN impairment)) (PP (IN of) (NP (NN gluconeogenesis)))) (, ,) (SBAR (WHNP-1 (WDT which)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (MD could) (VP (VB contribute) (PP (IN to) (NP (NP (DT the) (JJ pathophysiological) (NML (NN production) (CC and) (NN clearance))) (PP (IN of) (NP (NN glucose)))))))))))))) (. .)) )
( (S (PP (IN To) (NP (DT this) (NN end))) (, ,) (NP-SBJ (NP (NP (DT the) (NN administration)) (PP (IN of) (NP (NP (DT the) (NML (JJ gluconeogenic) (NN substrate)) (NN precursor)) (, ,) (NP (NN pyruvate))))) (-LRB- -LRB-) (NP (NML (NN pyruvate) (NN tolerance)) (NN test))) (-RRB- -RRB-) (, ,) (VP (VBD showed) (SBAR (IN that) (S (NP-SBJ (EX there)) (VP (VBD was) (NP-PRD (NP (DT no) (NN difference)) (PP (IN in) (NP (NN glucose) (NN production)))) (PP-LOC (IN in) (NP (NML (NN RanBP2) (SYM +) (HYPH /) (SYM −)) (NNS mice))) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 7D)) (-RRB- -RRB-)))))) (. .)) )
( (S (ADVP (RB Hence)) (, ,) (NP-SBJ (NP (JJ partial) (NML (NML (NN loss)) (HYPH -) (PP (IN of) (HYPH -) (NP (NN function))))) (PP (IN of) (NP (NN RanBP2)))) (VP (VBD had) (NP (NP (DT no) (NN impact)) (PP (IN on) (NP (DT the) (NN gluconeogenesis) (NN pathway))))) (. .)) )
( (S (ADVP (RB However)) (, ,) (PP-TMP (IN upon) (NP (NN glucose) (NN production) (PRN (-LRB- -LRB-) (NP (CD 15) (NNS min)) (-RRB- -RRB-)))) (, ,) (NP-SBJ (NP (DT the) (NN clearance) (NNS rates)) (PP (IN of) (NP (NN glucose)))) (VP (VBD were) (ADVP-TMP (RB again)) (ADJP-PRD (ADJP (RB significantly) (JJR slower)) (PP-1 (-NONE- *ICH*))) (PP-LOC (IN in) (NP (NN RanBP2) (SYM +) (HYPH /) (SYM −))) (PP-1 (IN than) (PP-LOC (IN in) (NP (NML (NN RanBP2) (SYM +) (HYPH /) (SYM +)) (NNS mice) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 7D)) (-RRB- -RRB-))))) (, ,) (S-ADV (NP-SBJ (-NONE- *PRO*)) (VP (VBG confirming) (NP (NP (DT an) (NN impairment)) (PP (IN in) (NP (NN glucose) (NN breakdown))))))) (. .)) )
( (HEADING (NP (NN Figure) (CD 7))) )
( (HEADING (NP (NP (JJ Metabolic) (NNS Phenotypes)) (PP (IN of) (NP (NP (NML (NN RanBP2) (SYM +) (HYPH /) (SYM −)) (JJ Inbred) (NNS Mice)) (PP (IN on) (NP (NML (JJ High) (HYPH -) (NN Fat)) (NN Diet))))))) )
( (CAPTION (S (LST (-LRB- -LRB-) (LS A) (-RRB- -RRB-)) (NP-SBJ (ADJP (NP (CD 3) (HYPH -) (NN mo)) (HYPH -) (JJ old)) (JJ inbred) (NML (NN RanBP2) (SYM +) (HYPH /) (SYM −)) (NNS mice) (PRN (-LRB- -LRB-) (S-FRM (NP-SBJ (NN n)) (VP (SYM =) (NP (CD 5)))) (-RRB- -RRB-))) (VP (VBP have) (NP (JJ normal) (NML (NN glucose) (NN clearance)) (NNS rates)) (PP-TMP (IN upon) (NP (NP (NN glucose) (NN challenge)) (CC and) (NP (JJ overnight) (NN fasting))))) (. .))) )
( (CAPTION (S (LST (-LRB- -LRB-) (LS B) (-RRB- -RRB-)) (PP (IN In) (NP (NN contrast))) (, ,) (NP-SBJ (ADJP (NP (CD 6) (HYPH -) (NN mo)) (HYPH -) (JJ old)) (JJ inbred) (NML (NN RanBP2) (SYM +) (HYPH /) (SYM −)) (NNS mice) (PRN (-LRB- -LRB-) (S-FRM (NP-SBJ (NN n)) (VP (SYM =) (NP (CD 5)))) (-RRB- -RRB-))) (VP (VBP have) (NP (ADJP (RB significantly) (VBN decreased)) (NML (NN glucose) (NN clearance)) (NNS rates)) (PP-TMP (IN upon) (NP (NP (NN glucose) (NN challenge)) (CC and) (NP (JJ overnight) (NN fasting))))) (. .))) )
( (CAPTION (S (LST (-LRB- -LRB-) (LS C) (-RRB- -RRB-)) (NP-SBJ (VBN Fasted) (ADJP (NP (QP (CD 6) (HYPH -) (IN to) (CD 8)) (HYPH -) (NN mo)) (HYPH -) (JJ old)) (NML (NML (NN RanBP2) (SYM +) (HYPH /) (SYM +)) (CC and) (NML (NN RanBP2) (SYM +) (HYPH /) (SYM −))) (NNS mice)) (VP (VBP have) (NP (NP (DT no) (NN difference)) (PP (IN in) (NP (ADJP (NN insulin) (HYPH -) (JJ mediated)) (NN glucose) (NN uptake)))) (SBAR-ADV (IN as) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (VBN assayed) (NP-1 (-NONE- *)) (PP-MNR (IN by) (NP (NML (NN insulin) (NN tolerance)) (NN test)))))) (PRN (-LRB- -LRB-) (S-FRM (NP-SBJ (NN n)) (VP (SYM =) (NP (CD 5)))) (-RRB- -RRB-))) (. .))) )
( (CAPTION (S (LST (-LRB- -LRB-) (LS D) (-RRB- -RRB-)) (NP-SBJ (NML (NN Pyruvate) (NN tolerance)) (NN test)) (VP (VBZ shows) (NP (NP (NP (NP (JJ normal) (NN rise)) (PP (IN in) (NP (NN glucose)))) (CC but) (NP (VBN decreased) (NN glucose) (NN clearance))) (PP (IN between) (NP (JJ inbred) (NML (NML (NN RanBP2) (SYM +) (HYPH /) (SYM +)) (CC and) (NML (NN RanBP2) (SYM +) (HYPH /) (SYM −))) (NNS mice)))) (PRN (-LRB- -LRB-) (S-FRM (NP-SBJ (NN n)) (VP (SYM =) (NP (CD 5)))) (-RRB- -RRB-))) (. .))) )
( (HEADING (S (NP-SBJ (NP (NN Haploinsufficiency)) (PP (IN of) (NP (NN RanBP2)))) (VP (VBZ Causes) (NP (NNS Deficits)) (PP (IN in) (NP (NP (DT the) (JJ Electrophysiological) (NN Output)) (PP (IN of) (NP (ADJP (JJ Receptoral) (CC and) (JJ Postreceptoral)) (JJ Retinal) (NNS Neurons)))))))) )
( (S (PP (IN In) (NP (NP (NN light)) (PP (IN of) (NP (NP (NP (DT the) (JJ prominent) (NN expression)) (PP (IN of) (NP (NN RanBP2) (CC and) (NN HKI))) (PP-LOC (IN in) (NP (JJ retinal) (NNS neurons))) (PRN (-LRB- [) (NP (CD 1) (, ,) (CD 19)) (-RRB- ]))) (, ,) (NP (NP (DT the) (JJ vital) (NN dependence)) (PP (IN of) (NP (DT the) (NML (NML (JJ neuronal) (NN retina)) (-LRB- -LRB-) (CC and) (NML (NN brain))))) (-RRB- -RRB-) (PP (IN on) (NP (NN glucose))) (PP (IN as) (NP (NP (DT the) (JJ main) (NN substrate) (NN source)) (PP (IN for) (NP (NN energy) (NN production)))))) (, ,) (CC and) (NP (NP (NP (DT the) (JJ determinant) (NN impact)) (PP (IN of) (NP (NP (JJ metabolic) (NNS disorders)) (, ,) (PP (IN such) (IN as) (NP (NN diabetes))))) (, ,) (PP (IN in) (NP (JJ retinal) (NN function)))) (-LRB- -LRB-) (NP (ADVP (FW e.g.)) (, ,) (JJ diabetic) (NN retinopathy)) (-RRB- -RRB-) (PRN (-LRB- [) (NP (CD 37)) (-RRB- ]))))))) (, ,) (NP-SBJ (PRP we)) (VP (VBD probed) (NP (NP (DT the) (NN impact)) (PP (IN of) (NP (NP (NNS deficits)) (PP (IN in) (NP (NN RanBP2) (, ,) (NN HKI) (, ,) (CC and) (NN ATP))))) (, ,) (PP (PP (IN on) (NP (NP (DT the) (JJ electrophysiological) (NNS responses)) (PP (IN of) (NP (NP (NML (NML (NNS subclasses)) (-LRB- -LRB-) (NML (NN rod) (CC and) (NN cone)) (-RRB- -RRB-)) (NML (NN photoreceptor) (CC and) (NN postreceptor)) (JJ retinal) (NNS neurons)) (PP (IN of) (NP (NN RanBP2) (SYM +) (HYPH /) (SYM −))))))) (CC and) (PP-LOC (IN in) (NP (NML (NN RanBP2) (SYM +) (HYPH /) (SYM +)) (NNS mice)))))) (. .)) )
( (S (NP-SBJ-1 (NP (DT The) (ADJP (JJ scotopic) (PRN (-LRB- -LRB-) (ADJP (NN dark) (HYPH -) (VBN adapted)) (-RRB- -RRB-))) (NNS responses)) (VP (VBN mediated) (NP (-NONE- *)) (PP (IN by) (NP-LGS (NP (NP (DT the) (NML (NN rod) (NN photoreceptor)) (NN pathway)) (PP (IN at) (NP (NML (JJ low) (HYPH -) (NN stimulus)) (NNS intensities)))) (CC and) (NP (NP (JJ mixed) (NML (NN rod) (CC and) (NN cone)) (NNS pathways)) (PP (IN at) (NP (NML (JJ high) (HYPH -) (NN stimulus)) (NNS intensities)))))))) (VP (VBD were) (ADVP (RB substantially)) (VP (VBN reduced) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (NML (NN RanBP2) (SYM +) (HYPH /) (SYM −)) (NNS mice))) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 8A)) (-RRB- -RRB-)))) (. .)) )
( (S (NP-SBJ (NP (DT The) (NNS differences)) (PP (IN in) (NP (NP (DT the) (ADJP (JJ photopic) (PRN (-LRB- -LRB-) (ADJP (NN light) (HYPH -) (VBN adapted)) (-RRB- -RRB-))) (NNS responses)) (, ,) (VP (VBN initiated) (NP (-NONE- *)) (PP (IN by) (NP-LGS (NP (NN cone) (NNS photoreceptors)) (, ,) (SBAR (WHNP-1 (WDT which)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBP make) (PRT (RP up)) (NP (NP (CD 3) (NN %)) (PP (IN of) (NP (NP (DT the) (JJ photosensory) (NNS neurons)) (PP-LOC (IN in) (NP (DT the) (NN mouse) (NN retina)))))))))))))) (PRN (-LRB- [) (NP (CD 38)) (-RRB- ]))) (, ,) (VP (VP (VBD were) (ADJP-PRD (RBR less) (JJ obvious))) (CC but) (VP (ADVP (RB still)) (VBD exhibited) (NP (NP (DT a) (NN trend)) (PP (IN toward) (NP (VBN reduced) (NNS amplitudes))) (PP (IN across) (NP (NP (DT a) (NN range)) (PP (IN of) (NP (VBG increasing) (NML (JJ light) (NN stimulus)) (NNS intensities)))))) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 8B)) (-RRB- -RRB-)))) (. .)) )
( (S (NP-SBJ (NP (DT The) (NN reduction)) (PP (IN in) (NP (DT the) (JJ scotopic) (NNS responses)))) (VP (VBD included) (NP (NP (NNS decreases)) (PP (IN in) (NP (NP (NML (CC both) (NML (NN b) (HYPH -) (NN wave) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 8C)) (-RRB- -RRB-))) (CC and) (NML (NN a) (HYPH -) (NN wave) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 8D)) (-RRB- -RRB-)))) (NNS amplitudes)) (VP (VBN mediated) (NP (-NONE- *)) (PP (IN by) (NP-LGS (ADJP (JJ postreceptoral) (CC and) (JJ receptoral)) (NNS neurons))))))) (, ,) (ADVP (RB respectively))) (. .)) )
( (S (NP-SBJ-1 (NP (JJ Postreceptoral) (NML (JJ second) (HYPH -) (NN order)) (NN neuron) (NNS responses)) (, ,) (VP (VBN represented) (NP (-NONE- *)) (PP (IN by) (NP-LGS (DT the) (NN b) (HYPH -) (NN wave))))) (, ,) (VP (VBD tended) (S (NP-SBJ-1 (-NONE- *)) (VP (TO to) (VP (VB be) (ADJP-PRD (ADJP (ADVP (RBR more) (ADVP (RB consistently) (CC and) (RB substantially))) (VBN reduced)) (PP (IN than) (NP (NP (DT the) (NN a) (HYPH -) (NNS waves)) (, ,) (SBAR (WHNP-2 (WDT which)) (S (NP-SBJ-2 (-NONE- *T*)) (ADVP (RB directly)) (VP (VBP reflect) (NP (NN photoreceptor) (NN activity)))))))))))) (. .)) )
( (S (SBAR-TMP (IN Since) (S (NP-SBJ (NML (JJ second) (HYPH -) (NN order)) (NN neuron) (NNS responses)) (VP (VBP depend) (PP (IN on) (NP (NP (NN input)) (PP (IN from) (NP (NNS photoreceptors)))))))) (, ,) (NP-SBJ (DT this)) (VP (VBZ suggests) (SBAR (IN that) (S (NP-SBJ (VBN reduced) (NML (NN b) (HYPH -) (NN wave)) (NNS amplitudes)) (VP (VBP are) (NP-PRD (NP (DT the) (NN result)) (PP (IN of) (NP (NP (DT the) (NN accumulation)) (PP (IN of) (NP (NP (NNS decreases)) (PP (IN in) (NP (NP (DT the) (JJ light) (NN response)) (PP (IN of) (NP (CC both) (NP (NNS photoreceptors)) (CC and) (NP (JJ postreceptoral) (NNS neurons))))))))))))))) (. .)) )
( (S (NP-SBJ (NP (NNS Anesthetics)) (, ,) (NP (ADVP (RB particularly)) (NN ketamine))) (, ,) (VP (MD can) (VP (VB cause) (NP (NP (NP (JJ sustained) (NN elevation)) (PP (IN of) (NP (NN glucose))) (PP-LOC (IN in) (NP (NNS mice)))) (, ,) (SBAR (WHNP-1 (WDT which)) (S (NP-SBJ-1 (-NONE- *T*)) (PP (IN in) (NP (NN turn))) (VP (VBZ affects) (NP (NN electroretinogram) (NNS responses)) (PRN (-LRB- [) (NP (CD 39)) (-RRB- ])))))))) (. .)) )
( (S (ADVP (RB Thus)) (, ,) (NP-SBJ (PRP we)) (VP (VBD were) (ADJP-PRD (JJ concerned) (SBAR (IN that) (S (NP-SBJ (NP (NNS differences)) (PP (IN in) (NP (NN electroretinogram) (NNS amplitudes))) (PP (IN between) (NP (NP (NN RanBP2) (SYM +) (HYPH /) (SYM −)) (CC and) (NP (NN RanBP2) (SYM +) (HYPH /) (SYM +))))) (VP (MD may) (VP (VB reflect) (NP (NP (NNS differences)) (PP (IN in) (NP (NP (NML (NN glucose) (NN level)) (NNS changes)) (PP (IN in) (NP (NP (NN response)) (PP (IN to) (NP (NN anesthesia)))))))))))))) (. .)) )
( (S (ADVP (RB However)) (, ,) (NP-SBJ (PRP we)) (VP (VBD found) (NP (NP (DT no) (JJ significant) (NNS differences)) (PP (IN in) (NP (NP (NN glucose) (NNS levels)) (VP (VBN measured) (NP (-NONE- *)) (PP-TMP (IN before) (NP-1 (-NONE- *RNR*))) (CC and) (PP-TMP (NP-TMP (DT every) (CD 15) (NNS min)) (IN during) (NP-1 (-NONE- *RNR*))) (NP-1 (NP (CD 75) (NNS min)) (PP (IN of) (NP (NN anesthesia)))))))) (PRN (-LRB- -LRB-) (S-FRM (NP-SBJ (NN n)) (VP (SYM =) (NP (QP (CD 4) (SYM –) (CD 5))))) (-RRB- -RRB-))) (. .)) )
( (S (NP-SBJ (NN Glucose)) (VP (VP (VBD rose) (PP (IN at) (NP (DT the) (JJ same) (NN rate)))) (CC and) (VP (VBD reached) (NP (NP (DT a) (NN maximum)) (PP (IN of) (NP (QP (RB approximately) (CD 3.3) (NNS times)) (DT the) (JJ pre-anesthesia) (NN level)))) (PP-LOC (IN in) (NP (DT both) (NNS genotypes))) (CIT (-LRB- -LRB-) (JJ unpublished) (NNS data) (-RRB- -RRB-)))) (. .)) )
( (HEADING (NP (NN Figure) (CD 8))) )
( (HEADING (NP (NP (NNS Electroretinograms)) (PP (IN from) (NP (NP (ADJP (NP (CD 6) (HYPH -) (NN Mo)) (HYPH -) (JJ Old)) (NML (NML (NN RanBP2) (SYM +) (HYPH /) (SYM −)) (CC and) (NML (NN RanBP2) (SYM +) (HYPH /) (SYM +))) (JJ Inbred) (NNS Mice)) (VP (VBG Showing) (NP (NML (NML (NN Photoreceptor) (CC and) (NN Postreceptor)) (NN Neuron)) (NML (JJ Electrophysiological) (NN Response)) (NNS Phenotypes))))))) )
( (CAPTION (S (LST (-LRB- -LRB-) (LS A) (-RRB- -RRB-)) (NP-SBJ (NP (ADJP (JJ Scotopic) (PRN (-LRB- -LRB-) (NN dark) (HYPH -) (VBN adapted) (-RRB- -RRB-))) (NNS responses)) (PP (IN from) (NP (NML (NN RanBP2) (SYM +) (HYPH /) (SYM −)) (NNS mice))) (PP (IN to) (NP (NP (JJ light) (NNS stimuli)) (PP (IN of) (NP (VBG increasing) (NN intensity)))))) (, ,) (S-ADV (NP-SBJ (-NONE- *PRO*)) (VP (VBG beginning) (PP-TMP (IN at) (NP (NN threshold))))) (, ,) (VP (VBP have) (NP (JJ reduced) (NNS amplitudes)) (PP (VBN compared) (PP (IN to) (NP (NP (DT those)) (VP (VBN observed) (NP (-NONE- *)) (PP-LOC (IN in) (NP (NML (NN RanBP2) (SYM +) (HYPH /) (SYM +)) (NNS mice)))))))) (. .))) )
( (CAPTION (S (NP-SBJ (DT The) (CD three) (JJR lower) (NNS intensities)) (VP (VBP represent) (NP (NP (NNS responses)) (VP (VBN generated) (NP (-NONE- *)) (PP-LOC (IN in) (NP (DT the) (NML (NN rod) (NN photoreceptor)) (JJ neuronal) (NN pathway)))))) (. .))) )
( (CAPTION (S (NP-SBJ-1 (DT The) (JJ upper) (NNS intensities)) (VP (VBP are) (VP (VBN comprised) (NP-1 (-NONE- *)) (PP (IN of) (NP (NP (NNS responses)) (VP (VBN generated) (NP (-NONE- *)) (PP-LOC (IN in) (NP (CC both) (DT the) (NML (NN rod) (CC and) (NN cone)) (NNS pathways)))))))) (. .))) )
( (CAPTION (S (LST (-LRB- -LRB-) (LS B) (-RRB- -RRB-)) (NP-SBJ (NP (ADJP (JJ Photopic) (PRN (-LRB- -LRB-) (ADJP (NN light) (HYPH -) (VBN adapted)) (, ,) (NP (NML (NN cone) (NN photoreceptor)) (NN pathway)) (-RRB- -RRB-))) (NNS responses)) (PP (IN of) (NP (NML (NN RanBP2) (SYM +) (HYPH /) (SYM −)) (NNS mice))) (PP (IN to) (NP (VBG increasing) (NML (JJ light) (NN stimulus)) (NNS intensities)))) (ADVP (RB also)) (VP (VBD exhibited) (NP (VBN reduced) (NNS amplitudes)) (PP (VBN compared) (PP (IN to) (NP (NP (DT those)) (VP (VBN observed) (NP (-NONE- *)) (PP-LOC (IN in) (NP (NML (NN RanBP2) (SYM +) (HYPH /) (SYM +)) (NNS mice)))))))) (. .))) )
( (CAPTION (NP (LST (-LRB- -LRB-) (LS C) (-RRB- -RRB-)) (NP (NP (NP (NML (NN Average) (SYM ±) (NN SE) (PRN (-LRB- -LRB-) (S-FRM (NP-SBJ (NN n)) (VP (SYM =) (NP (CD 9)))) (-RRB- -RRB-))) (JJ scotopic) (NML (NN b) (HYPH -) (NN wave)) (NNS amplitudes)) (PP (IN from) (NP (NML (NML (NN RanBP2) (SYM +) (HYPH /) (SYM −) (PRN (-LRB- -LRB-) (NP (JJ open) (NNS circles)) (-RRB- -RRB-))) (CC and) (NML (NN RanBP2) (SYM +) (HYPH /) (SYM +) (PRN (-LRB- -LRB-) (NP (VBN filled) (NNS squares)) (-RRB- -RRB-)))) (NNS mice)))) (VP (VBG representing) (NP (NML (JJ postreceptoral) (NN neuron)) (NN function)))) (. .))) )
( (CAPTION (FRAG (-LRB- -LRB-) (NP (NN Note)) (: :) (NP (NML (NN log) (NN amplitude)) (NN scale)) (. .) (-RRB- -RRB-))) )
( (CAPTION (NP (LST (-LRB- -LRB-) (LS D) (-RRB- -RRB-)) (NP (NML (JJ Average) (SYM ±) (NN SE) (PRN (-LRB- -LRB-) (S-FRM (NP-SBJ (NN n)) (VP (SYM =) (NP (CD 5)))) (-RRB- -RRB-))) (JJ scotopic) (NML (NN a) (HYPH -) (NN wave)) (NNS amplitudes)) (, ,) (VP (VBG representing) (NP (NN photoreceptor) (NN function)) (, ,) (PP (IN for) (NP (NML (NML (NN RanBP2) (SYM +) (HYPH /) (SYM −)) (CC and) (NML (NN RanBP2) (SYM +) (HYPH /) (SYM +))) (NNS mice))) (PP (IN in) (NP (NP (NN response)) (PP (IN to) (NP (JJ bright) (NNS flashes)))))) (. .))) )
( (CAPTION (S (NP-SBJ (NP (NNS Amplitudes)) (PP (IN of) (NP (NP (NNS responses)) (PP (IN from) (NP (NML (NN RanBP2) (SYM +) (HYPH /) (SYM −)) (NNS mice)))))) (VP (VBD were) (ADJP-PRD (JJR lower)) (PP (IN over) (NP (NP (DT the) (JJ entire) (NN range)) (PP (IN of) (NP (NP (NN stimulus) (NNS intensities)) (PP (IN for) (NP (NML (CC both) (NN b) (HYPH -) (CC and) (NN a) (HYPH -)) (NNS waves)))))))) (. .))) )
( (CAPTION (S (NP-SBJ (NNS Asterisks)) (VP (VBP represent) (NP (NP (JJ significant) (NNS differences)) (PP (IN between) (NP (DT the) (NNS groups)))) (PRN (-LRB- -LRB-) (NP (NP (NN Student) (POS 's)) (NN t) (NN test)) (, ,) (S-FRM (NP-SBJ (NN p)) (VP (SYM <) (NP (CD 0.05)))) (-RRB- -RRB-))) (. .))) )
( (CAPTION (S (NP-SBJ-1 (JJ Statistical) (NN significance)) (VP (VBD was) (VP (VBN found) (NP-1 (-NONE- *)) (PP (IN across) (NP (DT all) (NNS intensities))) (PP (PP (IN for) (NP (NML (NN b) (HYPH -) (NN wave)) (NNS amplitudes) (PRN (-LRB- -LRB-) (NP (NML (CD 2) (HYPH -) (NN way)) (NNP ANOVA)) (, ,) (S-FRM (NP-SBJ (NN p)) (VP (SYM <) (NP (CD 0.0001)))) (-RRB- -RRB-)))) (, ,) (CONJP (CC but) (RB not)) (PP (IN for) (NP (DT the) (NN a) (HYPH -) (NN wave)))))) (. .))) )
( (HEADING (NP (NN Discussion))) )
( (S (NP-SBJ (PRP$ Our) (NNS findings)) (VP (VBP support) (SBAR (IN that) (S (NP-SBJ (NN RanBP2)) (VP (VBZ plays) (NP (DT a) (JJ determinant) (NN role)) (PP (IN in) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG modulating) (NP (NP (NN glucose)) (CC and) (NP (NN energy) (NN homeostasis)))))))))) (. .)) )
( (S (NP-SBJ (DT The) (NNS data)) (VP (VBP support) (SBAR (IN that) (S (NP-SBJ (NN Cox1) (CC and) (NN HKI)) (VP (VBP are) (NP-PRD (JJ novel) (NNS partners)) (ADVP (FW in) (FW vivo)) (PP (IN for) (NP (NP (DT the) (JJ large) (NN LD)) (PP (IN of) (NP (NN RanBP2))))) (PRN (-LRB- -LRB-) (NP (NNS Figures) (NML (CD 1) (CC and) (CD 2))) (-RRB- -RRB-)))))) (. .)) )
( (S (NP-SBJ (NP (DT The) (NN LD)) (PP (IN of) (NP (NN RanBP2)))) (VP (VBZ exhibits) (NP (NP (NN chaperone) (NN activity)) (PP (IN toward) (NP (NP (NP (NN folding) (NNS intermediates)) (PP (IN of) (NP (NN Cox11)))) (, ,) (CC and) (NP (ADVP (RB possibly)) (, ,) (DT the) (JJ mature) (NN HKI))))) (PRN (-LRB- -LRB-) (NP (NN Figure) (CD 1)) (-RRB- -RRB-))) (. .)) )
( (S (NP-SBJ (NN Cox11)) (VP (VBZ inhibits) (ADVP-MNR (RB noncompetitively)) (NP (NP (DT the) (NN activity)) (PP (IN of) (NP (NN HKI)))) (SBAR-ADV (IN with) (S (NP-SBJ-1 (NP (QP (SYM ~) (CD 2) (SYM –) (CD 3)) (NNS molecules)) (PP (IN of) (NP (NN Cox11))) (PRN (-LRB- -LRB-) (S (NP-SBJ (-NONE- *PRO*)) (VP (VBG assuming) (NP (NP (NN formation)) (PP (IN of) (NP (NN Cox11) (NN dimer)))))) (-RRB- -RRB-))) (VP (VBN required) (NP-1 (-NONE- *)) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB inhibit) (ADVP (RB completely)) (NP (NP (DT the) (NN activity)) (PP (IN of) (NP (NP (DT a) (NN molecule)) (PP (IN of) (NP (NN HKI)))))))))))) (PRN (-LRB- -LRB-) (NP (NN Figure) (NML (NN 2A) (CC and) (NN 2B))) (-RRB- -RRB-))) (. .)) )
( (S (NP-SBJ (NN Cox11)) (VP (VBZ sequesters) (NP (NN HKI)) (PP-MNR (IN by) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG binding) (PP (IN to) (NP (NN HKI))) (PP-LOC (IN at) (NP (NP (DT a) (NN site)) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VP (VBZ is) (ADJP-PRD (JJ distinct) (PP (IN from) (NP (DT the) (JJ active) (NN site))))) (CC and) (VP (ADVP (RB effectively)) (VBZ reduces) (NP (NP (DT the) (NN availability)) (PP (IN of) (NP (-LRB- [) (NN HKI) (-RRB- ]) (NN tot))) (PP (IN for) (NP (NN catalysis)))))))))))))) (. .)) )
( (S (NP-SBJ-1 (DT This)) (VP (VBZ is) (VP (VBN reflected) (NP-1 (-NONE- *)) (PP (IN by) (NP-LGS (NP (DT a) (NN reduction)) (PP (IN of) (NP (NP (DT the) (NN Vmax)) (PP (IN of) (NP (NN HKI))))) (PP (IN without) (S-NOM (NP-SBJ (-NONE- *PRO*)) (ADVP (RB significantly)) (VP (VBG affecting) (NP (NP (DT the) (NN Km)) (PP (IN of) (NP (NP (DT the) (JJ active) (NN site)) (PP (IN of) (NP (NN HKI))))) (PP (IN toward) (NP (NN glucose))))))))) (PRN (-LRB- -LRB-) (NP (NN Figure) (NML (NN 2A) (CC and) (NN 2B))) (-RRB- -RRB-)))) (. .)) )
( (S (NP-SBJ-1 (NP (DT The) (JJ inhibitory) (NN property)) (PP (IN of) (NP (NN Cox11))) (PP (IN over) (NP (NN HKI)))) (VP (VBZ is) (VP (VBN suppressed) (NP-1 (-NONE- *)) (PP (IN by) (NP-LGS (NP (NN RanBP2) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 2C)) (-RRB- -RRB-))) (, ,) (SBAR (WHNP-2 (WDT which)) (S (NP-SBJ-2 (-NONE- *T*)) (PP (IN by) (NP (PRP itself))) (VP (VBZ has) (NP (NP (DT a) (ADJP (JJ weak) (CC but) (JJ significant)) (JJ inhibitory) (NN activity)) (PP (IN over) (NP (NN HKI)))) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 2D)) (-RRB- -RRB-))))))))) (. .)) )
( (S (NP-SBJ (NP (DT The) (JJ sub-stochiometry) (NN effect)) (PP (IN of) (NP (NP (DT the) (NN LD)) (PP (IN of) (NP (NN RanBP2))))) (PP (IN over) (NP (NP (DT the) (NN inhibition)) (PP (IN of) (NP (NN HKI))) (PP (IN by) (NP (NN Cox11)))))) (VP (VBZ supports) (SBAR (SBAR (IN that) (S (NP-SBJ (DT a) (ADJP (NN LD) (HYPH -) (JJ dependent)) (ADJP (NN chaperonin) (HYPH -) (JJ like)) (NN mechanism)) (VP (VBZ underlies) (NP (NP (DT the) (NN suppression)) (PP (IN of) (NP (NP (ADJP (JJ Cox11) (HYPH -) (JJ dependent)) (NN inhibition)) (PP (IN of) (NP (NN HKI))) (PP (IN by) (NP (NN RanBP2))))))))) (, ,) (CC and) (SBAR (IN that) (S (NP-SBJ (NN RanBP2)) (VP (VBZ acts) (PP (IN as) (NP (NP (DT a) (JJ molecular) (`` “) (NN buffer)) ('' ”) (PP (IN over) (NP (NML (NN HK1) (CC and) (NN Cox11)) (NNS activities)))))))))) (. .)) )
( (S (NP-SBJ (NP (DT The) (JJ partial) (NN loss)) (PP (IN of) (NP (DT the) (NN RanBP2) (NN chaperone) (NN activity))) (PP-LOC (IN in) (NP (NML (NN RanBP2) (SYM +) (HYPH /) (SYM −)) (NNS mice)))) (ADVP (RB also)) (VP (VBZ leads) (PP (IN to) (NP (NP (NNS deficits)) (PP (IN in) (NP (NP (DT the) (NN sequestration)) (PP (IN of) (NP (NN HKI))))) (PP-LOC (IN in) (NP (NP (DT the) (JJ ellipsoid) (NN compartment)) (PP (IN of) (NP (JJ photosensory) (NNS neurons)))))))) (. .)) )
( (S (NP-SBJ (DT This)) (ADVP (RB possibly)) (VP (VBZ underlies) (NP (NP (DT the) (NN mistargeting)) (PP (IN of) (NP (NN HKI))) (PP (IN to) (NP (NP (DT the) (JJ myoid) (NN compartment)) (PP (IN of) (NP (DT these) (NNS neurons)))))) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN S2)) (-RRB- -RRB-))) (. .)) )
( (S (NP-SBJ (DT The) (NNS data)) (VP (VBP support) (SBAR (IN that) (S (NP-SBJ (NP (NP (DT the) (JJ ultimate) (JJ pathophysiological) (NN outcome)) (PP (IN in) (NP (NN HKI)))) (, ,) (VP (VBN caused) (NP (-NONE- *)) (PP (IN by) (NP-LGS (NP (DT a) (NN reduction)) (PP (IN in) (NP (NP (NN RanBP2) (NNS levels)) (CC and) (NP (PRP$ its) (NN chaperone) (NN activity)))))))) (, ,) (VP (VBZ is) (NP-PRD (NP (DT the) (JJ selective) (NN degradation)) (PP (IN of) (NP (NN HKI)))) (SBAR-ADV (IN as) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (VBN reflected) (NP-1 (-NONE- *)) (PP (IN by) (NP-LGS (NP (DT the) (VBN reduced) (NNS levels)) (PP (PP (IN of) (NP (NN HKI) (-LRB- -LRB-) (CC and) (NN ATP))) (-RRB- -RRB-) (CONJP (CC but) (RB not)) (PP (IN of) (NP (JJ other) (UCP (JJ mitochondrial) (CC and) (NN NPC)) (NNS components))))))))) (PRN (-LRB- -LRB-) (NP (NN Figure) (CD 5)) (-RRB- -RRB-)))))) (. .)) )
( (S (PP-MNR (IN Through) (NP (DT this) (NN process))) (, ,) (NP-SBJ (NP (PRP it)) (SBAR-1 (-NONE- *EXP*))) (VP (VBZ is) (ADVP (RB also)) (ADJP-PRD (JJ possible)) (SBAR-1 (IN that) (S (NP-SBJ (NP (NNS deficits)) (PP (IN in) (NP (NN RanBP2)))) (VP (VBP cause) (NP (NP (DT a) (NN disturbance)) (PP (IN in) (NP (NP (DT the) (NN equilibrium)) (PP (IN between) (NP (NN Cox11) (, ,) (NN HK1) (, ,) (CC and) (NN RanBP2)))))) (PP-MNR (IN by) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG leading) (PP (IN to) (NP (NP (DT an) (NN increase)) (PP (IN of) (NP (NP (NP (DT the) (JJ inhibitory) (NN activity)) (PP (IN of) (NP (NN Cox11))) (PP (IN over) (NP (NN HKI)))) (SBAR (WHNP-2 (WDT that)) (S (NP-SBJ-2 (-NONE- *T*)) (VP (VBZ promotes) (NP (NP (DT the) (NN uncoupling)) (PP (IN of) (NP (NP (DT the) (NN interaction)) (PP (IN of) (NP (NN HKI))))) (PP (IN from) (NP (NN RanBP2)))) (, ,) (S-ADV (NP-SBJ (-NONE- *PRO*)) (ADVP-TMP (RB ultimately)) (VP (VBG causing) (NP (NN HKI) (NN degradation)))))))))))))))))) (. .)) )
( (S (ADVP (RB Regardless)) (, ,) (NP-SBJ (NP (JJR lower) (NNS levels)) (PP (IN of) (NP (NN HKI)))) (ADVP (RB likely)) (VP (VBP contribute) (PP (IN to) (NP (NP (NP (DT the) (VBN decreased) (NNS levels)) (PP (IN in) (NP (NN ATP)))) (, ,) (NP (JJR slower) (NN growth) (NNS rates)) (, ,) (CC and) (NP (VBN diminished) (NN ability) (S (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB metabolize) (NP (NP (NN glucose)) (PP (IN of) (NP (NML (NN RanBP2) (SYM +) (HYPH /) (SYM −)) (NNS mice)))))))))) (PRN (-LRB- -LRB-) (NP (NP (NNS Figures) (CD 5)) (PP (SYM –) (NP (CD 7)))) (-RRB- -RRB-))) (. .)) )
( (S (SBAR-ADV (IN As) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (VBN discussed) (NP-1 (-NONE- *)) (ADVP-TMP (RB subsequently))))) (, ,) (NP-SBJ (NP (DT the) (NN ATP) (NNS deficits)) (PP (IN in) (NP (DT the) (NN retina)))) (ADVP (RB likely)) (VP (VBP account) (PP (IN for) (NP (NP (DT the) (VBN reduced) (JJ electrophysiological) (NNS responses)) (PP (IN of) (NP (JJ retinal) (NNS neurons))))) (PRN (-LRB- -LRB-) (NP (NN Figure) (CD 8)) (-RRB- -RRB-))) (. .)) )
( (S (NP-SBJ-1 (NP (JJ Various) (NNS domains)) (PP (IN of) (NP (NN RanBP2)))) (VP (VBP have) (VP (VBN been) (ADVP-TMP (RB previously)) (VP (VBN implicated) (NP-1 (-NONE- *)) (PP (IN with) (NP (NP (DT a) (NN chaperone) (NN role)) (PP (IN in) (NP (DT the) (NN cell)))))))) (. .)) )
( (S (NP-SBJ (DT These)) (VP (VBP include) (NP (NP (NP (DT the) (NN enhancement)) (PP (IN of) (NP (NP (DT the) (NN biogenesis)) (PP (IN of) (NP (ADJP (JJ red) (HYPH /) (JJ green)) (NN opsin))))) (PP (IN by) (NP (NP (DT the) (NN combination)) (PP (IN of) (NP (DT the) (NML (NN RBD4) (HYPH -) (NN CY)) (NNS domains))))) (PRN (-LRB- [) (NP (CD 6) (, ,) (CD 7)) (-RRB- ]))) (CC and) (NP (NP (DT the) (NN stabilization)) (PP (IN by) (NP (NP (DT the) (ADJP (NN Ran) (HYPH -) (VBG binding)) (NNS domains)) (PP (IN of) (NP (NN RanBP2))))) (PP (IN of) (NP (NP (DT the) (ADJP (NP (NN guanosine) (NN triphosphate)) (HYPH -) (VBN bound)) (JJ conformational) (NN state)) (PP (IN of) (NP (NN RanGTPase)))))) (CC and) (NP (NP (NN interaction)) (PP (IN of) (NP (NN Ran))) (PP (IN with) (NP (NN importin) (HYPH -) (NN β))))) (PRN (-LRB- [) (NP (CD 11) (, ,) (CD 40) (, ,) (CD 41)) (-RRB- ]))) (. .)) )
( (S (NP-SBJ (NP (DT The) (NNS data)) (ADVP (RB herein))) (VP (VBP show) (SBAR (IN that) (S (NP-SBJ (NP (DT the) (JJ multi-chaperone) (NN role)) (PP (IN of) (NP (NN RanBP2)))) (VP (VBZ extends) (ADVP (RB also)) (PP (IN to) (NP (PRP$ its) (NN LD))) (PP (IN in) (NP (NP (NN light)) (PP (IN of) (NP (PRP$ its) (NN ability) (S (NP-SBJ (-NONE- *PRO*)) (VP (VP (TO to) (VP (VB associate) (PP (IN to) (NP (NP (JJ distinct) (NN folding) (NNS species)) (PP (IN of) (NP (NN Cox11))))))) (CC and) (VP (TO to) (VP (VB prevent) (NP (NN HKI)) (PP (IN from) (S-NOM (NP-SBJ-1 (-NONE- *PRO*)) (VP (VBG being) (VP (VBN degraded) (NP-1 (-NONE- *)))))))))))))))))) (. .)) )
( (S (NP-SBJ-1 (DT This) (NN chaperone) (NN function)) (VP (VBZ is) (ADJP-PRD (JJ likely) (S (NP-SBJ-1 (-NONE- *)) (VP (TO to) (VP (VB be) (VP (VBN complemented) (NP-1 (-NONE- *)) (PP (IN by) (NP-LGS (NP (JJ other) (NNS partners)) (PP (IN of) (NP (NN RanBP2))) (PP (IN with) (NP (ADJP (JJ similar) (CC and) (JJ pleiotropic)) (NNS functions))))))))))) (. .)) )
( (S (PP (IN For) (NP (NN example))) (, ,) (NP-SBJ (NP (NP (DT the) (NN combination)) (PP=2 (IN of) (NP (NP (DT the) (NN CLD)) (PP (IN of) (NP (NN RanBP2))))) (PP=1 (IN with) (NP (NP (JJ several) (NNS subunits)) (PP (IN of) (NP (NP (DT the) (NN 19S) (NN cap)) (PP (IN of) (NP (DT the) (NN proteasome))))) (PRN (-LRB- [) (NP (CD 14)) (-RRB- ]))))) (, ,) (CC and) (NP (PP=2 (IN of) (NP (NP (PRP$ its) (VBG neighboring) (JJ internal) (NN repeat)) (, ,) (NP (NN W1W2) (HYPH /) (NN IR)))) (PP=1 (IN with) (NP (NP (NP (DT the) (NML (NN E3) (HYPH -) (NN ubiquitin)) (NN ligase)) (, ,) (NP (NN parkin) (PRN (-LRB- [) (NP (CD 20)) (-RRB- ])))) (, ,) (CC and) (NP (NP (DT the) (NN E2) (ADJP (NP (NN SUMO) (HYPH -) (CD 1)) (HYPH -) (VBG conjugating)) (NN protein)) (, ,) (NP (NN Ubc9) (PRN (-LRB- [) (NP (CD 15)) (-RRB- ])))))))) (VP (MD may) (VP (VB contribute) (PP (IN to) (NP (NP (DT the) (JJ down) (HYPH -) (NN regulation)) (PP (IN of) (NP (NN HKI))) (PP (IN by) (NP (NP (ADJP (NP (NN 26S) (NN proteasome)) (HYPH -) (VBN mediated)) (NML (NN proteolysis) (CC and) (NN modulation))) (PP (IN of) (NP (NP (DT the) (ADJP (JJ molecular) (CC and) (JJ subcellular)) (NN partitioning)) (PP (IN of) (NP (DT these) (NNS partners))))))))))) (. .)) )
( (S (PP (IN In) (NP (DT this) (NN regard))) (, ,) (NP-SBJ (NP (PRP it)) (S-2 (-NONE- *EXP*))) (VP (MD will) (VP (VB be) (ADJP-PRD (JJ interesting)) (S-2 (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB probe) (SBAR (IN whether) (S (NP-SBJ (NN parkin)) (ADVP (RB also)) (VP (VBZ causes) (NP (NP (NNS deficits)) (PP (IN in) (NP (NN HKI)))) (PP-LOC (IN in) (NP (JJ dopaminergic) (NNS neurons))))))))) (, ,) (SBAR-PRP (IN since) (S (S (NP-SBJ-1 (NN parkin)) (VP (VBD was) (VP (VBN reported) (S (NP-SBJ-1 (-NONE- *)) (VP (TO to) (VP (VB modulate) (NP (NN RanBP2) (NN turnover))))) (PRN (-LRB- [) (NP (CD 20)) (-RRB- ]))))) (, ,) (CC and) (S (NP-SBJ (NN parkin) (NML (NML (NN loss)) (HYPH -) (PP (IN of) (HYPH -) (NP (NN function))))) (ADVP (RB also)) (VP (VBZ causes) (NP (NML (NN energy) (CC and) (NN growth)) (NNS deficits)) (PRN (-LRB- [) (NP (NP (CD 26)) (PP (SYM –) (NP (CD 29)))) (, ,) (NP (CD 42)) (-RRB- ])))))))) (. .)) )
( (S (NP-SBJ (DT These) (NNS data)) (VP (VBP add) (NP (DT a) (JJ new) (NN dimension)) (PP (IN to) (NP (NP (DT the) (NN complexity)) (PP (IN of) (NP (NP (DT the) (NN regulation)) (PP (IN of) (NP (DT the) (JJ glycolytic) (NN pathway))) (, ,) (PP-LOC (PP (IN in) (ADJP (JJ particular))) (IN in) (NP (NP (DT the) (NN CNS)) (, ,) (SBAR (SBAR (WHADVP-1 (WRB where)) (S (NP-SBJ (NN glycolysis)) (VP (VBZ plays) (NP (DT a) (JJ major) (NN role)) (PP (IN in) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG supplying) (NP (NN energy))))) (ADVP-LOC-1 (-NONE- *T*))))) (CC and) (SBAR (WHADVP-2 (WRB where)) (S (NP-SBJ (DT the) (NN proteasome) (NN machinery)) (VP (MD may) (VP (VB play) (NP (DT a) (JJ critical) (NN role)) (PP (IN in) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG modulating) (NP (NP (NNS components)) (PP (IN of) (NP (DT the) (NML (NN energy) (NN supply)) (NN machinery))))))) (PRN (-LRB- [) (NP (CD 43)) (-RRB- ])) (ADVP-LOC-2 (-NONE- *T*)))))))))))))) (. .)) )
( (S (NP-SBJ-1 (DT This)) (VP (VBZ is) (ADVP (RB further)) (VP (VBN evidenced) (NP-1 (-NONE- *)) (PP (IN by) (NP-LGS (NP (DT the) (NN presence)) (PP (IN of) (NP (JJ genetic) (NNS modifiers))) (PP-LOC (IN in) (NP (NP (NML (NN RanBP2) (SYM +) (HYPH /) (SYM −)) (NNS mice)) (PP (IN on) (NP (NP (DT a) (JJ mixed) (JJ genetic) (NN background)) (SBAR (WHNP-2 (WDT that)) (S (NP-SBJ-2 (-NONE- *T*)) (VP (VBZ compensates) (PP (IN for) (NP (NP (NP (NNS deficits)) (PP (IN in) (NP (NN RanBP2)))) (CC and) (NP (NP (NN deregulation)) (PP (IN of) (NP (NP (PRP$ its) (NNS partners)) (PP (IN in) (NP (NML (NN glucose) (HYPH /) (NN energy)) (NN homeostasis)))))))) (SBAR-ADV (IN as) (S (NP-SBJ-3 (-NONE- *PRO*)) (VP (VBN observed) (NP-3 (-NONE- *)) (PP (IN in) (NP (DT the) (JJ coisogenic) (NN line))))))))))))))))) (. .)) )
( (S (NP-SBJ-2 (NP (DT The) (NN presence)) (PP (IN of) (NP (JJ such) (JJ compensatory) (NNS mechanisms)))) (VP (VP (VBZ is) (RB also) (VP (VBN supported) (NP-2 (-NONE- *)) (PP (IN by) (NP-LGS (NP (DT the) (NN identification)) (PP (IN of) (NP (NP (DT a) (JJ quantitative) (NN trait) (NN locus)) (, ,) (SBAR (WHNP-1 (WDT which)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBZ encompasses) (NP (NN RanBP2))))))))))) (, ,) (CC and) (VP (VBZ modifies) (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (ADJP (NN diabetes) (HYPH -) (VBN related)) (NNS phenotypes)))) (PRN (-LRB- [) (NP (CD 44)) (-RRB- ])))) (. .)) )
( (S (S (NP-SBJ (NP (DT The) (NNS data)) (ADVP (RB herein))) (VP (VBP show) (NP (NP (NNS tissues)) (PP (IN with) (NP (NP (DT a) (NN decrease)) (PP (IN of) (NP (NN RanBP2)))))))) (CC and) (S (NP-SBJ (NN HKI) (NNS levels)) (VP (VBP mirror) (NP (NP (DT a) (NN reduction)) (PP (IN in) (NP (DT the) (NN ATP) (NNS levels)))))) (. .)) )
( (S (SBAR-PRP (IN Since) (S (NP-SBJ (NP (DT the) (JJ constitutive) (NML (NN Na+) (HYPH /) (NN K+)) (NN ATPase) (NN pump)) (CC and) (NP (NP (DT the) (ADJP (NN ATP) (HYPH -) (JJ dependent)) (NN conversion)) (PP (IN of) (NP (NN glutamine))) (PP (IN to) (NP (NN glutamate))))) (-LRB- -LRB-) (S-ADV (NP-SBJ (DT both)) (ADJP-PRD (JJ fundamental)) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB maintain) (NP (DT the) (JJ electrical) (NN activity)) (PP-LOC (IN in) (NP (DT the) (NN CNS))))))) (-RRB- -RRB-) (VP (VBZ consumes) (NP (NP (DT the) (JJ vast) (NN majority)) (PP (IN of) (NP (NP (DT the) (NN energy)) (VP (VBN produced) (NP (-NONE- *)) (PP (IN by) (NP-LGS (DT the) (NN CNS))))))) (PRN (-LRB- [) (NP (NP (CD 45)) (PP (SYM –) (NP (CD 47)))) (-RRB- ]))))) (, ,) (NP-SBJ (DT this)) (ADVP (RB likely)) (VP (VBZ underlies) (NP (NP (DT the) (NN suppression)) (PP (IN of) (NP (NP (DT the) (NML (JJ electrophysiological) (NN output)) (NNS responses)) (PP (IN of) (NP (JJ retinal) (NNS neurons)))))) (PRN (-LRB- -LRB-) (NP (NN Figure) (CD 8)) (-RRB- -RRB-))) (. .)) )
( (S (ADVP (RB Moreover)) (, ,) (NP-SBJ (NP (NNS deficits)) (PP (IN in) (NP (NN HKI)))) (VP (MD may) (VP (VP (VB lead) (PP (IN to) (NP (JJ intracellular) (NN hyperglycemia))) (PP-LOC (IN in) (NP (DT the) (NN CNS)))) (, ,) (VP (VB promote) (NP (ADJP (NN sorbitol) (HYPH -) (VBN induced)) (JJ osmotic) (NN stress))) (, ,) (CC and) (VP (VB compromise) (ADVP (RB further)) (NP (DT the) (ADJP (NN ATPase) (HYPH -) (JJ dependent)) (NML (NN Na+) (HYPH /) (NN K+)) (NN pump) (NN activity))) (PRN (-LRB- [) (NP (NP (CD 48)) (PP (SYM –) (NP (CD 50)))) (-RRB- ])))) (. .)) )
( (S (NP-SBJ-1 (DT This)) (VP (MD may) (VP (VB be) (VP (VBN exacerbated) (NP-1 (-NONE- *)) (PP (IN by) (NP-LGS (NP (DT a) (NN decrease)) (PP (IN of) (NP (NN ATP))))) (, ,) (SBAR-PRP (IN since) (S (NP-SBJ-2 (NP (DT the) (NN activity)) (PP (IN of) (NP (NN HKI)))) (VP (VBZ is) (ADVP (RB also)) (VP (VBN stimulated) (NP-2 (-NONE- *)) (PP (IN by) (NP-LGS (NN ATP))) (PRN (-LRB- [) (NP (CD 51)) (-RRB- ]))))))))) (. .)) )
( (S (NP-SBJ-1 (NP (DT The) (JJ cumulative) (NNS effects)) (PP (IN of) (NP (NP (NP (DT a) (NN reduction)) (PP (IN in) (NP (NN ATP)))) (CC and) (NP (JJ intracellular) (NN hyperglycemia))))) (VP (VBP are) (VP (VBN known) (S (NP-SBJ-1 (-NONE- *)) (VP (TO to) (VP (VP (VB act) (ADVP-MNR (RB synergistically))) (CC and) (VP (VB modulate) (NP (NP (DT the) (JJ electrophysiological) (NNS properties)) (PP (IN of) (NP (JJ neuronal) (NN activity)))))))))) (. .)) )
( (S (NP-SBJ (NN Figure) (CD 9)) (VP (VBZ integrates) (PP (IN in) (NP (DT a) (NN model))) (NP (NP (DT these) (NNS variables)) (CC and) (NP (NP (NNS implications)) (PP (IN of) (NP (NP (DT the) (NNS data)) (VP (VBN presented) (NP (-NONE- *)) (ADVP (RB herein)))))))) (. .)) )
( (S (ADVP (RB Still)) (, ,) (NP-SBJ-1 (NP (JJ other) (ADJP (FW bona) (FW fide)) (NN RanBP2) (NNS partners)) (VP (ADVP-TMP (RB previously)) (VBN identified) (CC and) (VBN described) (NP (-NONE- *)) (PP (IN in) (NP (DT the) (NN Introduction))))) (ADVP (RB also)) (VP (VBP become) (NP-PRD (NP (JJ strong) (NNS candidates)) (SBAR (WHNP-2 (-NONE- *0*)) (S (NP-SBJ-2 (-NONE- *T*)) (VP (TO to) (VP (VB play) (NP (DT a) (NN role)) (PP (IN in) (NP (NN energy) (NN homeostasis))))))))) (. .)) )
( (S (PP (IN For) (NP (NN example))) (, ,) (NP-SBJ-1 (NP (DT the) (NML (JJ unfolding) (CC and) (NN chaperone)) (NN activity)) (PP (IN of) (NP (NP (NNS components)) (PP (IN of) (NP (NP (DT the) (NN 19S) (NN cap)) (PP (IN of) (NP (DT the) (NN proteasome)))))))) (VP (MD may) (VP (VP (VP (VB be) (VP (VBN modulated) (NP-1 (-NONE- *)) (PP (IN by) (NP-LGS (NP (DT the) (NN CLD)) (PP (IN of) (NP (NN RanBP2))))) (PRN (-LRB- [) (NP (CD 14)) (-RRB- ])))) (CC and) (VP (VB contribute) (PP (IN to) (NP (DT the) (JJ selective) (NML (NML (NN HKI)) (-LRB- -LRB-) (CC and) (NML (JJ other) (NNS substrates))) (-RRB- -RRB-) (NN degradation))) (PRN (-LRB- [) (NP (CD 43)) (-RRB- ])))) (, ,) (SBAR-ADV (IN while) (S (NP-SBJ (NP (NN association)) (PP (IN of) (NP (NP (JJ nuclear) (NN import) (NN receptor)) (, ,) (NP (NN importin) (HYPH -) (NN β)))) (PP (IN with) (NP (NP (DT the) (ADJP (NN Ran) (HYPH -) (VBG binding)) (NNS domains)) (PP (IN of) (NP (NN RanBP2))))) (PRN (-LRB- [) (NP (CD 10) (, ,) (CD 11)) (-RRB- ]))) (, ,) (VP (MD may) (VP (VB mediate) (NP (NP (DT the) (JJ nuclear) (NN translocation)) (PP (IN of) (NP (NP (JJ multifunctional) (NNS substrates)) (, ,) (PP (JJ such) (IN as) (NP (NML (NN glyceraldehyde) (HYPH -) (CD 3) (HYPH -) (NN phosphate)) (NN dehydrogenase)))))))))))) (. .)) )
( (S (NP-SBJ-1 (DT This) (NN trafficking) (NN process)) (VP (VP (VBZ is) (ADVP (RB selectively)) (VP (VBN inhibited) (NP-1 (-NONE- *)) (PP (IN by) (NP-LGS (NP (NP (DT the) (JJ neuroprotective) (NN drug)) (, ,) (NP (NML (NN R) (HYPH -) (-LRB- -LRB-) (SYM -) (-RRB- -RRB-) (HYPH -)) (NN deprenyl))) (CC and) (NP (NP (VBZ derivates)) (ADVP (RB thereof))))))) (, ,) (CC and) (VP (VBP are) (ADVP-TMP (RB often)) (VP (VBN employed) (NP-1 (-NONE- *)) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB treat) (NP (NNP Parkinson) (NN disease))))) (PRN (-LRB- [) (NP (NP (CD 52)) (PP (SYM –) (NP (CD 57)))) (-RRB- ]))))) (. .)) )
( (S (ADVP (RB Hence)) (, ,) (NP-SBJ (NP (NN RanBP2)) (CC and) (NP (PRP$ its) (NNS partners))) (VP (VBP emerge) (PP (IN as) (NP (NP (JJ key) (NNS players)) (CC and) (NP (NN target) (NNS genes)))) (PP (IN in) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG mediating) (NP (NP (JJ neuropathophysiological) (NNS mechanisms)) (VP (VBN implicated) (NP (-NONE- *)) (PP (IN in) (NP (NP (JJ various) (ADJP (JJ genetic) (CC and) (JJ environmental)) (NNS lesions)) (PP (IN to) (NP (DT the) (NN CNS))) (, ,) (PP (IN as) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (NNP Parkinson)) (, ,) (NP (NP (NN diabetes)) (PP (IN with) (NP (NN insulin) (HYPH -) (NN resistance)))) (, ,) (CC and) (NP (NP (JJ other) (NML (NML (NNS neuropathies)) (CC and) (NML (JJ neurodegenerative) (NNS diseases)))) (, ,) (VP (ADVP-TMP (RB often)) (VBN linked) (NP (-NONE- *)) (PP (IN to) (NP (NN aging) (NNS manifestations)))))))))))))))))) (. .)) )
( (S (PP-PRP (IN To) (NP (DT this) (NN effect))) (, ,) (NP-SBJ (DT the) (NN RanBP2) (NN mouse) (NN model)) (VP (MD will) (VP (VB serve) (PP (IN as) (NP (NP (DT a) (JJ unique) (JJ genetic) (NN tool)) (SBAR (WHNP-2 (-NONE- *0*)) (S (NP-SBJ-2 (-NONE- *T*)) (VP (TO to) (VP (VB probe) (NP (NP (ADJP (JJ selective) (, ,) (JJ multiple) (CC and) (JJ novel)) (NNS pathways)) (, ,) (SBAR (WHNP-1 (WDT which)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (MD may) (VP (VB have) (RB not) (VP (VBN been) (VP (VBN anticipated) (S (NP-SBJ-1 (-NONE- *)) (VP (TO to) (VP (VB be) (VP (VBN linked) (NP-1 (-NONE- *)) (PP (IN to) (NP (NP (JJ metabolic) (NNS processes)) (CC and) (NP (VBN allied) (JJ pathophysiological) (NNS states))))))))))))))))))))))) (. .)) )
( (HEADING (NP (NN Figure) (CD 9))) )
( (HEADING (NP (NP (NN Model)) (VP (VBG Depicting) (NP (NP (DT a) (NN Role)) (PP (IN of) (NP (NP (NN RanBP2)) (CC and) (NP (NP (DT Some)) (PP (IN of) (NP (PRP$ Its) (NNS Partners)))))) (PP (IN in) (NP (ADJP (JJ Metabolic) (CC and) (JJ Neuronal)) (NN Function))))))) )
( (CAPTION (S (S (NP-SBJ (NN RanBP2)) (VP (VBZ interacts) (PP (IN with) (NP (NN Cox11) (CC and) (NN HKI))))) (CC and) (S (NP-SBJ (DT the) (NN triad)) (VP (VBZ is) (PP-PRD (IN in) (NP (NN equilibrium))) (PP (IN under) (NP (JJ normal) (JJ physiological) (NNS conditions))))) (. .))) )
( (CAPTION (S (NP-SBJ (NN RanBP2)) (VP (VBZ prevents) (NP (NP (DT the) (NN inhibition)) (PP (IN of) (NP (NN HKI))) (PP (IN by) (NP (NP (NN Cox11)) (CC and) (NP (PRP$ its) (NN degradation)))))) (. .))) )
( (CAPTION (S (NP-SBJ (NP (DT The) (JJ ultimate) (NN effect)) (PP (IN of) (NP (NN RanBP2))) (PP (IN on) (NP (PRP$ its) (NNS partners)))) (VP (VBZ is) (NP-PRD (NP (NP (DT the) (NN stimulation)) (PP (IN of) (NP (DT the) (JJ glycolytic) (NN pathway)))) (CC and) (NP (NP (NN production)) (PP (IN of) (NP (NN ATP)))))) (. .))) )
( (CAPTION (S (NP-SBJ (DT The) (JJ glycolytic) (NN pathway)) (VP (VBZ is) (ADJP-PRD (JJ critical)) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB fuel) (NP (DT the) (JJ constitutive) (NML (NML (NN Na+) (SYM /) (NN K+)) (HYPH -) (NN ATPase)) (NN pump)) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB maintain) (NP (NP (DT the) (JJ dark) (NN current)) (PP-LOC (IN between) (NP (NP (DT the) (ADJP (JJ inner) (CC and) (JJ outer)) (NN segment) (NNS compartments)) (PP (IN of) (NP (JJ photosensory) (NNS neurons))))))))))))) (. .))) )
( (CAPTION (S (NP-SBJ (NP (NP (DT A) (NN deficit)) (-LRB- -LRB-) (NP (NN haploinsufficiency))) (-RRB- -RRB-) (PP-LOC (IN in) (NP (NN RanBP2)))) (VP (VBZ disturbs) (NP (NP (DT the) (NN equilibrium)) (PP (IN between) (NP (NN RanBP2) (, ,) (NN HKI) (, ,) (CC and) (NN Cox11))))) (. .))) )
( (CAPTION (S (NP-SBJ (DT This) (JJ pathophysiological) (NN event)) (VP (VBZ promotes) (NP (NP (NP (DT the) (NML (NN destabilization) (CC and) (NN degradation))) (PP (IN of) (NP (NN HKI)))) (CC and) (NP (NP (DT a) (NN decrease)) (PP (IN in) (NP (NP (NN ATP) (NN production)) (VP (VBN required) (NP (-NONE- *)) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB maintain) (NP (DT the) (NN depolarization) (NN state) (NNS neurons))))))))) (, ,) (CC and) (, ,) (NP (ADVP (RB hence)) (, ,) (NP (DT a) (NN reduction)) (PP (IN in) (NP (NP (DT the) (NN response)) (PP (IN of) (NP (ADJP (JJ receptoral) (CC and) (JJ postreceptoral)) (NNS neurons)))))))) (. .))) )
( (CAPTION (S (NP-SBJ (NP (DT A) (NN reduction)) (PP (IN in) (NP (NN ATP) (NNS levels)))) (ADVP (RB also)) (ADVP-MNR (RB negatively)) (VP (VBZ modulates) (NP (NP (NN HKI) (NN activity)) (PP (SYM /) (NP (NN level))))) (. .))) )
( (CAPTION (S (NP-SBJ (NP (VBN Decreased) (NNS levels)) (PP (IN of) (NP (NN HKI)))) (VP (VP (VBP promote) (NP (JJ intracellular) (NN hyperglycemia))) (CC and) (VP (VBP activate) (NP (NP (NN stress) (NNS kinases)) (, ,) (SBAR (WHNP-1 (WDT which)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBP modulate) (ADVP-MNR (RB negatively)) (NP (DT the) (NML (NML (NN Na+) (HYPH /) (NN K+)) (HYPH -) (NN ATPase)) (NN pump)) (PP-MNR (IN by) (NP (NN phosphorylation))))))))) (. .))) )
( (CAPTION (S (NP-SBJ-1 (NP (JJ Pathophysiological) (NNS pathways)) (VP (VBN promoted) (NP (-NONE- *)) (PP (IN by) (NP-LGS (NN RanBP2) (NN haploinsufficiency))))) (VP (VBP are) (VP (VBN represented) (NP-1 (-NONE- *)) (PP (IN by) (NP-LGS (NN dash) (NNS lines))))) (. .))) )
( (CAPTION (NP (NP (NP (NN RIS)) (, ,) (NP (NN rod) (JJ inner) (NN segment))) (: ;) (NP (NP (NN ROS)) (, ,) (NP (NN rod) (JJ outer) (NN segment))) (. .))) )
( (S (ADVP (RB Finally)) (, ,) (NP-SBJ-1 (NN RanBP2)) (VP (VBZ appears) (S (NP-SBJ-1 (-NONE- *)) (VP (TO to) (VP (VB join) (NP (NP (JJ other) (NNS nucleoporins)) (, ,) (PP (JJ such) (IN as) (NP (NN Nup96)))) (PRN (-LRB- [) (CD 58) (-RRB- ])) (, ,) (PP (IN in) (NP (NP (JJ novel) (JJ physiological) (NNS functions)) (SBAR (SBAR (WHNP-3 (WDT that)) (S (NP-SBJ-3 (-NONE- *T*)) (VP (VBP are) (ADJP-PRD (JJ vital) (PP (IN for) (NP (JJ complex) (NNS organisms))))))) (CC and) (SBAR (WHNP-2 (WDT that)) (S (NP-SBJ-2 (-NONE- *T*)) (VP (VBD were) (RB not) (VP (VBN anticipated) (NP-2 (-NONE- *)) (PP (IN from) (NP (ADJP (NN cell) (HYPH -) (VBN based)) (NNS studies)))))))))))))) (. .)) )
( (S (NP-SBJ (NP (DT The) (VBN reduced) (NN expression)) (PP (IN of) (NP (DT these) (NN proteins))) (PP (IN in) (NP (NML (JJ whole) (HYPH -) (NN animal)) (NNS models)))) (VP (VBZ generates) (NP (NP (NNS phenotypes)) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VP (VBP are) (ADJP-PRD (NN tissue) (HYPH -) (JJ restricted))) (CC and) (VP (ADVP (RBR more) (RB importantly)) (, ,) (VBP do) (RB not) (VP (VB seem) (S (NP-SBJ-1 (-NONE- *)) (VP (TO to) (VP (VB recapitulate) (NP (NP (NNS phenotypes)) (VP (VBN observed) (NP (-NONE- *)) (PP-MNR (IN with) (NP (NP (NN knockdown) (NNS experiments)) (PP (IN in) (NP (ADJP (NN cell) (HYPH -) (VBN based)) (NN culture) (NNS assays))))))))))))))))) (. .)) )
( (S (PP (IN For) (NP (NN example))) (, ,) (NP-SBJ-1 (NP (NP (JJ short) (VBG interfering) (ADJP (NN RNA) (HYPH -) (VBN mediated)) (NN knockdown)) (PP (IN of) (NP (NN RanBP2))) (PRN (-LRB- [) (NP (CD 9)) (-RRB- ]))) (CC and) (NP (NP (NNS members)) (PP (IN of) (NP (DT the) (NML (NN Nup107) (HYPH -) (NN Nup160)) (NN complex))) (PRN (-LRB- [) (NP (NP (CD 59)) (PP (SYM –) (NP (CD 61)))) (-RRB- ])))) (VP (VBP have) (VP (VBN shown) (, ,) (ADVP (RB respectively)) (, ,) (S (NP-SBJ-1 (-NONE- *)) (VP (TO to) (VP (VB cause) (NP (NP (JJ mitotic) (NN arrest)) (CC and) (NP (NP (NN disruption)) (PP (IN of) (NP (NML (JJ nuclear) (NN pore)) (NN assembly)))) (CC and) (NP (NP (NNS deficits)) (PP (IN in) (NP (NN mRNA) (NN export))))) (PP-LOC (IN in) (NP (NN cell) (NN culture)))))))) (. .)) )
( (S (ADVP (RB Yet)) (, ,) (NP-SBJ (NP (NN haploinsufficiency)) (PP (IN of) (NP (NP (NN RanBP2) (PRN (-LRB- -LRB-) (NP (DT this) (NN work)) (-RRB- -RRB-))) (CC and) (NP (NN Nup96) (PRN (-LRB- [) (NP (CD 58)) (-RRB- ])))))) (ADVP (RB predominantly)) (VP (VBP produce) (, ,) (ADVP (RB instead)) (, ,) (NP (NP (NP (ADJP (NN CNS) (HYPH -) (JJ restricted)) (NNS deficits)) (PP (IN in) (NP (NN energy) (NN metabolism)))) (CC and) (NP (NP (NP (NNS alterations)) (PP (IN in) (NP (DT the) (JJ immune) (NN system)))) (VP (VBN linked) (NP (-NONE- *)) (PP (IN to) (NP (NP (NP (DT the) (JJ down) (HYPH -) (NN regulation)) (PP (IN of) (NP (ADJP (NP (NN interferon) (HYPH -) (NN β)) (HYPH -) (VBN regulated)) (NN proteins)))) (CC and) (NP (NP (VBN increased) (NN susceptibility)) (PP (IN of) (NP (JJ viral) (NN infection)))))) (, ,) (ADVP (RB respectively)))))) (. .)) )
( (S (SBAR-ADV (IN While) (S (NP-SBJ-1 (NP (DT these) (JJ apparent) (NN outcome) (NNS disparities)) (PP (IN among) (NP (JJ experimental) (NNS systems)))) (VP (VBP remain) (ADJP-PRD (JJ unclear))))) (, ,) (NP-SBJ (PRP they)) (VP (MD could) (ADVP (RB potentially)) (VP (VB result) (PP (IN from) (NP (NP (NNS variations)) (PP (IN in) (NP (NP (NP (NNS redundancies)) (CC and) (NP (JJ compensatory) (NNS mechanisms))) (ADJP (JJ inherent) (PP (IN to) (NP (DT each) (JJ experimental) (NN system)))))))))) (. .)) )
( (S (ADVP (RB Regardless)) (, ,) (NP-SBJ (DT these) (UCP (ADJP (JJ genetic)) (CC and) (NML (JJ whole) (HYPH -) (NN animal))) (NNS models)) (VP (VBD set) (NP (DT the) (NN stage)) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VP (VB probe) (NP (JJ novel) (JJ molecular) (NNS pathways)) (PP (IN in) (NP (JJ various) (ADJP (JJ physiological) (CC and) (JJ genetic)) (NNS contexts)))) (, ,) (CC and) (VP (VB provide) (ADVP (RB also)) (NP (NP (DT a) (NN link)) (PP (IN to) (NP (NP (JJ pathophysiological) (NNS processes)) (VP (VBG underlying) (NP (JJ several) (JJ human) (NNS diseases))))))))))) (. .)) )
( (HEADING (NP (NNS Materials) (CC and) (NNS Methods))) )
( (HEADING (NP (NN Yeast) (NML (CD two) (HYPH -) (NN hybrid)) (NML (NN screening) (CC and) (NNS assays)) (. .))) )
( (S (NP-SBJ-1 (NP (DT The) (NN LD)) (PP (IN of) (NP (JJ human) (NN RanBP2))) (PRN (-LRB- -LRB-) (NP (NNS residues) (NML (NML (CD 62)) (PP (SYM –) (NP (CD 711))))) (-RRB- -RRB-))) (VP (VBD was) (VP (VBN subcloned) (NP-1 (-NONE- *)) (PP-MNR (IN in) (HYPH -) (NP (NN frame))) (PP-LOC (IN into) (NP (NP (DT the) (NN GAL4) (NML (NN DNA) (HYPH -) (NN binding)) (NN domain)) (PP (IN of) (NP (NP (NN bait) (NN vector)) (, ,) (NP (NP (NN pBUTE)) (-LRB- -LRB-) (NP (NP (DT a) (ADJP (NN kanamycin) (HYPH -) (JJ resistant)) (NN version)) (PP (IN of) (NP (NP (NN GAL4) (NN bait) (NN vector)) (NP (NN pGBDUC1))))) (-RRB- -RRB-) (PRN (-LRB- [) (NP (CD 62)) (-RRB- ]))) (CC and) (NP (NN HybriZAP) (NML (NN pBD) (HYPH -) (NN GAL4)) (NN vector) (PRN (-LRB- -LRB-) (NP (NP (NNP Stratagene)) (, ,) (NP-LOC (NNP La) (NNP Jolla)) (, ,) (NP-LOC (NNP California)) (, ,) (NP-LOC (NNP United) (NNP States))) (-RRB- -RRB-))))))))) (. .)) )
( (S (NP-SBJ-1 (DT The) (JJ former)) (VP (VBD was) (VP (VBN used) (NP-1 (-NONE- *)) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB screen) (NP (NP (QP (SYM ~) (CD 18) (CD million)) (NNS clones)) (PP (IN via) (NP (VBG mating))) (PP (IN from) (NP (NP (NN murine) (ADJP (NP (QP (CD 9) (HYPH -) (IN to) (CD 10) (HYPH -)) (NN d)) (HYPH -) (JJ old)) (NML (NN embryo) (CC and) (NN brain)) (NN cDNA) (NNS libraries)) (PP-LOC (IN at) (NP (NP (NP (DT the) (NNP Molecular) (NNP Interaction) (NNP Facility)) (-LRB- -LRB-) (NP (NNP MIF))) (-RRB- -RRB-) (, ,) (NP-LOC (NP (NP (NNP University)) (PP (IN of) (NP (NNP Wisconsin)))) (, ,) (NP-LOC (NNP Madison)) (, ,) (NP-LOC (NNP Wisconsin))))))))))))) (. .)) )
( (S (NP-SBJ-1 (DT The) (JJ latter)) (VP (VBD was) (VP (VBN used) (NP-1 (-NONE- *)) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB screen) (PP-MNR (IN via) (NP (NP (NN transformation)) (PP (IN of) (NP (NP (QP (SYM ~) (CD 5) (CD million)) (NNS clones)) (PP (IN from) (NP (JJ bovine) (JJ retinal) (NN cDNA) (NNS libraries))))))) (PRN (-LRB- [) (NP (CD 32)) (-RRB- ]))))))) (. .)) )
( (S (NP-SBJ (DT The) (NNS screens)) (VP (VBD generated) (NP (CD six) (NNS clones))) (. .)) )
( (S (S (NP-SBJ-2 (NML (CD One) (CC and) (CD two)) (NML (PP (IN in) (HYPH -) (NP (NN frame)))) (NNS clones)) (VP (VBD were) (ADVP (RB independently)) (VP (VBN isolated) (NP-2 (-NONE- *)) (PP (IN from) (NP (DT the) (ADJP (JJ embryonic) (CC and) (JJ adult)) (NN brain) (NNS libraries))) (, ,) (ADVP (RB respectively))))) (, ,) (CC and) (S (NP-SBJ-1 (DT the) (NNS interactions)) (VP (VBD were) (VP (VBN validated) (NP-1 (-NONE- *))))) (. .)) )
( (S (NP-SBJ (DT The) (CD three) (NNS clones)) (VP (VBD encoded) (NP (NN Cox11))) (. .)) )
( (S (NP-SBJ-1 (NP (NNS Interactions)) (PP (IN between) (NP (NP (NN Cox11)) (, ,) (NP (NN LD)) (, ,) (CC and) (NP (NP (NNS subdomains)) (ADVP (RB thereof)))))) (VP (VBD were) (VP (VBN quantified) (NP-1 (-NONE- *)) (PP-MNR (IN by) (NP (NP (JJ liquid) (NN β) (HYPH -) (NN galactosidase) (PRN (-LRB- -LRB-) (NP (NP (NNP Applied) (NNP Biosystems)) (, ,) (NP-LOC (NNP Foster) (NNP City)) (, ,) (NP-LOC (NNP California)) (, ,) (NP-LOC (NNP United) (NNP States))) (-RRB- -RRB-))) (CC and) (NP (NN growth) (NNS assays)))) (PRN (-LRB- [) (NP (CD 63)) (-RRB- ])))) (. .)) )
( (S (NP-SBJ-1 (NP (DT The) (NN maximum) (JJ specific) (NN growth) (NN speed)) (-LRB- -LRB-) (NP (NN μmax))) (-RRB- -RRB-) (VP (VBD was) (VP (VBN determined) (NP-1 (-NONE- *)) (PP-MNR (IN by) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG calculating) (S-TTL-FRM (NP-SBJ (NN μmax)) (VP (SYM =) (-LRB- -LRB-) (NP (NP (NP (NN ln) (-LRB- -LRB-) (NN xt)) (-RRB- -RRB-) (SYM −) (NP (NN ln) (-LRB- -LRB-) (NN x0))) (-RRB- -RRB-) (-RRB- -RRB-) (SYM /) (NP (NN t))) (, ,) (SBAR-ADV (WHADVP-2 (WRB where)) (S (S (S (NP-SBJ (NN xt)) (VP (VBZ is) (NP-PRD (NP (DT the) (NN OD600)) (PP (IN of) (NP (DT the) (NN culture))) (PP (IN at) (S-TTL-FRM (NP-SBJ (NN t)) (VP (SYM =) (NP (NN t)))))))) (, ,) (S (NP-SBJ (NN x0)) (VP (VBZ is) (NP-PRD (DT the) (NN OD600)) (PP (IN at) (S-TTL-FRM (NP-SBJ (NN t)) (VP (SYM =) (NP (CD 0))))))) (CC and) (S (NP-SBJ (NN t)) (VP (VBZ is) (NP-PRD (NP (DT the) (NN time)) (PP (IN between) (NP (NN x0) (CC and) (NN xt))))))) (ADVP-LOC-2 (-NONE- *T*))))))))))) (. .)) )
( (S (S (NP-SBJ-1 (NNS Assays)) (VP (VBD were) (VP (VBN performed) (NP-1 (-NONE- *)) (PP-MNR (IN with) (NP (NP (CD three) (JJ independent) (NNS clones)) (CC and) (NP (NP (CD three) (NNS samples)) (PP (IN of) (NP (DT each) (NN clone))))))))) (, ,) (S (NP-SBJ-2=4 (DT the) (NNS results)) (VP (VBD were) (VP=3 (VBN averaged) (NP-2 (-NONE- *))))) (, ,) (CC and) (S (NP-SBJ-5=4 (DT the) (JJ standard) (NNS deviations)) (VP=3 (VBN calculated) (NP-5 (-NONE- *)))) (. .)) )
( (HEADING (NP (NP (UCP (ADJP (NN Site) (HYPH -) (VBN directed)) (CC and) (NML (NN deletion))) (NN mutagenesis)) (CC and) (NP (NN plasmid) (NN construction)) (. .))) )
( (S (NP-SBJ-1 (NN Deletion) (NN mutagenesis)) (VP (VBD was) (VP (VBN carried) (NP-1 (-NONE- *)) (PRT (RP out)) (PP-MNR (IN with) (NP (NP (NNS pairs)) (PP (IN of) (NP (NP (NNS primers)) (PP (IN against) (NP (NP (NP (NNS domains)) (PP (IN of) (NP (NN interest)))) (VP (VBN described) (NP (-NONE- *)) (PP (IN in) (NP (DT the) (NN figure) (NNS legends)))))))))))) (. .)) )
( (S (NP-SBJ-1 (NN PCR) (NNS products)) (VP (VBD were) (VP (VBN subcloned) (NP-1 (-NONE- *)) (PP-LOC (IN into) (NP (NP (NN pGEX) (HYPH -) (NN KG) (PRN (-LRB- [) (NP (CD 64)) (-RRB- ]))) (, ,) (NP (NN HybriZAP) (NML (NN pBD) (HYPH -) (NN GAL4)) (NN vector) (PRN (-LRB- -LRB-) (NP (NNP Stratagene)) (-RRB- -RRB-))) (, ,) (CC and) (NP (NML (NN pBUTE) (PRN (-LRB- [) (NP (CD 62)) (-RRB- ]))) (NNS vectors)))))) (. .)) )
( (S (NP-SBJ (NP (NN GST) (HYPH -) (NN LDZIP)) (ADVP (RB alone))) (VP (VBN comprised) (NP (NP (NNS residues) (NML (NML (CD 447)) (PP (SYM –) (NP (CD 483))))) (PP (IN of) (NP (JJ human) (NN RanBP2))))) (. .)) )
( (HEADING (NP (NN GST) (UCP (ADJP (VB pull) (HYPH -) (RP down)) (CC and) (NML (NN immunoprecipitation))) (NNS assays) (. .))) )
( (S (NP-SBJ-2 (NP (ADJP (NN CHAPS) (HYPH -) (VBN solubilized)) (JJ retinal) (NNS extracts)) (, ,) (NP (NN expression)) (, ,) (CC and) (NP (NP (NN purification)) (PP (IN of) (NP (ADJP (NN GST) (HYPH -) (VBN fused)) (NNS constructs))))) (VP (VBD were) (VP (VBN prepared) (NP-2 (-NONE- *)) (SBAR-MNR (IN as) (S (NP-SBJ-1 (-NONE- *PRO*)) (ADVP-TMP (RB previously)) (VP (VBN described) (NP-1 (-NONE- *))))) (PRN (-LRB- [) (NP (CD 65)) (-RRB- ])))) (. .)) )
( (S (NP-SBJ-1 (NN GST) (ADJP (VB pull) (HYPH -) (RP down)) (NNS assays)) (VP (VBD were) (VP (VBN carried) (NP-1 (-NONE- *)) (PRT (RP out)) (PP-MNR (IN with) (NP (NP (QP (CD 0.5) (SYM –) (CD 2.2)) (NNS μM)) (PP (IN of) (NP (ADJP (NN GST) (HYPH -) (VBN fused)) (NN proteins))))) (PRN (-LRB- [) (NP (CD 65)) (-RRB- ])))) (. .)) )
( (S (NP-SBJ-1 (NNS Co-precipitates)) (VP (VBD were) (VP (VP (VBN resolved) (NP-1 (-NONE- *)) (PP (IN on) (NP (NN SDS) (HYPH -) (NN PAGE)))) (CC and) (VP (VBN analyzed) (NP-1 (-NONE- *)) (PP-MNR (IN by) (NP (NNP Western) (NN blot))) (PP-MNR (IN with) (NP (NP (NNS antibodies)) (VP (VBN described) (NP (-NONE- *)) (PP (IN in) (NP (DT the) (NNS Results) (NN section))))))))) (. .)) )
( (S (NP-SBJ-1 (ADJP (ADJP (VBN Unfolded)) (CC and) (ADJP (RB partially) (VBN denatured))) (NN Cox11)) (VP (VBD were) (VP (VBN generated) (NP-1 (-NONE- *)) (PP-MNR (IN by) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG incubating) (NP (ADJP (JJ recombinant) (CC and) (JJ native)) (NN Cox11))))) (ADVP-TMP (RB overnight)) (PP-MNR (IN with) (NP (NML (NML (CD 5.6) (CC and) (CD 7)) (NNS M)) (NML (NML (NN guanidine) (NN hydrochloride)) (CC and) (NML (NN urea))))) (, ,) (ADVP (RB respectively)))) (. .)) )
( (S (NP-SBJ-1 (DT The) (NN Cox11) (NNS conformers)) (VP (VBD were) (ADVP-TMP (RB then)) (VP (VBN diluted) (NP-1 (-NONE- *)) (ADVP-EXT (QP (SYM ~) (RB 20-fold))) (PP-LOC (IN in) (NP (NP (NML (NN CHAPS) (HYPH -) (NN binding)) (NN buffer)) (VP (VBG containing) (NP (NN GST) (HYPH -) (NN LD))))))) (. .)) )
( (S (NP-SBJ-1 (NP (NP (NN Immunoprecipitation) (NNS assays)) (PP (IN with) (NP (NP (CD 5) (NNS μg)) (PP (IN of) (NP (NN antibody)))))) (CC and) (NP (NNP Western) (NNS blots) (PRN (-LRB- -LRB-) (NP (NP (QP (SYM ~) (CD 200) (SYM –) (CD 400)) (NN ng)) (PP (SYM /) (NP (NP (NN ml)) (PP (IN of) (NP (NN antibody)))))) (-RRB- -RRB-)))) (VP (VBD were) (VP (VBN performed) (NP-1 (-NONE- *)) (SBAR-MNR (ADVP (RB exactly)) (IN as) (S (NP-SBJ-2 (-NONE- *PRO*)) (VP (VBN described) (NP-2 (-NONE- *)) (ADVP-TMP (RB previously)) (PRN (-LRB- [) (NP (CD 13)) (-RRB- ]))))))) (. .)) )
( (HEADING (NP (NML (NN Hexokinase) (CD I)) (NN assay) (. .))) )
( (S (NP-SBJ-1 (NML (NN Hexokinase) (CD I)) (NN activity)) (VP (VBD was) (VP (VBN determined) (NP-1 (-NONE- *)) (ADVP-MNR (RB spectrophotometrically)) (PP (IN at) (NP (CD 25) (NN °C))) (UCP-MNR (PP (IN by) (NP (NP (DT the) (NN method)) (PP (IN of) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG coupling) (NP (NP (DT the) (NML (NN glucose) (HYPH -) (CD 6) (HYPH -) (NN phosphate)) (NN production)) (PP (IN via) (NP (NML (NN glucose) (HYPH -) (CD 6) (HYPH -) (NN phosphate)) (NN dehydrogenase)))) (PP (IN with) (NP (NP (DT the) (NN change)) (PP (IN in) (NP (NP (DT the) (NN absorbance)) (PP (IN of) (NP (NN NADPH))))) (PP (IN at) (NP (CD 340) (NN nm)))))))))) (CC and) (SBAR (IN as) (S (NP-SBJ (-NONE- *PRO*)) (VP (VBN described) (NP (-NONE- *)) (PP (IN by) (NP-LGS (-LRB- [) (CD 66))))))))) (-RRB- ]) (. .)) )
( (S (NP-SBJ-1 (DT The) (NN reaction)) (VP (VBD was) (VP (VBN started) (NP-1 (-NONE- *)) (PP (IN by) (NP-LGS (NP (DT the) (NN addition)) (PP (IN of) (NP (VBN purified) (NN brain) (NN hexokinase) (CD I) (PRN (-LRB- -LRB-) (NP (CD 0.24) (NNS μg)) (-RRB- -RRB-)) (PRN (-LRB- -LRB-) (NP (NP (NN gift)) (PP (IN from) (NP (NNP J.) (NNP Wilson)))) (-RRB- -RRB-)))) (PP (IN to) (NP (NP (NP (CD 1.0) (NN ml)) (PP (IN of) (NP (NN reaction) (NN mixture)))) (VP (VBG containing) (NP (NP (NML (CD 0.05) (NNS M)) (NN Tris) (HYPH -) (NN HCl) (PRN (-LRB- -LRB-) (NP (NN pH) (CD 8.5)) (-RRB- -RRB-))) (, ,) (NP (NML (CD 7.4) (NNS mM)) (NN MgCl2)) (, ,) (NP (NML (CD 6.6) (NNS mM)) (NN ATP)) (, ,) (NP (NML (CD 0.65) (NNS mM)) (NN NADP)) (, ,) (NP (NML (CD 11.1) (NNS mM)) (NN monothioglycerol)) (, ,) (CC and) (NP (NP (CD 1) (NN unit)) (PP (IN of) (NP (NML (NN glucose) (CD 6) (HYPH -) (NN phosphate)) (NN dehydrogenase)))))))))))) (. .)) )
( (S (PP (IN In) (NP (NP (DT the) (NN case)) (PP (IN of) (NP (NP (NN hexokinase) (NN activity)) (VP (VBN measured) (NP (-NONE- *)) (PP (IN in) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NN Cox11) (CC and) (NN LD)))))))))) (, ,) (NP-SBJ-1 (DT the) (VBN purified) (NN HKI)) (VP (VBD was) (VP (VBN incubated) (NP-1 (-NONE- *)) (PP-MNR (IN with) (NP (DT the) (JJ recombinant) (NN proteins))) (PP-TMP (IN for) (NP (CD 15) (NNS min))) (PP (IN at) (NP (CD 4) (NN °C))) (PP-TMP (IN before) (NP (NP (NN measurement)) (PP (IN of) (NP (DT the) (NN activity))))))) (. .)) )
( (S (NP-SBJ-1 (DT The) (NNS data)) (VP (VBD were) (VP (VBN fitted) (NP-1 (-NONE- *)) (ADVP-MNR (RB directly)) (PP (IN into) (NP (DT the) (NML (NNP Michaelis) (HYPH -) (NNP Menten)) (NN equation))) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (NNP SIGMAPLOT) (PRN (-LRB- -LRB-) (NP (NNP SPSS) (NNP Science)) (-RRB- -RRB-))))))) (. .)) )
( (HEADING (NP (NNS Antibodies) (. .))) )
( (S (NP-SBJ-1 (NN Rabbit) (NNS antisera)) (VP (VBD were) (VP (VP (VBN raised) (NP-1 (-NONE- *)) (PP (IN against) (NP (DT the) (JJ recombinant) (JJ murine) (NN Cox11)) (PRN (-LRB- -LRB-) (NP (NNS residues) (NML (NML (CD 40)) (PP (SYM –) (NP (CD 275))))) (-RRB- -RRB-)))) (CC and) (VP (NN affinity) (HYPH -) (VBN purified) (NP-1 (-NONE- *)) (PP (IN under) (NP (NN non-denaturing) (NNS conditions) (PRN (-LRB- -LRB-) (NP (NNP Stereogene)) (-RRB- -RRB-)))) (SBAR-MNR (IN as) (S (NP-SBJ-2 (-NONE- *PRO*)) (ADVP-TMP (RB previously)) (VP (VBN described) (NP-2 (-NONE- *)) (PRN (-LRB- [) (NP (CD 13)) (-RRB- ])))))))) (. .)) )
( (S (NP-SBJ-1 (NN Cox11) (NNS antibodies)) (VP (VBD were) (VP (VBN used) (NP-1 (-NONE- *)) (PP (IN at) (NP (NP (CD 200) (NNS ng)) (PP (SYM /) (NP (NN ml))))) (PP-PRP (IN for) (NP (NNP Western) (NN analysis))))) (. .)) )
( (S (S (NP-SBJ (DT The) (JJ monoclonal) (NN antibody) (NN Hsp70)) (VP (VBD was) (PP-PRD (IN from) (NP (NNP Affinity) (NNPS Bioreagents) (PRN (-LRB- -LRB-) (NP (NP (NNP Golden)) (, ,) (NP-LOC (NNP Colorado)) (, ,) (NP-LOC (NNP United) (NNP States))) (-RRB- -RRB-)))))) (CC and) (S (NP-SBJ-1 (NP (NNS antibodies)) (PP (IN against) (NP (NP (DT the) (NML (NML (NN KBD) (PRN (-LRB- -LRB-) (NP (NN JX2)) (-RRB- -RRB-))) (CC and) (NML (NN ZnF))) (NNS domains)) (PP (IN of) (NP (NN RanBP2)))))) (VP (VBP have) (VP (VBN been) (VP (VBN described) (NP-1 (-NONE- *)) (PRN (-LRB- [) (NP (CD 13) (, ,) (CD 16)) (-RRB- ]))))) (. .))) )
( (S (NP-SBJ-1 (NP (ADJP (JJ Polyclonal) (CC and) (JJ monoclonal)) (NNS antibodies)) (PP (IN against) (NP (NN Hexokinase) (PRP I)))) (VP (VBD were) (VP (VBN provided) (NP-1 (-NONE- *)) (PP (IN by) (NP-LGS (NNP J.) (NNP Wilson))))) (. .)) )
( (S (NP-SBJ-1 (DT The) (NN mAb414)) (VP (VBD was) (VP (VBN purchased) (NP-1 (-NONE- *)) (PP (IN from) (NP (NNP Abcam) (PRN (-LRB- -LRB-) (NP (NP (NNP Cambridge)) (, ,) (NP-LOC (NNP Massachusetts)) (, ,) (NP-LOC (NNP United) (NNP States))) (-RRB- -RRB-)))))) (. .)) )
( (HEADING (NP (NN Immunocytochemistry) (CC and) (NN microscopy) (. .))) )
( (S (NP-SBJ-1 (NP (NN Retina) (NNS dissections)) (, ,) (NP (JJ radial) (NNS cryosections) (PRN (-LRB- -LRB-) (NP (QP (SYM ~) (CD 6)) (NNS μm)) (-RRB- -RRB-))) (, ,) (CC and) (NP (NN immunohistochemistry) (NNS procedures))) (VP (VBD were) (VP (VBN carried) (NP-1 (-NONE- *)) (PRT (RP out)) (SBAR-MNR (IN as) (S (NP-SBJ-2 (-NONE- *PRO*)) (VP (VBN described) (NP-2 (-NONE- *)) (ADVP (RB elsewhere)) (PRN (-LRB- [) (NP (CD 19)) (-RRB- ]))))))) (. .)) )
( (S (NP-SBJ-1 (NP (NNS Brains)) (PP (IN from) (NP (ADJP (NP (QP (CD 3) (HYPH -) (IN to) (CD 5)) (HYPH -) (NN mo)) (HYPH -) (JJ old)) (NML (NN C57Bl) (HYPH /) (CD 6)) (NNS mice)))) (VP (VBD were) (VP (VP (VBN fixed) (NP-1 (-NONE- *)) (ADVP-TMP (RB overnight)) (PP-LOC (IN in) (NP (NML (CD 2) (NN %)) (NN paraformaldehyde)))) (, ,) (VP (VBN infused) (NP-1 (-NONE- *)) (PP (IN with) (NP (NML (CD 30) (NN %)) (NN sucrose)))) (, ,) (CC and) (VP (VBN processed) (NP-1 (-NONE- *)) (PP-PRP (IN for) (NP (VBG cryosectioning)))))) (. .)) )
( (S (NP-SBJ-1 (NP (JJ Primary) (NML (NML (NN brain) (NNS neurons)) (CC and) (NML (JJ glial) (NNS cells)))) (PP-2 (-NONE- *ICH*))) (VP (VBD were) (VP (VBN prepared) (NP-1 (-NONE- *)) (PP-2 (IN from) (NP (DT the) (JJ cerebral) (NN cortex))))) (. .)) )
( (S (NP-SBJ-1 (DT This)) (VP (VBD was) (VP (VP (VBN macerated) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (DT the) (NML (NP (NNP Hank) (POS 's)) (NNP Balanced) (NNP Salt)) (NN solution)))) (CC and) (VP (VBN triturated) (NP-1 (-NONE- *))))) (. .)) )
( (S (NP-SBJ-1 (JJ Primary) (NNS cells)) (VP (VBD were) (VP (VP (VBN cultured) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (NP (NN DMEM) (PRN (-LRB- -LRB-) (NP (NP (NNP GIBCO)) (, ,) (NP-LOC (NNP San) (NNP Diego)) (, ,) (NP-LOC (NNP California)) (, ,) (NP-LOC (NNP United) (NNP States))) (-RRB- -RRB-))) (CC and) (NP (ADJP (NN collagen) (HYPH -) (VBN coated)) (NML (CD 35) (HYPH -) (NN mm)) (NML (NN glass) (NN bottom)) (NN culture) (NNS dishes) (PRN (-LRB- -LRB-) (NP (NP (NNP MatTek) (NNP Corporation)) (, ,) (NP-LOC (NNP Ashland)) (, ,) (NP-LOC (NNP Maine))) (-RRB- -RRB-))))) (PP (IN at) (NP (NP (NML (CD 5) (NN %)) (NN CO2)) (HYPH /) (NP (CD 37) (NN °C)))) (PP-TMP (IN for) (NP (QP (SYM ~) (CD 2)) (NNS d)))) (CC and) (VP (VBN processed) (NP-1 (-NONE- *)) (PP (IN for) (NP (NN immunocytochemistry)))))) (. .)) )
( (S (NP-SBJ-1 (JJ Primary) (NNS antibodies)) (VP (VBD were) (VP (VBN used) (NP-1 (-NONE- *)) (PP (IN at) (NP (NP (NNS concentrations)) (NP-ADV (NP (QP (SYM ~) (CD 2.5) (SYM –) (CD 10)) (NN μg)) (PP (SYM /) (NP (NN ml)))))))) (. .)) )
( (S (NP-SBJ-1 (ADJP (NP (NP (NNP Alexa) (CD 488)) (HYPH -) (CC and) (NP (NNP Alexa) (JJ 594))) (HYPH -) (JJ conjugated)) (JJ secondary) (NNS antibodies) (PRN (-LRB- -LRB-) (NP (NP (CD 2.5) (NNS μg)) (PP (SYM /) (NP (NN ml)))) (-RRB- -RRB-)) (PRN (-LRB- -LRB-) (NP (NNP Molecular) (NNP Probes)) (-RRB- -RRB-))) (VP (VBD were) (VP (VBN used) (NP-1 (-NONE- *)) (PP-PRP (IN for) (NP (NP (NN visualization)) (PP (IN of) (NP (NN proteins))))))) (. .)) )
( (S (NP-SBJ-1 (NP (NN Crossover)) (PP (IN of) (NP (NP (JJ fluorescent) (NNS probes)) (, ,) (NP (NN background)) (, ,) (CC and) (NP (NN autofluorescence))))) (VP (VBD were) (VP (VBN found) (S (NP-SBJ-1 (-NONE- *)) (VP (TO to) (VP (VB be) (ADJP-PRD (JJ negligible))))))) (. .)) )
( (S (NP-SBJ-1 (NP (NP (NN Visualization)) (PP (IN of) (NP (NNS specimens)))) (CC and) (NP (NP (NN localization)) (PP (IN of) (NP (NN proteins))))) (VP (VBD were) (VP (VBN carried) (NP-1 (-NONE- *)) (PRT (RP out)) (PP-MNR (IN by) (NP (NML (JJ wide) (HYPH -) (NN field)) (NN epifluorescence) (NN microscopy))) (PP-LOC (IN on) (NP (NP (NP (NML (NNP Nikon) (PRN (-LRB- -LRB-) (NP (NP (NNP Tokyo)) (, ,) (NP-LOC (NNP Japan))) (-RRB- -RRB-))) (NN E600) (NN upright) (NML-2 (-NONE- *RNR*))) (CC and) (NP (NN TE2000U) (VBN inverted) (NML-2 (-NONE- *RNR*))) (NML-2 (NN research) (NNS microscopes))) (VP (VBN equipped) (NP (-NONE- *)) (PP (IN with) (NP (JJ similar) (NN Apochromat) (NNS objectives)))))))) (. .)) )
( (S (NP-SBJ-1 (NP (NNS Images)) (PP (IN with) (NP (DT the) (NNP Nikon) (NN E600)))) (VP (VBD were) (VP (VBN acquired) (NP-1 (-NONE- *)) (PP-MNR (IN with) (NP (NP (DT a) (NML (NN SPOT) (HYPH -) (NN RT)) (JJ digital) (NN camera)) (VP (VP (VBN coupled) (NP (-NONE- *)) (PP (IN to) (NP (DT the) (NN microscope)))) (CC and) (VP (VBN driven) (NP (-NONE- *)) (PP (IN by) (NP-LGS (NML (NN SPOT) (NN Imaging) (NN v4.0)) (NN software) (PRN (-LRB- -LRB-) (NP (NP (NNP Diagnostic) (NNPS Instruments)) (, ,) (NP-LOC (NNP Sterling) (NNP Heights)) (, ,) (NP-LOC (NNP Michigan)) (, ,) (NP-LOC (NNP United) (NNP States))) (-RRB- -RRB-)))))))))) (. .)) )
( (S (NP-SBJ-1 (DT All) (NNS images)) (VP (VBD were) (VP (VP (VBN captured) (NP-1 (-NONE- *)) (PP (IN at) (NP (NP (NN nonsaturating) (NN integration) (NNS levels)) (, ,) (NP (NML (CD 12) (HYPH -) (JJ bit)) (NN mono) (NML (JJ black) (HYPH /) (JJ white)))))) (, ,) (CC and) (VP (ADVP-TMP (RB then)) (VBN pseudo-colored) (NP-1 (-NONE- *))))) (. .)) )
( (S (NP-SBJ-1 (NML (NN Protein) (NN colocalization)) (NN analysis)) (VP (VBD was) (VP (VBN carried) (NP-1 (-NONE- *)) (PRT (RP out)) (PP (IN on) (NP (NP (DT the) (NML (NNP Nikon) (NN TE2000U)) (NN microscope)) (VP (VBN equipped) (NP (-NONE- *)) (PP-MNR (IN with) (NP (NP (JJ appropriate) (NML (NN excitation) (CC and) (NN emission)) (NN filter) (NNS wheels)) (, ,) (NP (NN cube) (NNS filters)) (, ,) (NP (NML (CD 100) (NNP W)) (NN mercury) (NN light) (NN source)) (, ,) (NP (NP (NML (NML (NNP Nomarski) (HYPH /) (NNP DIC)) (, ,) (CC and) (NML (NNP Plan) (NNP Apochromat))) (NNS optics)) (-LRB- -LRB-) (NP (NP (NP (QP (QP (CD 100) (SYM ×)) (, ,) (QP (CD 60) (SYM ×)) (, ,) (CC and) (QP (CD 40) (SYM ×))) (NN oil) (NNS objectives)) (PP (IN with) (NP (NP (NN NA)) (PP (IN of) (NP (CD 1.4)))))) (, ,) (NP (NML (NML (QP (CD 40) (SYM ×)) (NN LWD)) (, ,) (CC and) (NML (QP (CD 20) (SYM ×)) (NN LWD))) (NNS objectives)) (CC and) (NP (VBN encoded) (VBN motorized) (NNP Z) (HYPH -) (NNP Stage) (PRN (-LRB- -LRB-) (NP (NP (NNP Prior) (NNP Scientific)) (, ,) (NP-LOC (NNP Rockland)) (, ,) (NP-LOC (NNP Maryland)) (, ,) (NP-LOC (NNP United) (NNP States))) (-RRB- -RRB-)))))))))))) (. .)) )
( (S (NP-SBJ-1 (NP (NNS Images)) (PP (IN with) (NP (DT the) (VBN inverted) (NML (NNP Nikon) (NN TE2000U)) (NN microscope)))) (VP (VBD were) (VP (VBN obtained) (NP-1 (-NONE- *)) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (NP (DT a) (NN CCD) (NN camera)) (-LRB- -LRB-) (NP (NNP CoolSNAP) (NNP HQ)) (PRN (: ;) (NP (NP (NNP Roper) (NNP Scientific)) (, ,) (NP-LOC (NNP Trenton)) (, ,) (NP-LOC (NNP New) (NNP Jersey)) (, ,) (NP-LOC (NNP United) (NNP States))) (-RRB- -RRB-))))))) (. .)) )
( (S (NP-SBJ-1 (NP (NNS Images)) (VP (VBN acquired) (NP (-NONE- *)) (PP (IN under) (NP (JJ identical) (NN acquisition) (NNS parameters))))) (VP (VBD were) (VP (VBN analyzed) (NP-1 (-NONE- *)) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (NNP Metamorph) (NNP Software) (NN v6.2) (PRN (-LRB- -LRB-) (NP (NP (NNP Universal) (NNP Imaging)) (, ,) (NP-LOC (NNP Glendale)) (, ,) (NP-LOC (NNP Wisconsin)) (, ,) (NP-LOC (NNP United) (NNP States))) (-RRB- -RRB-))))))) (. .)) )
( (S (SBAR-TMP (WHADVP-1 (RB Whenever)) (FRAG (ADJP (JJ applicable)) (ADVP-TMP-1 (-NONE- *T*)))) (, ,) (NP-SBJ-2 (NP (JJ serial) (JJ optical) (NN Z) (HYPH -) (NNS stacks)) (-LRB- -LRB-) (NP (NP (QP (CD 20) (SYM –) (CD 30)) (JJ focal) (NNS planes)) (PP (IN at) (NP (NML (CD 100) (HYPH -) (NN nm)) (NNS intervals))))) (-RRB- -RRB-) (VP (VBD were) (VP (VP (VBN captured) (NP-2 (-NONE- *))) (CC and) (VP (ADVP-MNR (RB computationally)) (VBN processed) (NP-2 (-NONE- *)) (PP-MNR (IN by) (NP (NML (CD 3) (HYPH -) (NN D)) (JJ blind) (NN deconvolution) (NNS methods))) (PP-MNR (IN with) (NP (DT the) (JJ same) (NN software)))))) (. .)) )
( (HEADING (NP (NP (NP (NN Generation)) (PP (IN of) (NP (NP (DT a) (NN mouse) (NN line)) (PP (IN with) (NP (DT a) (VBN disrupted) (NN RanBP2) (NN locus)))))) (CC and) (NP (NP (JJ histological) (NN analysis)) (PP (IN of) (NP (VBN trapped) (NN RanBP2) (NNS mice)))) (. .))) )
( (S (NP-SBJ-1 (NP (DT A) (ADJP (NN feeder) (HYPH -) (JJ independent)) (NN mouse) (NML (NN ES) (NN cell)) (NN line)) (VP (VP (VBN derived) (NP (-NONE- *)) (PP (IN from) (NP (DT the) (NML (NN 129P2) (HYPH /) (NN OlaHsd)) (NN strain)))) (CC and) (VP (VBG harboring) (NP (NP (DT a) (VBN disrupted) (NN RanBP2) (NN locus)) (PP (IN by) (NP (NP (NN insertion) (NN mutagenesis)) (PP (IN with) (NP (NP (NP (DT the) (NN gene) (NN trap) (NN vector)) (, ,) (NP (NN pGT0pfs) (PRN (-LRB- [) (NP (CD 67) (, ,) (CD 68)) (-RRB- ])))) (-LRB- -LRB-) (VP (VBN generated) (NP (-NONE- *)) (PP (IN by) (NP-LGS (NNP W.) (NNP Skarnes)))))))))))) (-RRB- -RRB-) (, ,) (VP (VBD was) (VP (VBN obtained) (NP-1 (-NONE- *)) (PP (IN from) (NP (DT the) (NML (NNP Mutant) (NNP Mouse)) (NNP Regional) (NNP Resource) (NNP Center) (PRN (-LRB- -LRB-) (NP (NP (NP (NNP University)) (PP (IN of) (NP (NNP California) (NNP Davis)))) (, ,) (NP-LOC (NNP Davis)) (, ,) (NP-LOC (NNP California)) (, ,) (NP-LOC (NNP United) (NNP States))) (-RRB- -RRB-)))))) (. .)) )
( (S (NP-SBJ (DT The) (NML (NN gene) (NN trap)) (NN vector)) (VP (VBZ contains) (NP (NP (DT a) (JJ promoterless) (NN neo-lacZ) (NN fusion) (NN gene)) (PP (IN with) (NP (NP (NP (DT a) (NN splice) (NN acceptor) (NN site)) (PP-LOC (IN at) (NP (DT the) (NML (CD 5) (SYM ′)) (NN end)))) (VP (VBN followed) (NP (-NONE- *)) (PP (IN by) (NP-LGS (NP (NP (DT an) (JJ internal) (NN ribosome) (NN entry) (NN site)) (-LRB- -LRB-) (NP (NN IRES))) (-RRB- -RRB-) (CC and) (NP (DT the) (JJ human) (NML (NML (JJ placental) (NN alkaline) (NN phosphatase)) (-LRB- -LRB-) (NML (NN PLAP))) (-RRB- -RRB-) (NN reporter) (NN cassette))))))))) (. .)) )
( (S (S (NP-SBJ-1 (DT The) (NML (NN RanBP2) (NN 129Ola)) (NN ES) (NN line)) (VP (VBD was) (VP (VBN injected) (NP-1 (-NONE- *)) (PP-DIR (IN into) (NP (NML (NN C57BL) (HYPH /) (NN 6J)) (NNS blastocysts)))))) (CC and) (S (NP-SBJ-2 (CD four) (JJ male) (NNS chimeras)) (VP (VBD were) (VP (VBN generated) (NP-2 (-NONE- *))))) (. .)) )
( (S (NP-SBJ-1 (DT These)) (VP (VBD were) (VP (VBN bred) (NP-1 (-NONE- *)) (PP-LOC (IN into) (NP (NML (NML (NN 129P2) (HYPH /) (NN OlaHsd) (PRN (-LRB- -LRB-) (NP (NP (NNP Harlan)) (, ,) (NP-LOC (NNP Indianapolis)) (, ,) (NP-LOC (NNP Indiana)) (, ,) (NP-LOC (NNP United) (NNP States))) (-RRB- -RRB-))) (CC and) (NML (NN C57BL) (HYPH /) (NN 6J) (PRN (-LRB- -LRB-) (NP (NP (NNP Jackson) (NNP Laboratory)) (, ,) (NP-LOC (NNP Bar) (NNP Harbor)) (, ,) (NP-LOC (NNP Maine)) (, ,) (NP-LOC (NNP United) (NNP States))) (-RRB- -RRB-)))) (NNS females))))) (. .)) )
( (S (NP-SBJ-1 (NP (DT The) (CD two) (ADJP (VBG resulting) (CC and) (JJ independent)) (NN F1s) (NNS lines)) (, ,) (PP (IN with) (NP (NP (NML (NN 129P2) (HYPH /) (NN OlaHsd)) (JJ inbred) (NML-2 (-NONE- *RNR*))) (CC and) (NP (NML (NN 129P2) (HYPH /) (NN OlaHsd) (HYPH /) (NN C57BL) (HYPH /) (NN 6J)) (JJ mixed) (JJ genetic) (NML-2 (-NONE- *RNR*))) (NML-2 (NNS backgrounds))))) (, ,) (VP (VBD were) (VP (VBN tested) (NP-1 (-NONE- *)) (PP-PRP (IN for) (NP (NN germline) (NN transmission))) (PP-MNR (IN by) (NP (NP (NML (NML (NN PCR)) (CC and) (NML (NNP Southern) (NN blot))) (NN analysis)) (PP (IN of) (NP (NN tail) (JJ genomic) (NN DNA))))))) (. .)) )
( (S (NP-SBJ-2 (NP (NML (NML (NN β) (HYPH -) (NN gal)) (CC and) (NML (NN PLAP))) (NNS activities)) (PP-LOC (IN in) (NP (NP (NML (JJ whole) (NN mount)) (NNS embryos)) (CC and) (NP (JJ retinal) (NNS sections))))) (VP (VBD were) (VP (VBN detected) (NP-2 (-NONE- *)) (, ,) (ADVP (RB respectively)) (, ,) (PP-MNR (IN by) (NP (NP (NN incubation)) (PP (IN with) (NP (NML (NML (NML (CD 5) (HYPH -) (NN bromo)) (HYPH -) (NML (CD 4) (HYPH -)) (NN chloro) (HYPH -) (NML (CD 3) (HYPH -) (NN indolyl) (NN β)) (HYPH -) (NN D) (HYPH -) (NN galactopyranoside)) (CC and) (NML (NN AP))) (NN staining) (NN buffer))) (PRN (-LRB- -LRB-) (NP (NML (NML (CD 0.1) (NNS mg)) (PP (SYM /) (NP (NN ml)))) (NML (CD 5) (HYPH -) (NN bromo)) (HYPH -) (NML (CD 4) (HYPH -) (NN chloro)) (HYPH -) (CD 3) (HYPH -) (NN indolyl) (NN phosphate)) (, ,) (NP (NP (NML (NP (CD 1) (NNS mg)) (PP (SYM /) (NP (NN ml)))) (JJ nitroblue) (NN tetrazolium)) (PP-LOC (IN in) (NP (NP (NML (CD 100) (NNS mM)) (NN Tris) (HYPH -) (NN HCl) (PRN (-LRB- -LRB-) (NP (NN pH) (CD 9.5)) (-RRB- -RRB-))) (, ,) (NP (NML (CD 100) (NNS mM)) (NN NaCl)) (, ,) (NP (NML (CD 5) (NNS mM)) (NN MgCl2))))) (-RRB- -RRB-)))) (SBAR-MNR (IN as) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (VBN described) (NP-1 (-NONE- *)) (ADVP (RB elsewhere)) (PRN (-LRB- [) (NP (CD 67) (, ,) (CD 68)) (-RRB- ]))))))) (. .)) )
( (HEADING (NP (NP (NP (NNP Western) (NN blot)) (CC and) (NP (NN quantitation) (NN analysis))) (PP (IN of) (NP (NP (NN protein) (NN expression)) (CC and) (NP (NN ATP) (NNS levels)))) (. .))) )
( (S (NP-SBJ-1 (NP (NP (NNS Homogenates)) (CC and) (NP (ADJP (NN detergent) (VBN solubilized)) (NNS extracts))) (PP (IN of) (NP (NNS tissues) (CC and) (NNS immunoblots)))) (VP (VBD were) (VP (VBN prepared) (NP-1 (-NONE- *)) (SBAR-MNR (IN as) (S (NP-SBJ-2 (-NONE- *PRO*)) (VP (VBN described) (NP-2 (-NONE- *)) (ADVP (RB elsewhere)) (PRN (-LRB- [) (NP (CD 69)) (-RRB- ]))))))) (. .)) )
( (S (NP-SBJ-1 (NP (NP (NN Quantitation)) (PP (IN of) (NP (NN immunoblot) (NNS bands)))) (VP (VBN calibrated) (NP (-NONE- *)) (PP (IN against) (NP (NP (JJ internal) (NN marker) (NNS bands)) (, ,) (PP (JJ such) (IN as) (NP (NN mHsp70) (CC and) (NN Nup153))))))) (, ,) (VP (VBD was) (VP (VBN carried) (NP-1 (-NONE- *)) (PRT (RP out)) (PP-MNR (IN with) (NP (NNP Gel) (NNP Pro) (NNP Analyzer) (PRN (-LRB- -LRB-) (NP (NP (NNPS MediaCybernetics)) (, ,) (NP-LOC (NNP San) (NNP Diego)) (, ,) (NP-LOC (NNP California)) (, ,) (NP-LOC (NNP United) (NNP States))) (-RRB- -RRB-)))))) (. .)) )
( (S (PP-PRP (IN For) (NP (NP (NN determination)) (PP (IN of) (NP (NN ATP) (NNS levels))))) (, ,) (NP-SBJ-1 (ADJP (ADJP (RB freshly) (VBN dissected)) (CC and) (ADJP (NN flash) (HYPH -) (VBN frozen))) (NNS tissues)) (VP (VBD were) (VP (VP (VBN homogenized) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (NML (CD 2.5) (NN %)) (NML (NML (JJ trichloroacetic) (NN acid)) (-LRB- -LRB-) (NML (NN TCA)))))) (-RRB- -RRB-) (, ,) (VP (VBN neutralized) (NP-1 (-NONE- *))) (, ,) (CC and) (VP (VBD diluted) (NP-1 (-NONE- *)) (PP (IN to) (NP (NP (DT a) (JJ final) (NN concentration)) (PP (IN of) (NP (CD 0.1) (NN %))))) (PP-MNR (IN with) (NP (NN Tris) (HYPH -) (NN Acetate) (PRN (-LRB- -LRB-) (NP (NN pH) (CD 7.75)) (-RRB- -RRB-))))))) (. .)) )
( (S (NP-SBJ-1 (NN ATP) (NNS measurements)) (VP (VBD were) (VP (VBN carried) (NP-1 (-NONE- *)) (PRT (RP out)) (PP-MNR (IN with) (NP (NP (DT the) (NNP ENLITEN) (NML (NNP ATP) (NNP Assay) (NNP System)) (NML (NNP Bioluminescence) (NNP Detection)) (NNP Kit)) (PP (IN for) (NP (NN ATP))) (PRN (-LRB- -LRB-) (NP (NP (NNP Promega)) (, ,) (NP-LOC (NNP Madison)) (, ,) (NP-LOC (NNP Wisconsin)) (, ,) (NP-LOC (NNP United) (NNP States))) (-RRB- -RRB-)))) (PP (IN as) (PP (IN per) (NP (NP (DT the) (NN manufacturer) (POS 's)) (NN instruction)))) (PP-LOC (IN in) (NP (NNP SpectraMax) (HYPH -) (NNP M5) (PRN (-LRB- -LRB-) (NP (NP (NNP Molecular) (NNPS Devices)) (, ,) (NP-LOC (NNP Sunnyvale)) (, ,) (NP-LOC (NNP California)) (, ,) (NP-LOC (NNP United) (NNP States))) (-RRB- -RRB-)))))) (. .)) )
( (S (NP-SBJ-1 (NN Protein) (NN concentration)) (VP (VBD was) (VP (VBN measured) (NP-1 (-NONE- *)) (PP-MNR (IN by) (NP (DT the) (NN BCA) (NN method) (PRN (-LRB- -LRB-) (NP (NP (NNP BioRad)) (, ,) (NP-LOC (NNP Hercules)) (, ,) (NP-LOC (NNP California)) (, ,) (NP-LOC (NNP United) (NNP States))) (-RRB- -RRB-)))) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (NN BSA)) (PP (IN as) (NP (DT a) (NN standard))))))) (. .)) )
( (HEADING (NP (JJ Metabolic) (NNS assays) (. .))) )
( (S (NP-SBJ-1 (NP (CD Two) (NNS groups)) (PP (IN of) (NP (JJ male) (NNS mice)))) (VP (VBD were) (VP (VBN kept) (NP-1 (-NONE- *)) (PP (IN under) (NP (JJ separate) (NN diet))) (PP-TMP (IN since) (NP (NN gestation) (CC or) (NN birth))))) (. .)) )
( (S (NP-SBJ-1 (CD One) (NN group)) (VP (VBD was) (VP (VBN fed) (NP-1 (-NONE- *)) (PP-MNR (IN with) (NP (NP (DT a) (JJ normal) (NN chow) (NN diet)) (-LRB- -LRB-) (NP (NNP PicoLab) (NNP Rodent) (NNP Diet) (CD 20) (HYPH −) (CD 5053)) (PRN (: ;) (NP (NP (NNP LabDiet)) (, ,) (NP-LOC (NNP Richmond)) (, ,) (NP-LOC (NNP Indiana)) (, ,) (NP-LOC (NNP United) (NNP States))) (-RRB- -RRB-)))) (, ,) (SBAR-ADV (IN while) (S (NP-SBJ-2 (DT the) (NN other)) (VP (VBD was) (VP (VBN placed) (NP-2 (-NONE- *)) (PP (IN on) (NP (NP (DT a) (NML (JJR higher) (NML (NN energy) (CC and) (NN fat))) (NN diet)) (-LRB- -LRB-) (NP (NNP PicoLab) (NNP Mouse) (NNP Diet) (CD 20) (HYPH −) (CD 5058)) (PRN (: ;) (NP (NNP LabDiet)) (-RRB- -RRB-)))))))))) (. .)) )
( (S (NP-SBJ-1 (NML (NN Glucose) (NN tolerance)) (NN test)) (VP (VBD was) (VP (VBN performed) (NP-1 (-NONE- *)) (PP (IN on) (NP (NP (ADJP (JJ overnight) (HYPH -) (VBN fasted)) (NNS mice)) (VP (VBN injected) (NP (-NONE- *)) (ADVP-MNR (RB intraperitoneally)) (PP-MNR (IN with) (NP (NP (CD 2) (NNS g)) (PP (IN of) (NP (NN glucose))) (PP (IN per) (NP (NP (NN kg)) (PP (IN of) (NP (NN body) (NN weight)))))))))))) (. .)) )
( (S (NP-SBJ-1 (JJ Venous) (NML (NN blood) (NN glucose)) (NNS values)) (VP (VBD were) (VP (VBN determined) (NP-1 (-NONE- *)) (PP-TMP (IN at) (UCP (PP-TMP (ADVP (RB immediately)) (IN before) (PRN (-LRB- -LRB-) (NP (CD 0) (NNS min)) (-RRB- -RRB-)) (NP-2 (-NONE- *RNR*))) (, ,) (CC and) (NP-TMP (NP (NML (CD 15) (, ,) (CD 30) (, ,) (CD 60) (, ,) (CC and) (CD 120)) (NN min)) (PP (IN after) (NP-2 (-NONE- *RNR*)))) (NP-2 (NP (DT the) (NN injection)) (PP (IN with) (NP (NP (DT an) (JJ automatic) (NN glucose) (NN monitor) (NN instrument)) (-LRB- -LRB-) (NP (CD One) (NNP Touch) (NNP Ultra)) (PRN (, ,) (NP (NNP Lifescan)) (-RRB- -RRB-))))))))) (. .)) )
( (S (NP-SBJ-1 (NML (NN Insulin) (NN tolerance)) (NN test)) (VP (VBD was) (VP (VBN performed) (NP-1 (-NONE- *)) (NP-MNR (NP (DT the) (JJ same) (NN way)) (PP (IN as) (NP (NP (DT that)) (VP (VBN described) (NP (-NONE- *)) (PP (IN for) (NP (DT the) (NML (NN glucose) (NN tolerance)) (NN test)))))) (PP (IN with) (NP (DT the) (NN exception) (SBAR (IN that) (S (NP-SBJ-2 (JJ human) (NN insulin) (PRN (-LRB- -LRB-) (NP (NP (CD 0.75) (NNS U)) (PP (SYM /) (NP (NP (NN kg)) (PP (IN of) (NP (NN body) (NN mass)))))) (-RRB- -RRB-))) (VP (VBD was) (VP (VBN injected) (NP-2 (-NONE- *)) (ADVP-MNR (RB intraperitoneally)) (PP-LOC (IN in) (NP (JJ non-fasted) (NNS mice)))))))))))) (. .)) )
( (S (NP-SBJ-1 (NML (NN Pyruvate) (NN challenge)) (NN test)) (VP (VBD was) (VP (VBN performed) (NP-1 (-NONE- *)) (NP-MNR (NP (DT the) (JJ same) (NN way)) (PP (IN as) (NP (NP (DT that)) (VP (VBN described) (NP (-NONE- *)) (PP (IN for) (NP (DT the) (NML (NN glucose) (NN tolerance)) (NN test)))))) (PP (IN with) (NP (DT the) (NN exception) (SBAR (IN that) (S (NP-SBJ-2 (NP (NN pyruvate)) (VP (VBN dissolved) (NP (-NONE- *)) (PP-LOC (IN in) (NP (NN saline) (PRN (-LRB- -LRB-) (NP (NP (CD 2) (NNS g)) (PP (SYM /) (NP (NP (NN kg)) (PP (IN of) (NP (NN body) (NN mass)))))) (-RRB- -RRB-)))))) (VP (VBD was) (VP (VBN injected) (NP-2 (-NONE- *)) (ADVP-MNR (RB intraperitoneally)) (PP-LOC (IN in) (NP (ADJP (JJ overnight) (HYPH -) (VBN fasted)) (NNS mice)))))))))))) (. .)) )
( (HEADING (NP (NN Electroretinography) (. .))) )
( (S (NP-SBJ-1 (NP (CD Five) (ADJP (NP (QP (SYM ~) (CD 6)) (HYPH -) (NN mo)) (HYPH -) (JJ old)) (JJ male) (NML (NML (NN RanBP2) (SYM +) (HYPH /) (SYM +)) (CC and) (NML (NN RanBP2) (SYM +) (HYPH /) (SYM −))) (NNS mice)) (PP (IN in) (NP (NN 129ola) (NN background)))) (VP (VBD were) (VP (VBN kept) (NP-1 (-NONE- *)) (PP (IN in) (NP (NN dim) (JJ cyclic) (NN light) (PRN (-LRB- -LRB-) (NP (CD 10) (NN lux)) (-RRB- -RRB-)))) (PP-TMP (IN for) (NP (CD 2) (NNS wk))) (SBAR-TMP (IN before) (S (NP-SBJ-2 (JJ electroretinographic) (NNS responses)) (VP (VBD were) (VP (VBN recorded) (NP-2 (-NONE- *)))))))) (. .)) )
( (S (NP-SBJ-1 (DT The) (NNS mice)) (VP (VBD were) (VP (VBN anesthetized) (NP-1 (-NONE- *)) (ADVP-MNR (RB intraperitoneally)) (PP-MNR (IN with) (NP (NP (NN ketamine) (PRN (-LRB- -LRB-) (NP (NP (CD 80) (NNS mg)) (PP (SYM /) (NP (NN kg)))) (-RRB- -RRB-))) (CC and) (NP (NN xylazine) (PRN (-LRB- -LRB-) (NP (NP (CD 4) (NNS mg)) (PP (SYM /) (NP (NN kg)))) (-RRB- -RRB-))))))) (. .)) )
( (S (NP-SBJ-1 (NN Body) (NN temperature)) (VP (VBD was) (VP (VBN maintained) (NP-1 (-NONE- *)) (PP-MNR (IN with) (NP (DT a) (NN heating) (NN pad))) (PP (IN at) (NP (QP (CD 37.5) (SYM ±) (CD 1)) (NN °C))) (PP-TMP (IN throughout) (NP (DT the) (NN recording))))) (. .)) )
( (S (S (NP-SBJ-1 (DT The) (NNS pupils)) (VP (VBD were) (ADVP (RB fully)) (VP (VBN dilated) (NP-1 (-NONE- *)) (PP-MNR (IN with) (NP (NP (NML (CD 0.5) (NN %)) (NN tropicamide)) (CC and) (NP (NML (CD 2.5) (NN %)) (NN phenylephrine) (NN HCl))))))) (, ,) (CC and) (S (NP-SBJ-2 (DT both) (NNS eyes)) (VP (VBD were) (VP (VBN recorded) (NP-2 (-NONE- *)) (ADVP-TMP (RB simultaneously))))) (. .)) )
( (S (NP-SBJ-1 (JJ Corneal) (NML (JJ gold) (HYPH -) (NN wire)) (NNS loops)) (VP (VBD were) (VP (VBN used) (NP-1 (-NONE- *)) (PP (IN as) (NP (DT the) (JJ active) (NNS electrodes))) (PP (IN under) (NP (NML (NML (CD 0.5) (NN %)) (NN proparacaine) (NN hydrochloride)) (JJ topical) (NN anesthesia))))) (. .)) )
( (S (NP-SBJ (NP (NML (JJ Gold) (HYPH -) (NN wire)) (NNS electrodes)) (VP (VBN placed) (NP (-NONE- *)) (PP-LOC (IN on) (NP (NP (DT the) (NN sclera)) (PP-LOC (IN near) (NP (DT the) (NN limbus))))))) (VP (VBD served) (PP (IN as) (NP (NN reference) (NNS electrodes)))) (. .)) )
( (S (NP-SBJ-1 (DT A) (NN ground) (NN wire)) (VP (VBD was) (VP (VBN attached) (NP-1 (-NONE- *)) (PP (IN to) (NP (DT the) (NN ear))))) (. .)) )
( (S (NP-SBJ-1 (JJ Scotopic) (NNS responses)) (VP (VBD were) (VP (VP (VBN recorded) (NP-1 (-NONE- *)) (PP-TMP (PP (IN from) (NP (NN threshold))) (PP (IN to) (NP (NP (CD 9) (NN log) (NNS units)) (PP (IN of) (NP (NN intensity))) (PP (IN above) (NP (NN threshold))))))) (, ,) (VP (VBN amplified) (NP-1 (-NONE- *))) (, ,) (CC and) (VP (VBN filtered) (NP-1 (-NONE- *)) (PRN (-LRB- -LRB-) (NP (CD 5,000) (NN gain)) (, ,) (NP (QP (CD 0.1) (SYM –) (CD 1,000)) (NN Hz)) (-RRB- -RRB-))))) (. .)) )
( (S (PP-PRP (IN For) (NP (JJ photopic) (NNS recordings))) (NP-SBJ-1 (NP (NN background) (NN light)) (PP (IN at) (NP (NP (CD 34) (NNS cd)) (PP (SYM /) (NP (NN m2)))))) (VP (VBD was) (VP (VBN used) (NP-1 (-NONE- *)) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB suppress) (NP (NN rod) (NN function))))))) (. .)) )
( (HEADING (NP (VBG Supporting) (NN Information))) )
( (HEADING (NP (NN Figure) (NN S1))) )
( (HEADING (NP (NP (NML (NNP Western) (NN Blot)) (NN Analysis)) (PP (IN of) (NP (NP (DT the) (NN Association)) (PP (IN of) (NP (NP (NN LD)) (PP (IN of) (NP (NN RanBP2))))) (PP (IN with) (NP (NN HKI) (CC and) (NN Cox11))) (PP (IN across) (NP (NNS Tissues))))))) )
( (CAPTION (S (S (NP-SBJ-1 (NN GST) (HYPH -) (NN JX2) (PRN (-LRB- -LRB-) (NP (CD 2.2) (NNS μM)) (-RRB- -RRB-))) (VP (VBD was) (VP (VBN incubated) (NP-1 (-NONE- *)) (PP-MNR (IN with) (NP (JJ different) (NN tissue) (NNS extracts))) (PRN (-LRB- -LRB-) (NP (QP (SYM ~) (CD 2.0)) (NNS mg)) (-RRB- -RRB-))))) (CC and) (S (NP-SBJ-2 (NP (DT the) (NML (NN GST) (HYPH -) (NN JX2)) (VBZ coprecipitates)) (PP (IN from) (NP (CD seven) (JJ different) (NNS tissues)))) (VP (VBD were) (VP (VBN analyzed) (NP-2 (-NONE- *)) (PP-MNR (IN by) (NP (NNP Western) (NN blot))) (PP-MNR (IN with) (NP (NP (DT the) (NNS antibodies)) (PP (IN against) (NP (NN HKI) (CC and) (NN Cox11)))))))) (. .))) )
( (CAPTION (NP (NP (NP (DT The) (NN LD)) (PP (IN of) (NP (NN RanBP2)))) (VP (VBN associated) (NP (-NONE- *)) (PP (IN with) (NP (DT the) (NML (NN HKI) (CC and) (NN Cox11)))) (PP-LOC (IN in) (NP (NP (DT all) (CD seven) (NNS tissues)) (VP (VBN tested) (NP (-NONE- *)))))) (. .))) )
( (CAPTION (NP (-LRB- -LRB-) (NML (CD 59) (NN KB)) (NN PDF) (-RRB- -RRB-))) )
( (CAPTION (S-IMP (NP-SBJ (-NONE- *PRO*)) (VP (VB Click) (ADVP-LOC (RB here)) (PP-PRP (IN for) (NP (JJ additional) (NNS data) (NN file))) (. .)))) )
( (HEADING (NP (NN Figure) (NN S2))) )
( (HEADING (NP (NP (NN Immunostaining)) (PP (IN of) (NP (NP (NN Radial) (NNS Cryosections)) (PP (IN of) (NP (NP (NML (NML (NML (NML (JJ Wild) (HYPH -) (NN Type)) (-LRB- -LRB-) (NML (SYM +) (HYPH /) (SYM +))) (-RRB- -RRB-) (CC and) (NML (NML (NN Heterozygote)) (-LRB- -LRB-) (NML (SYM +) (HYPH /) (SYM −)))) (-RRB- -RRB-) (NN RanBP2) (NNS Mice)) (NNS Retinas)) (PP (IN with) (NP (UCP (JJ Anti-HKI) (CC and) (HYPH −) (NN Cox11)) (NNS Antibodies))))))))) )
( (CAPTION (S (NP-SBJ (NN A1) (CC and) (NN B1)) (VP (VBP represent) (NP (NP (NNS magnifications)) (PP (IN of) (NP (NP (NP (RB just) (DT the) (JJ distal) (NN section)) (PP (IN of) (NP (DT the) (NN retina)))) (-LRB- -LRB-) (NP (NP (JJ inner) (NN segment) (JJ subcellular) (NN compartment)) (PP (IN of) (NP (DT the) (NML (JJ photosensory) (NN neuron)) (NN layer)))))))) (-RRB- -RRB-) (. .))) )
( (CAPTION (S-IMP (NP-SBJ (-NONE- *PRO*)) (VP (VB Note) (NP (NP (NP (DT the) (JJ partial) (NN delocalization)) (PP (IN of) (NP (NN HKI))) (PP (IN to) (NP (NP (DT the) (JJ myoid) (NN subcompartment)) (PP (IN of) (NP (NP (DT the) (JJ inner) (NN segment)) (PP (IN of) (NP (NN photoreceptor) (NNS neurons))) (PP-LOC (IN in) (NP (NML (SYM +) (HYPH /) (SYM −)) (NNS mice))) (PRN (-LRB- -LRB-) (NP (NN B1)) (-RRB- -RRB-))))))) (CC and) (NP (NP (VBN decreased) (NNS levels)) (PP (IN of) (NP (NN HKI))) (PP-LOC (IN in) (NP (NP (DT the) (NML (JJ inner) (NN plexiform)) (-LRB- -LRB-) (JJ synaptic) (-RRB- -RRB-) (NN layer)) (PP (IN of) (NP (DT the) (NN retina))) (PRN (-LRB- -LRB-) (NP (NN A) (CC and) (NN B)) (-RRB- -RRB-))))))) (. .))) )
( (CAPTION (S (NP-SBJ-1 (DT This)) (VP (VBZ is) (VP (VBN reflected) (NP-1 (-NONE- *)) (PP-MNR (IN by) (NP (NP (DT a) (JJ significant) (NML (NN increase) (CC and) (NN decrease))) (PP (IN of) (NP (NP (DT the) (JJ mean) (NN fluorescence) (NN intensity)) (-LRB- -LRB-) (PP (IN in) (NP (JJ arbitrary) (NNS units))) (-RRB- -RRB-) (PP (IN of) (NP (NN HKI))))) (PP-LOC (IN in) (NP (DT the) (NML (NML (JJ myoid)) (CC and) (NML (JJ inner) (JJ plexiform))) (-LRB- -LRB-) (JJ synaptic) (-RRB- -RRB-) (NNS layers))) (, ,) (ADVP (RB respectively)))) (PRN (-LRB- -LRB-) (NP (NN E)) (-RRB- -RRB-)))) (. .))) )
( (CAPTION (FRAG (NP (NP (NP (NN AU)) (, ,) (NP (JJ arbitrary) (NN unit))) (: ;) (NP (NP (NN ROS)) (, ,) (NP (NN rod) (JJ outer) (NN segment))) (: ;) (NP (NP (NN RIS)) (, ,) (NP (NN rod) (JJ inner) (NN segment))) (: ;) (NP (NP (NN ONL)) (, ,) (NP (JJ outer) (JJ nuclear) (NN layer))) (: ;) (NP (NP (NN OPL)) (, ,) (NP (JJ outer) (JJ plexiform) (NN layer))) (, ,) (NP (NP (NN INL)) (, ,) (NP (JJ inner) (JJ nuclear) (NN layer))) (: ;) (NP (NP (NN IPL)) (, ,) (NP (JJ inner) (JJ plexiform) (NN layer))) (: ;) (NP (NP (NN GCL)) (, ,) (NP (NN ganglion) (NN cell) (NN layer)))) (: ;) (S (NP-SBJ (NN E) (CC and) (NN M)) (VP (VBP are) (, ,) (ADVP (RB respectively)) (, ,) (NP-PRD (NP (NP (DT the) (JJ ellipsoid) (-LRB- -LRB-) (ADJP (NNS mitochondria) (HYPH -) (JJ rich)) (NML-1 (-NONE- *RNR*))) (-RRB- -RRB-) (CC and) (NP (JJ myoid) (NML-1 (-NONE- *RNR*))) (NML-1 (NNS compartments))) (PP (IN of) (NP (JJ photosensory) (NNS neurons)))))) (. .))) )
( (CAPTION (NP (-LRB- -LRB-) (NML (CD 476) (NN KB)) (NN PDF) (-RRB- -RRB-))) )
( (CAPTION (S-IMP (NP-SBJ (-NONE- *PRO*)) (VP (VB Click) (ADVP-LOC (RB here)) (PP-PRP (IN for) (NP (JJ additional) (NNS data) (NN file)))) (. .))) )
( (HEADING (NP (NN Figure) (NN S3))) )
( (HEADING (NP (NP (JJ Metabolic) (NN Phenotype)) (PP (IN of) (NP (NP (NML (NN RanBP2) (SYM +) (HYPH /) (SYM −)) (NNS Mice)) (PP-LOC (IN in) (NP (NP (DT a) (JJ Mixed) (NN Background)) (CC and) (NP (NML (JJ High) (HYPH -) (NN Fat)) (NN Diet)))))))) )
( (CAPTION (S (NP-SBJ (EX There)) (VP (VBD was) (NP-PRD (NP (DT no) (NN difference)) (PP (IN in) (NP (DT the) (NML (NN glucose) (NN tolerance)) (NN test))) (PP (IN between) (NP (NP (NML (NML (NN RanBP2) (SYM +) (HYPH /) (SYM +)) (CC and) (NML (NN RanBP2) (SYM +) (HYPH /) (SYM −))) (NNS mice)) (PP (IN on) (NP (DT a) (JJ mixed) (NML (NN 129Ola) (HYPH /) (NN C57Bl6)) (JJ genetic) (NN background))) (PRN (-LRB- -LRB-) (NP (NN C)) (-RRB- -RRB-)))))) (. .))) )
( (CAPTION (NP (-LRB- -LRB-) (NML (CD 38) (NN KB)) (NN PDF) (-RRB- -RRB-))) )
( (CAPTION (S-IMP (NP-SBJ (-NONE- *PRO*)) (VP (VB Click) (ADVP-LOC (RB here)) (PP-PRP (IN for) (NP (JJ additional) (NNS data) (NN file))) (. .)))) )
( (HEADING (NP (NNS Acknowledgements))) )
( (S (NP-SBJ (PRP We)) (VP (VP (VBP thank) (NP=2 (NNP John) (NNP Wilson)) (PP-PRP=1 (IN for) (NP (NP (VBN purified) (NN HKI)) (, ,) (NP (NP (NNS antibodies)) (PP (IN against) (NP (NN HKI) (, ,) (NN HKII) (, ,) (NN HKIII) (, ,) (CC and) (NN glucokinase)))) (, ,) (CC and) (NP (NN support))))) (: ;) (VP (NP=2 (NNP Arthur) (NNP Haas)) (PP-PRP=1 (IN for) (NP (NP (NN help)) (PP (IN with) (NP (NP (JJ kinetic) (NN analysis)) (PP (IN of) (NP (NN HKI)))))))) (: ;) (CC and) (VP (NP=2 (NNP William) (NNP Skarnes)) (PP-PRP=1 (IN for) (NP (NP (JJ helpful) (NNS suggestions)) (PP (IN with) (NP (NP (DT the) (NN analysis)) (PP (IN of) (NP (NN ES) (NN insertion) (NN trap) (NNS lines))))))))) (. .)) )
( (HEADING (NP (NNS Abbreviations))) )
( (NP (NP (NN CLD)) (: -) (NP (ADJP (JJ cyclophilin) (HYPH -) (JJ like)) (NN domain))) )
( (NP (NP (NN CNS)) (: -) (NP (JJ central) (JJ nervous) (NN system))) )
( (NP (NP (NN GST)) (: -) (NP (NN glutathione) (HYPH -) (NN S) (HYPH -) (NN transferase))) )
( (NP (NP (NN HKI)) (: -) (NP (NN hexokinase) (NN type) (CD I))) )
( (NP (NP (NN LD)) (: -) (NP (ADJP (NN leucine) (HYPH -) (JJ rich)) (NN domain))) )
( (NP (NP (NN NPC)) (: -) (NP (JJ nuclear) (NN pore) (NN complex))) )
( (NP (NP (NN RanBP2)) (: -) (NP (ADJP (NN Ran) (HYPH -) (VBG binding)) (NN protein) (CD 2))) )
( (HEADING (NP (NNS Footnotes))) )
( (FRAG (SYM ¤) (NP (JJ Current) (NN address)) (: :) (NP (NP (NNP Fugent) (NNP LLC)) (, ,) (NP-LOC (NNP Madison)) (, ,) (NP-LOC (NNP Wisconsin)) (, ,) (NP-LOC (NP (NNP United) (NNP States)) (PP (IN of) (NP (NNP America)))))) )
( (HEADING (NP (VBG Competing) (NNS interests) (. .))) )
( (S (NP-SBJ (DT The) (NNS authors)) (VP (VBP have) (VP (VBN declared) (SBAR (IN that) (S (NP-SBJ (DT no) (VBG competing) (NNS interests)) (VP (VBP exist)))))) (. .)) )
( (S (NP-SBJ (NP (DT A) (JJ previous) (NN version)) (PP (IN of) (NP (DT this) (NN article)))) (VP (VBD appeared) (PP (IN as) (NP (DT an) (JJ Early) (NN Online) (NN Release))) (PP-TMP (IN on) (NP (NP (NNP September) (CD 1)) (, ,) (NP-TMP (CD 2006)))) (PRN (-LRB- -LRB-) (NN DOI) (: :) (NN 10.1371/journal.pgen.0020177.eor) (-RRB- -RRB-))) (. .)) )
( (HEADING (NP (NN Author) (NNS contributions) (. .))) )
( (S (NP-SBJ (NNP AA) (, ,) (NNP RB) (, ,) (NNP MG) (, ,) (NNP DR) (, ,) (NNP RAB) (, ,) (CC and) (NNP PAF)) (VP (VBD conceived) (CC and) (VBD designed) (NP (DT the) (NNS experiments))) (. .)) )
( (S (NP-SBJ (NNP AA) (, ,) (NNP RB) (, ,) (NNP MG) (, ,) (NNP JO) (, ,) (NNP DR) (, ,) (NNP XL) (, ,) (CC and) (NNP CBB)) (VP (VBD performed) (NP (DT the) (NNS experiments))) (. .)) )
( (S (NP-SBJ (NNP AA) (, ,) (NNP RB) (, ,) (NNP MG) (, ,) (NNP JO) (, ,) (NNP DR) (, ,) (NNP RAB) (, ,) (NNP PAS) (, ,) (CC and) (NNP PAF)) (VP (VBD analyzed) (NP (DT the) (NNS data))) (. .)) )
( (S (NP-SBJ (NNP PAF)) (VP (VBD contributed) (NP (NP (NNS reagents)) (HYPH /) (NP (NNS materials)) (HYPH /) (NP (NN analysis) (NNS tools)))) (. .)) )
( (S (NP-SBJ (NNP PAF)) (VP (VBD wrote) (NP (DT the) (NN paper))) (. .)) )
( (HEADING (NP (NN Funding) (. .))) )
( (S (NP-SBJ-1 (NN Work)) (VP (VBN supported) (NP-1 (-NONE- *)) (PP (IN by) (NP-LGS (NP (NP (NML (NML (DT The) (NNP National) (NNPS Institutes)) (PP (IN of) (NP (NNP Health)))) (NML (NN EY11993) (HYPH /) (NN EY012665))) (PP (IN to) (NP (NNP PAF)))) (CC and) (NP (NML (NML (DT The) (NNP National) (NNPS Institutes)) (PP (IN of) (NP (NNP Health)))) (NN 2P30) (HYPH -) (NN EY005722) (HYPH –) (NNP 21))))) (. .)) )
( (S (NP-SBJ (NNP PAF)) (VP (VBZ is) (NP-PRD (DT the) (NML (NML (NNP Jules) (CC and) (NNP Doris)) (NNP Stein)) (NML (NML (NN Research)) (SBAR (WHNP-1 (-NONE- *0*)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (TO to) (VP (VB Prevent) (NP (NN Blindness))))))) (NN Professor))) (. .)) )
